EP4117432A2 - Fungicidal halomethyl ketones and hydrates and their mixtures - Google Patents
Fungicidal halomethyl ketones and hydrates and their mixturesInfo
- Publication number
- EP4117432A2 EP4117432A2 EP21766969.6A EP21766969A EP4117432A2 EP 4117432 A2 EP4117432 A2 EP 4117432A2 EP 21766969 A EP21766969 A EP 21766969A EP 4117432 A2 EP4117432 A2 EP 4117432A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- fungicides
- methyl
- independently
- composition
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 575
- 230000000855 fungicidal effect Effects 0.000 title claims abstract description 58
- -1 halomethyl ketones Chemical class 0.000 title claims description 238
- 150000004677 hydrates Chemical class 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 353
- 238000000034 method Methods 0.000 claims abstract description 75
- 201000010099 disease Diseases 0.000 claims abstract description 39
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 39
- 150000003839 salts Chemical class 0.000 claims abstract description 34
- 241000607479 Yersinia pestis Species 0.000 claims abstract description 5
- 239000000417 fungicide Substances 0.000 claims description 350
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 235
- 125000000217 alkyl group Chemical group 0.000 claims description 186
- 125000001424 substituent group Chemical group 0.000 claims description 186
- 229910052736 halogen Inorganic materials 0.000 claims description 115
- 150000002367 halogens Chemical class 0.000 claims description 115
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 95
- 125000003545 alkoxy group Chemical group 0.000 claims description 87
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 87
- 125000001188 haloalkyl group Chemical group 0.000 claims description 80
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 78
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 78
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 71
- 125000004432 carbon atom Chemical group C* 0.000 claims description 70
- 229910052799 carbon Inorganic materials 0.000 claims description 61
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 56
- 125000004429 atom Chemical group 0.000 claims description 54
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 52
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 50
- 229910052760 oxygen Inorganic materials 0.000 claims description 45
- 239000003112 inhibitor Substances 0.000 claims description 43
- 229910052717 sulfur Inorganic materials 0.000 claims description 39
- 229920006395 saturated elastomer Polymers 0.000 claims description 36
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 35
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 34
- 125000005842 heteroatom Chemical group 0.000 claims description 33
- 125000000623 heterocyclic group Chemical group 0.000 claims description 31
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 31
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 30
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 28
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 27
- 125000004414 alkyl thio group Chemical group 0.000 claims description 25
- 229910052739 hydrogen Inorganic materials 0.000 claims description 25
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 24
- 125000005225 alkynyloxycarbonyl group Chemical group 0.000 claims description 24
- 125000004692 haloalkylcarbonyl group Chemical group 0.000 claims description 24
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 claims description 24
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 claims description 23
- 125000004122 cyclic group Chemical group 0.000 claims description 23
- 239000007787 solid Substances 0.000 claims description 23
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 22
- 230000009471 action Effects 0.000 claims description 22
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 22
- 230000015572 biosynthetic process Effects 0.000 claims description 22
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 22
- 229910052757 nitrogen Inorganic materials 0.000 claims description 22
- 125000003342 alkenyl group Chemical group 0.000 claims description 21
- 229910052801 chlorine Inorganic materials 0.000 claims description 21
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 21
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims description 20
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 20
- 125000003282 alkyl amino group Chemical group 0.000 claims description 20
- 125000000304 alkynyl group Chemical group 0.000 claims description 20
- 229910052731 fluorine Inorganic materials 0.000 claims description 20
- 230000008099 melanin synthesis Effects 0.000 claims description 20
- 230000003115 biocidal effect Effects 0.000 claims description 17
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 17
- 125000000262 haloalkenyl group Chemical group 0.000 claims description 17
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 17
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 16
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims description 15
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 15
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 15
- ZMYFCFLJBGAQRS-IRXDYDNUSA-N (2R,3S)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@@]1(CN2N=CN=C2)[C@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IRXDYDNUSA-N 0.000 claims description 14
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 claims description 14
- 239000005757 Cyproconazole Substances 0.000 claims description 14
- 239000005767 Epoxiconazole Substances 0.000 claims description 14
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 claims description 14
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 claims description 14
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 claims description 13
- MNHVNIJQQRJYDH-UHFFFAOYSA-N 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound N1=CNC(=S)N1CC(C1(Cl)CC1)(O)CC1=CC=CC=C1Cl MNHVNIJQQRJYDH-UHFFFAOYSA-N 0.000 claims description 13
- 239000005730 Azoxystrobin Substances 0.000 claims description 13
- 239000005818 Picoxystrobin Substances 0.000 claims description 13
- 239000005825 Prothioconazole Substances 0.000 claims description 13
- 239000005869 Pyraclostrobin Substances 0.000 claims description 13
- 239000005839 Tebuconazole Substances 0.000 claims description 13
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 claims description 13
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims description 13
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 13
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 claims description 13
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 claims description 13
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 13
- IBSNKSODLGJUMQ-SDNWHVSQSA-N picoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC(C(F)(F)F)=N1 IBSNKSODLGJUMQ-SDNWHVSQSA-N 0.000 claims description 13
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 claims description 13
- JWUCHKBSVLQQCO-UHFFFAOYSA-N 1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol Chemical compound C=1C=C(F)C=CC=1C(C=1C(=CC=CC=1)F)(O)CN1C=NC=N1 JWUCHKBSVLQQCO-UHFFFAOYSA-N 0.000 claims description 12
- 239000005787 Flutriafol Substances 0.000 claims description 12
- 239000005788 Fluxapyroxad Substances 0.000 claims description 12
- 239000005857 Trifloxystrobin Substances 0.000 claims description 12
- 125000005108 alkenylthio group Chemical group 0.000 claims description 12
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims description 12
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 12
- 125000005109 alkynylthio group Chemical group 0.000 claims description 12
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 12
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 12
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 12
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 12
- SXSGXWCSHSVPGB-UHFFFAOYSA-N fluxapyroxad Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C(F)=C1 SXSGXWCSHSVPGB-UHFFFAOYSA-N 0.000 claims description 12
- 125000000232 haloalkynyl group Chemical group 0.000 claims description 12
- 125000001072 heteroaryl group Chemical group 0.000 claims description 12
- 125000002883 imidazolyl group Chemical group 0.000 claims description 12
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 12
- ONCZDRURRATYFI-TVJDWZFNSA-N trifloxystrobin Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-TVJDWZFNSA-N 0.000 claims description 12
- XCGBHLLWJZOLEM-UHFFFAOYSA-N 3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide Chemical compound CC1CC(C)(C)C(C(=CC=2)F)=C1C=2NC(=O)C1=CN(C)N=C1C(F)F XCGBHLLWJZOLEM-UHFFFAOYSA-N 0.000 claims description 11
- 239000005737 Benzovindiflupyr Substances 0.000 claims description 11
- 239000005738 Bixafen Substances 0.000 claims description 11
- CCCGEKHKTPTUHJ-UHFFFAOYSA-N N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC2=C1C1CCC2C1=C(Cl)Cl CCCGEKHKTPTUHJ-UHFFFAOYSA-N 0.000 claims description 11
- 150000001412 amines Chemical class 0.000 claims description 11
- LDLMOOXUCMHBMZ-UHFFFAOYSA-N bixafen Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C(Cl)=C1 LDLMOOXUCMHBMZ-UHFFFAOYSA-N 0.000 claims description 11
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 11
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 11
- 125000005347 halocycloalkyl group Chemical group 0.000 claims description 11
- YLZGKZDEFJIHIJ-UHFFFAOYSA-N (1-methylbenzimidazol-2-yl) carbamate Chemical compound C1=CC=C2N(C)C(OC(N)=O)=NC2=C1 YLZGKZDEFJIHIJ-UHFFFAOYSA-N 0.000 claims description 10
- 125000002947 alkylene group Chemical group 0.000 claims description 10
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 claims description 10
- 239000003085 diluting agent Substances 0.000 claims description 10
- RYAUSSKQMZRMAI-ALOPSCKCSA-N (2S,6R)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1C[C@H](C)O[C@H](C)C1 RYAUSSKQMZRMAI-ALOPSCKCSA-N 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 239000005760 Difenoconazole Substances 0.000 claims description 9
- 239000005778 Fenpropimorph Substances 0.000 claims description 9
- 125000005195 alkyl amino carbonyloxy group Chemical group 0.000 claims description 9
- 229910052794 bromium Inorganic materials 0.000 claims description 9
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 9
- 238000010520 demethylation reaction Methods 0.000 claims description 9
- 125000005640 glucopyranosyl group Chemical group 0.000 claims description 9
- 125000004076 pyridyl group Chemical group 0.000 claims description 9
- 230000014616 translation Effects 0.000 claims description 9
- LUBJCRLGQSPQNN-UHFFFAOYSA-N 1-Phenylurea Chemical compound NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 claims description 8
- MGNFYQILYYYUBS-UHFFFAOYSA-N 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1CCCCC1 MGNFYQILYYYUBS-UHFFFAOYSA-N 0.000 claims description 8
- DGOAXBPOVUPPEB-UHFFFAOYSA-N 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-(2,4,6-trichlorophenyl)propan-2-yl]pyrazole-4-carboxamide Chemical compound C=1N(C)N=C(C(F)F)C=1C(=O)N(OC)C(C)CC1=C(Cl)C=C(Cl)C=C1Cl DGOAXBPOVUPPEB-UHFFFAOYSA-N 0.000 claims description 8
- 239000005747 Chlorothalonil Substances 0.000 claims description 8
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 claims description 8
- 239000005750 Copper hydroxide Substances 0.000 claims description 8
- 239000005777 Fenpropidin Substances 0.000 claims description 8
- 102000019259 Succinate Dehydrogenase Human genes 0.000 claims description 8
- 108010012901 Succinate Dehydrogenase Proteins 0.000 claims description 8
- 125000006323 alkenyl amino group Chemical group 0.000 claims description 8
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 claims description 8
- 125000006319 alkynyl amino group Chemical group 0.000 claims description 8
- 125000005095 alkynylaminocarbonyl group Chemical group 0.000 claims description 8
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 claims description 8
- 229910001956 copper hydroxide Inorganic materials 0.000 claims description 8
- 230000017858 demethylation Effects 0.000 claims description 8
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 8
- 125000004970 halomethyl group Chemical group 0.000 claims description 8
- HIIRDDUVRXCDBN-OBGWFSINSA-N metominostrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1OC1=CC=CC=C1 HIIRDDUVRXCDBN-OBGWFSINSA-N 0.000 claims description 8
- 125000001425 triazolyl group Chemical group 0.000 claims description 8
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 7
- QWEWLLNSJDTOKH-UHFFFAOYSA-N 1,3-thiazole-2-carboxamide Chemical compound NC(=O)C1=NC=CS1 QWEWLLNSJDTOKH-UHFFFAOYSA-N 0.000 claims description 7
- IRTLROCMFSDSNF-UHFFFAOYSA-N 2-phenyl-1h-pyrrole Chemical compound C1=CNC(C=2C=CC=CC=2)=C1 IRTLROCMFSDSNF-UHFFFAOYSA-N 0.000 claims description 7
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 7
- 229940124186 Dehydrogenase inhibitor Drugs 0.000 claims description 7
- 229930182764 Polyoxin Natural products 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 125000005089 alkenylaminocarbonyl group Chemical group 0.000 claims description 7
- 125000005090 alkenylcarbonyl group Chemical group 0.000 claims description 7
- 125000000278 alkyl amino alkyl group Chemical group 0.000 claims description 7
- 125000004949 alkyl amino carbonyl amino group Chemical group 0.000 claims description 7
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 claims description 7
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims description 7
- 125000005087 alkynylcarbonyl group Chemical group 0.000 claims description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- 230000000813 microbial effect Effects 0.000 claims description 7
- XGXNTJHZPBRBHJ-UHFFFAOYSA-N n-phenylpyrimidin-2-amine Chemical compound N=1C=CC=NC=1NC1=CC=CC=C1 XGXNTJHZPBRBHJ-UHFFFAOYSA-N 0.000 claims description 7
- 239000000419 plant extract Substances 0.000 claims description 7
- YEBIHIICWDDQOL-YBHNRIQQSA-N polyoxin Polymers O[C@@H]1[C@H](O)[C@@H](C(C=O)N)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 YEBIHIICWDDQOL-YBHNRIQQSA-N 0.000 claims description 7
- 125000004665 trialkylsilyl group Chemical group 0.000 claims description 7
- 125000006569 (C5-C6) heterocyclic group Chemical group 0.000 claims description 6
- PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 claims description 6
- XTDZGXBTXBEZDN-UHFFFAOYSA-N 3-(difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methylpyrazole-4-carboxamide Chemical compound CC(C)C1C2CCC1C1=C2C=CC=C1NC(=O)C1=CN(C)N=C1C(F)F XTDZGXBTXBEZDN-UHFFFAOYSA-N 0.000 claims description 6
- 239000005740 Boscalid Substances 0.000 claims description 6
- 239000005799 Isopyrazam Substances 0.000 claims description 6
- 239000005800 Kresoxim-methyl Substances 0.000 claims description 6
- 101001110310 Lentilactobacillus kefiri NADP-dependent (R)-specific alcohol dehydrogenase Proteins 0.000 claims description 6
- 239000005868 Metconazole Substances 0.000 claims description 6
- 239000005816 Penthiopyrad Substances 0.000 claims description 6
- 239000005824 Proquinazid Substances 0.000 claims description 6
- 239000005831 Quinoxyfen Substances 0.000 claims description 6
- 229940123934 Reductase inhibitor Drugs 0.000 claims description 6
- GNVMUORYQLCPJZ-UHFFFAOYSA-M Thiocarbamate Chemical compound NC([S-])=O GNVMUORYQLCPJZ-UHFFFAOYSA-M 0.000 claims description 6
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 claims description 6
- 125000004688 alkyl sulfonyl alkyl group Chemical group 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- 125000002393 azetidinyl group Chemical group 0.000 claims description 6
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 claims description 6
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 6
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 6
- 230000007123 defense Effects 0.000 claims description 6
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims description 6
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 claims description 6
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 6
- 244000053095 fungal pathogen Species 0.000 claims description 6
- 125000004994 halo alkoxy alkyl group Chemical group 0.000 claims description 6
- RONFGUROBZGJKP-UHFFFAOYSA-N iminoctadine Chemical compound NC(N)=NCCCCCCCCNCCCCCCCCN=C(N)N RONFGUROBZGJKP-UHFFFAOYSA-N 0.000 claims description 6
- 230000006698 induction Effects 0.000 claims description 6
- ZOTBXTZVPHCKPN-HTXNQAPBSA-N kresoxim-methyl Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC=C1C ZOTBXTZVPHCKPN-HTXNQAPBSA-N 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 claims description 6
- 125000002757 morpholinyl group Chemical group 0.000 claims description 6
- 230000010627 oxidative phosphorylation Effects 0.000 claims description 6
- 150000003904 phospholipids Chemical class 0.000 claims description 6
- 125000004193 piperazinyl group Chemical group 0.000 claims description 6
- 125000003386 piperidinyl group Chemical group 0.000 claims description 6
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 6
- FLVBXVXXXMLMOX-UHFFFAOYSA-N proquinazid Chemical compound C1=C(I)C=C2C(=O)N(CCC)C(OCCC)=NC2=C1 FLVBXVXXXMLMOX-UHFFFAOYSA-N 0.000 claims description 6
- 238000001243 protein synthesis Methods 0.000 claims description 6
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 6
- QJBZDBLBQWFTPZ-UHFFFAOYSA-N pyrrolnitrin Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C1=CNC=C1Cl QJBZDBLBQWFTPZ-UHFFFAOYSA-N 0.000 claims description 6
- WRPIRSINYZBGPK-UHFFFAOYSA-N quinoxyfen Chemical compound C1=CC(F)=CC=C1OC1=CC=NC2=CC(Cl)=CC(Cl)=C12 WRPIRSINYZBGPK-UHFFFAOYSA-N 0.000 claims description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 6
- PPDBOQMNKNNODG-NTEUORMPSA-N (5E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentanol Chemical compound C1=NC=NN1CC1(O)C(C)(C)CC\C1=C/C1=CC=C(Cl)C=C1 PPDBOQMNKNNODG-NTEUORMPSA-N 0.000 claims description 5
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 claims description 5
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 claims description 5
- PCCSBWNGDMYFCW-UHFFFAOYSA-N 5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-1,3-oxazolidine-2,4-dione Chemical compound O=C1C(C)(C=2C=CC(OC=3C=CC=CC=3)=CC=2)OC(=O)N1NC1=CC=CC=C1 PCCSBWNGDMYFCW-UHFFFAOYSA-N 0.000 claims description 5
- 229920001651 Cyanoacrylate Polymers 0.000 claims description 5
- 239000005755 Cyflufenamid Substances 0.000 claims description 5
- 239000005762 Dimoxystrobin Substances 0.000 claims description 5
- 239000005772 Famoxadone Substances 0.000 claims description 5
- 239000005797 Iprovalicarb Substances 0.000 claims description 5
- NWUWYYSKZYIQAE-ZBFHGGJFSA-N L-(R)-iprovalicarb Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C1=CC=C(C)C=C1 NWUWYYSKZYIQAE-ZBFHGGJFSA-N 0.000 claims description 5
- 239000005810 Metrafenone Substances 0.000 claims description 5
- 239000005811 Myclobutanil Substances 0.000 claims description 5
- 239000005822 Propiconazole Substances 0.000 claims description 5
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 5
- 239000005829 Pyriofenone Substances 0.000 claims description 5
- 229940123185 Squalene epoxidase inhibitor Drugs 0.000 claims description 5
- 229930190931 Stigmatellin Natural products 0.000 claims description 5
- UZHDGDDPOPDJGM-UHFFFAOYSA-N Stigmatellin A Natural products COC1=CC(OC)=C2C(=O)C(C)=C(CCC(C)C(OC)C(C)C(C=CC=CC(C)=CC)OC)OC2=C1O UZHDGDDPOPDJGM-UHFFFAOYSA-N 0.000 claims description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 5
- 239000005859 Triticonazole Substances 0.000 claims description 5
- 239000005860 Valifenalate Substances 0.000 claims description 5
- 125000004450 alkenylene group Chemical group 0.000 claims description 5
- 125000005136 alkenylsulfinyl group Chemical group 0.000 claims description 5
- 125000005083 alkoxyalkoxy group Chemical group 0.000 claims description 5
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 claims description 5
- 125000004687 alkyl sulfinyl alkyl group Chemical group 0.000 claims description 5
- 125000004419 alkynylene group Chemical group 0.000 claims description 5
- 125000005134 alkynylsulfinyl group Chemical group 0.000 claims description 5
- 229940118790 boscalid Drugs 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 125000004966 cyanoalkyl group Chemical group 0.000 claims description 5
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims description 5
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 5
- ACMXQHFNODYQAT-UHFFFAOYSA-N cyflufenamid Chemical compound FC1=CC=C(C(F)(F)F)C(C(NOCC2CC2)=NC(=O)CC=2C=CC=CC=2)=C1F ACMXQHFNODYQAT-UHFFFAOYSA-N 0.000 claims description 5
- WXUZAHCNPWONDH-DYTRJAOYSA-N dimoxystrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1COC1=CC(C)=CC=C1C WXUZAHCNPWONDH-DYTRJAOYSA-N 0.000 claims description 5
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 claims description 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 5
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 5
- WPOOICLZIIBUBM-UHFFFAOYSA-H iron;iron(3+);methyl-dioxido-oxo-$l^{5}-arsane Chemical compound [Fe].[Fe+3].[Fe+3].C[As]([O-])([O-])=O.C[As]([O-])([O-])=O.C[As]([O-])([O-])=O WPOOICLZIIBUBM-UHFFFAOYSA-H 0.000 claims description 5
- ZQEIXNIJLIKNTD-GFCCVEGCSA-N metalaxyl-M Chemical compound COCC(=O)N([C@H](C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-GFCCVEGCSA-N 0.000 claims description 5
- AMSPWOYQQAWRRM-UHFFFAOYSA-N metrafenone Chemical compound COC1=CC=C(Br)C(C)=C1C(=O)C1=C(C)C=C(OC)C(OC)=C1OC AMSPWOYQQAWRRM-UHFFFAOYSA-N 0.000 claims description 5
- 102000044160 oxysterol binding protein Human genes 0.000 claims description 5
- 108010040421 oxysterol binding protein Proteins 0.000 claims description 5
- 238000005502 peroxidation Methods 0.000 claims description 5
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims description 5
- 150000004291 polyenes Chemical class 0.000 claims description 5
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 claims description 5
- DWTVBEZBWMDXIY-UHFFFAOYSA-N pyrametostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=C(C)C(C=2C=CC=CC=2)=NN1C DWTVBEZBWMDXIY-UHFFFAOYSA-N 0.000 claims description 5
- URXNNPCNKVAQRA-XMHGGMMESA-N pyraoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C=2C=CC(Cl)=CC=2)=NN1C URXNNPCNKVAQRA-XMHGGMMESA-N 0.000 claims description 5
- NMVCBWZLCXANER-UHFFFAOYSA-N pyriofenone Chemical compound COC1=C(OC)C(OC)=CC(C)=C1C(=O)C1=C(C)C(Cl)=CN=C1OC NMVCBWZLCXANER-UHFFFAOYSA-N 0.000 claims description 5
- UZHDGDDPOPDJGM-CVOZLMQJSA-N stigmatellin A Chemical compound COC1=CC(OC)=C2C(=O)C(C)=C(CC[C@H](C)[C@H](OC)[C@H](C)[C@H](\C=C\C=C\C(\C)=C\C)OC)OC2=C1O UZHDGDDPOPDJGM-CVOZLMQJSA-N 0.000 claims description 5
- 125000004434 sulfur atom Chemical group 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims description 5
- DBXFMOWZRXXBRN-LWKPJOBUSA-N valifenalate Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)NC(CC(=O)OC)C1=CC=C(Cl)C=C1 DBXFMOWZRXXBRN-LWKPJOBUSA-N 0.000 claims description 5
- 125000006789 (C3-C7) alkenyloxycarbonyl group Chemical group 0.000 claims description 4
- BKBSMMUEEAWFRX-NBVRZTHBSA-N (E)-flumorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(F)=CC=1)=C\C(=O)N1CCOCC1 BKBSMMUEEAWFRX-NBVRZTHBSA-N 0.000 claims description 4
- QNBTYORWCCMPQP-JXAWBTAJSA-N (Z)-dimethomorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(Cl)=CC=1)=C/C(=O)N1CCOCC1 QNBTYORWCCMPQP-JXAWBTAJSA-N 0.000 claims description 4
- GVTLFGJNTIRUEG-ZHACJKMWSA-N (e)-n-(3-methoxyphenyl)-3-phenylprop-2-enamide Chemical compound COC1=CC=CC(NC(=O)\C=C\C=2C=CC=CC=2)=C1 GVTLFGJNTIRUEG-ZHACJKMWSA-N 0.000 claims description 4
- OWQPOVKKUWUEKE-UHFFFAOYSA-N 1,2,3-benzotriazine Chemical compound N1=NN=CC2=CC=CC=C21 OWQPOVKKUWUEKE-UHFFFAOYSA-N 0.000 claims description 4
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 claims description 4
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical compound OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 claims description 4
- STMIIPIFODONDC-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(O)(CCCC)CN1C=NC=N1 STMIIPIFODONDC-UHFFFAOYSA-N 0.000 claims description 4
- KWLVWJPJKJMCSH-UHFFFAOYSA-N 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide Chemical compound C1=C(OCC#C)C(OC)=CC(CCNC(=O)C(OCC#C)C=2C=CC(Cl)=CC=2)=C1 KWLVWJPJKJMCSH-UHFFFAOYSA-N 0.000 claims description 4
- LSBDFXRDZJMBSC-UHFFFAOYSA-N 2-phenylacetamide Chemical compound NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 claims description 4
- YNSCKPCDFIDINW-UHFFFAOYSA-N 3-[[2-[[1-[2-(dimethylamino)acetyl]-6-methoxy-4,4-dimethyl-2,3-dihydroquinolin-7-yl]amino]-7h-pyrrolo[2,3-d]pyrimidin-4-yl]amino]thiophene-2-carboxamide Chemical compound COC1=CC(C(CCN2C(=O)CN(C)C)(C)C)=C2C=C1NC(N=C1NC=CC1=1)=NC=1NC=1C=CSC=1C(N)=O YNSCKPCDFIDINW-UHFFFAOYSA-N 0.000 claims description 4
- RQDJADAKIFFEKQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile Chemical compound C1=CC(Cl)=CC=C1CCC(C=1C=CC=CC=1)(C#N)CN1N=CN=C1 RQDJADAKIFFEKQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000005736 Benthiavalicarb Substances 0.000 claims description 4
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 claims description 4
- 239000005741 Bromuconazole Substances 0.000 claims description 4
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 claims description 4
- 239000005761 Dimethomorph Substances 0.000 claims description 4
- 239000005769 Etridiazole Substances 0.000 claims description 4
- 239000005775 Fenbuconazole Substances 0.000 claims description 4
- 239000005783 Fluopyram Substances 0.000 claims description 4
- 239000005796 Ipconazole Substances 0.000 claims description 4
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical compound C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 claims description 4
- 239000005802 Mancozeb Substances 0.000 claims description 4
- 239000005804 Mandipropamid Substances 0.000 claims description 4
- 239000005807 Metalaxyl Substances 0.000 claims description 4
- 239000005808 Metalaxyl-M Substances 0.000 claims description 4
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 claims description 4
- XQJQCBDIXRIYRP-UHFFFAOYSA-N N-{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1C(C2CC2)C1 XQJQCBDIXRIYRP-UHFFFAOYSA-N 0.000 claims description 4
- 229940122272 Oxidoreductase inhibitor Drugs 0.000 claims description 4
- 239000005813 Penconazole Substances 0.000 claims description 4
- 239000005820 Prochloraz Substances 0.000 claims description 4
- 239000005834 Sedaxane Substances 0.000 claims description 4
- 125000005091 alkenylcarbonylamino group Chemical group 0.000 claims description 4
- 125000005193 alkenylcarbonyloxy group Chemical group 0.000 claims description 4
- 125000005137 alkenylsulfonyl group Chemical group 0.000 claims description 4
- 125000005081 alkoxyalkoxyalkyl group Chemical group 0.000 claims description 4
- 125000005130 alkyl carbonyl thio group Chemical group 0.000 claims description 4
- 125000005120 alkyl cycloalkyl alkyl group Chemical group 0.000 claims description 4
- 125000005088 alkynylcarbonylamino group Chemical group 0.000 claims description 4
- 125000005198 alkynylcarbonyloxy group Chemical group 0.000 claims description 4
- 125000005139 alkynylsulfonyl group Chemical group 0.000 claims description 4
- CJPQIRJHIZUAQP-MRXNPFEDSA-N benalaxyl-M Chemical compound CC=1C=CC=C(C)C=1N([C@H](C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-MRXNPFEDSA-N 0.000 claims description 4
- VVSLYIKSEBPRSN-PELKAZGASA-N benthiavalicarb Chemical compound C1=C(F)C=C2SC([C@@H](C)NC(=O)[C@@H](NC(O)=O)C(C)C)=NC2=C1 VVSLYIKSEBPRSN-PELKAZGASA-N 0.000 claims description 4
- USRKFGIXLGKMKU-ABAIWWIYSA-N benthiavalicarb-isopropyl Chemical compound C1=C(F)C=C2SC([C@@H](C)NC(=O)[C@H](C(C)C)NC(=O)OC(C)C)=NC2=C1 USRKFGIXLGKMKU-ABAIWWIYSA-N 0.000 claims description 4
- 229960000074 biopharmaceutical Drugs 0.000 claims description 4
- HJJVPARKXDDIQD-UHFFFAOYSA-N bromuconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCC(Br)C1 HJJVPARKXDDIQD-UHFFFAOYSA-N 0.000 claims description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 239000006013 carbendazim Substances 0.000 claims description 4
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 claims description 4
- 125000005724 cycloalkenylene group Chemical group 0.000 claims description 4
- 125000004858 cycloalkoxyalkyl group Chemical group 0.000 claims description 4
- 125000005201 cycloalkylcarbonyloxy group Chemical group 0.000 claims description 4
- 125000002993 cycloalkylene group Chemical group 0.000 claims description 4
- VMNULHCTRPXWFJ-UJSVPXBISA-N enoxastrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)\C=C\C1=CC=C(Cl)C=C1 VMNULHCTRPXWFJ-UJSVPXBISA-N 0.000 claims description 4
- KQTVWCSONPJJPE-UHFFFAOYSA-N etridiazole Chemical compound CCOC1=NC(C(Cl)(Cl)Cl)=NS1 KQTVWCSONPJJPE-UHFFFAOYSA-N 0.000 claims description 4
- KVDJTXBXMWJJEF-UHFFFAOYSA-N fluopyram Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CCNC(=O)C1=CC=CC=C1C(F)(F)F KVDJTXBXMWJJEF-UHFFFAOYSA-N 0.000 claims description 4
- 125000004993 haloalkoxycarbonyl group Chemical group 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- QTYCMDBMOLSEAM-UHFFFAOYSA-N ipconazole Chemical compound C1=NC=NN1CC1(O)C(C(C)C)CCC1CC1=CC=C(Cl)C=C1 QTYCMDBMOLSEAM-UHFFFAOYSA-N 0.000 claims description 4
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 claims description 4
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 4
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 4
- 125000002971 oxazolyl group Chemical group 0.000 claims description 4
- 239000002457 oxidoreductase inhibitor Substances 0.000 claims description 4
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 claims description 4
- 229940121649 protein inhibitor Drugs 0.000 claims description 4
- 239000012268 protein inhibitor Substances 0.000 claims description 4
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 claims description 4
- PUYXTUJWRLOUCW-UHFFFAOYSA-N spiroxamine Chemical compound O1C(CN(CC)CCC)COC11CCC(C(C)(C)C)CC1 PUYXTUJWRLOUCW-UHFFFAOYSA-N 0.000 claims description 4
- 229940072172 tetracycline antibiotic Drugs 0.000 claims description 4
- 125000000335 thiazolyl group Chemical group 0.000 claims description 4
- YFNCATAIYKQPOO-UHFFFAOYSA-N thiophanate Chemical compound CCOC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OCC YFNCATAIYKQPOO-UHFFFAOYSA-N 0.000 claims description 4
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 claims description 4
- YNWVFADWVLCOPU-MDWZMJQESA-N (1E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MDWZMJQESA-N 0.000 claims description 3
- XERJKGMBORTKEO-VZUCSPMQSA-N (1e)-2-(ethylcarbamoylamino)-n-methoxy-2-oxoethanimidoyl cyanide Chemical compound CCNC(=O)NC(=O)C(\C#N)=N\OC XERJKGMBORTKEO-VZUCSPMQSA-N 0.000 claims description 3
- NHOWDZOIZKMVAI-UHFFFAOYSA-N (2-chlorophenyl)(4-chlorophenyl)pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(Cl)C=C1 NHOWDZOIZKMVAI-UHFFFAOYSA-N 0.000 claims description 3
- SAPGTCDSBGMXCD-UHFFFAOYSA-N (2-chlorophenyl)-(4-fluorophenyl)-pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(F)C=C1 SAPGTCDSBGMXCD-UHFFFAOYSA-N 0.000 claims description 3
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 claims description 3
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 claims description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 3
- 125000006786 (C3-C7) alkynyloxycarbonyl group Chemical group 0.000 claims description 3
- CKPCAYZTYMHQEX-NBVRZTHBSA-N (e)-1-(2,4-dichlorophenyl)-n-methoxy-2-pyridin-3-ylethanimine Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=N/OC)/CC1=CC=CN=C1 CKPCAYZTYMHQEX-NBVRZTHBSA-N 0.000 claims description 3
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 claims description 3
- VGPIBGGRCVEHQZ-UHFFFAOYSA-N 1-(biphenyl-4-yloxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC(C=C1)=CC=C1C1=CC=CC=C1 VGPIBGGRCVEHQZ-UHFFFAOYSA-N 0.000 claims description 3
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 claims description 3
- PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 PZBPKYOVPCNPJY-UHFFFAOYSA-N 0.000 claims description 3
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical compound CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 claims description 3
- NFTOEHBFQROATQ-UHFFFAOYSA-N 2,3-dihydrofuran-5-carboxylic acid Chemical compound OC(=O)C1=CCCO1 NFTOEHBFQROATQ-UHFFFAOYSA-N 0.000 claims description 3
- NIOPZPCMRQGZCE-WEVVVXLNSA-N 2,4-dinitro-6-(octan-2-yl)phenyl (E)-but-2-enoate Chemical compound CCCCCCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)\C=C\C NIOPZPCMRQGZCE-WEVVVXLNSA-N 0.000 claims description 3
- YTOPFCCWCSOHFV-UHFFFAOYSA-N 2,6-dimethyl-4-tridecylmorpholine Chemical compound CCCCCCCCCCCCCN1CC(C)OC(C)C1 YTOPFCCWCSOHFV-UHFFFAOYSA-N 0.000 claims description 3
- YABFPHSQTSFWQB-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-(1,2,4-triazol-1-yl)-3-(trimethylsilyl)propan-2-ol Chemical compound C=1C=C(F)C=CC=1C(O)(C[Si](C)(C)C)CN1C=NC=N1 YABFPHSQTSFWQB-UHFFFAOYSA-N 0.000 claims description 3
- SIIJJFOXEOHODQ-UHFFFAOYSA-N 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C=1C=C(OC=2C=CC(Cl)=CC=2)C=C(C(F)(F)F)C=1C(O)(C(C)C)CN1C=NC=N1 SIIJJFOXEOHODQ-UHFFFAOYSA-N 0.000 claims description 3
- OWDLFBLNMPCXSD-UHFFFAOYSA-N 2-chloro-N-(2,6-dimethylphenyl)-N-(2-oxotetrahydrofuran-3-yl)acetamide Chemical compound CC1=CC=CC(C)=C1N(C(=O)CCl)C1C(=O)OCC1 OWDLFBLNMPCXSD-UHFFFAOYSA-N 0.000 claims description 3
- FEFZGUWAYDEBHK-UHFFFAOYSA-N 2-cyano-n'-hydroxyethanimidamide Chemical compound ON=C(N)CC#N FEFZGUWAYDEBHK-UHFFFAOYSA-N 0.000 claims description 3
- 229940044120 2-n-octyl-4-isothiazolin-3-one Drugs 0.000 claims description 3
- AVGVFDSUDIUXEU-UHFFFAOYSA-N 2-octyl-1,2-thiazolidin-3-one Chemical compound CCCCCCCCN1SCCC1=O AVGVFDSUDIUXEU-UHFFFAOYSA-N 0.000 claims description 3
- ZRDUSMYWDRPZRM-UHFFFAOYSA-N 2-sec-butyl-4,6-dinitrophenyl 3-methylbut-2-enoate Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)C=C(C)C ZRDUSMYWDRPZRM-UHFFFAOYSA-N 0.000 claims description 3
- SOUGWDPPRBKJEX-UHFFFAOYSA-N 3,5-dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide Chemical compound ClCC(=O)C(C)(CC)NC(=O)C1=CC(Cl)=C(C)C(Cl)=C1 SOUGWDPPRBKJEX-UHFFFAOYSA-N 0.000 claims description 3
- NRAYWXLNSHEHQO-UHFFFAOYSA-N 3-(1-benzothiophen-2-yl)-5,6-dihydro-1,4,2-oxathiazine 4-oxide Chemical compound O=S1CCON=C1C1=CC2=CC=CC=C2S1 NRAYWXLNSHEHQO-UHFFFAOYSA-N 0.000 claims description 3
- BZGLBXYQOMFXAU-UHFFFAOYSA-N 3-(2-methylpiperidin-1-yl)propyl 3,4-dichlorobenzoate Chemical compound CC1CCCCN1CCCOC(=O)C1=CC=C(Cl)C(Cl)=C1 BZGLBXYQOMFXAU-UHFFFAOYSA-N 0.000 claims description 3
- FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 claims description 3
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 claims description 3
- SBUKOHLFHYSZNG-UHFFFAOYSA-N 4-dodecyl-2,6-dimethylmorpholine Chemical compound CCCCCCCCCCCCN1CC(C)OC(C)C1 SBUKOHLFHYSZNG-UHFFFAOYSA-N 0.000 claims description 3
- NRTLIYOWLVMQBO-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)OC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1Cl NRTLIYOWLVMQBO-UHFFFAOYSA-N 0.000 claims description 3
- NEKULYKCZPJMMJ-UHFFFAOYSA-N 5-chloro-N-{1-[4-(difluoromethoxy)phenyl]propyl}-6-methylpyrimidin-4-amine Chemical compound C=1C=C(OC(F)F)C=CC=1C(CC)NC1=NC=NC(C)=C1Cl NEKULYKCZPJMMJ-UHFFFAOYSA-N 0.000 claims description 3
- GOFJDXZZHFNFLV-UHFFFAOYSA-N 5-fluoro-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]pyrazole-4-carboxamide Chemical compound CC(C)CC(C)C1=CC=CC=C1NC(=O)C1=C(F)N(C)N=C1C GOFJDXZZHFNFLV-UHFFFAOYSA-N 0.000 claims description 3
- 239000005726 Ametoctradin Substances 0.000 claims description 3
- 239000005727 Amisulbrom Substances 0.000 claims description 3
- 239000005734 Benalaxyl Substances 0.000 claims description 3
- 239000005735 Benalaxyl-M Substances 0.000 claims description 3
- 239000005742 Bupirimate Substances 0.000 claims description 3
- 239000005745 Captan Substances 0.000 claims description 3
- 239000005746 Carboxin Substances 0.000 claims description 3
- 239000005754 Cyazofamid Substances 0.000 claims description 3
- 239000005756 Cymoxanil Substances 0.000 claims description 3
- 239000005758 Cyprodinil Substances 0.000 claims description 3
- 239000005759 Diethofencarb Substances 0.000 claims description 3
- 239000005764 Dithianon Substances 0.000 claims description 3
- 239000005765 Dodemorph Substances 0.000 claims description 3
- 239000005766 Dodine Substances 0.000 claims description 3
- 239000005774 Fenamidone Substances 0.000 claims description 3
- 239000005776 Fenhexamid Substances 0.000 claims description 3
- 239000005779 Fenpyrazamine Substances 0.000 claims description 3
- 239000005780 Fluazinam Substances 0.000 claims description 3
- 239000005781 Fludioxonil Substances 0.000 claims description 3
- 239000005782 Fluopicolide Substances 0.000 claims description 3
- 239000005784 Fluoxastrobin Substances 0.000 claims description 3
- 239000005785 Fluquinconazole Substances 0.000 claims description 3
- 239000005786 Flutolanil Substances 0.000 claims description 3
- 239000005789 Folpet Substances 0.000 claims description 3
- 239000005791 Fuberidazole Substances 0.000 claims description 3
- 239000005795 Imazalil Substances 0.000 claims description 3
- 239000005867 Iprodione Substances 0.000 claims description 3
- 239000005805 Mepanipyrim Substances 0.000 claims description 3
- 239000005806 Meptyldinocap Substances 0.000 claims description 3
- 239000005809 Metiram Substances 0.000 claims description 3
- IUOKJNROJISWRO-UHFFFAOYSA-N N-(2-cyano-3-methylbutan-2-yl)-2-(2,4-dichlorophenoxy)propanamide Chemical compound CC(C)C(C)(C#N)NC(=O)C(C)OC1=CC=C(Cl)C=C1Cl IUOKJNROJISWRO-UHFFFAOYSA-N 0.000 claims description 3
- NQRFDNJEBWAUBL-UHFFFAOYSA-N N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NCC)=NC(CC)=C1C(=O)NC(C#N)C1=CC=CS1 NQRFDNJEBWAUBL-UHFFFAOYSA-N 0.000 claims description 3
- 239000004100 Oxytetracycline Substances 0.000 claims description 3
- 239000005814 Pencycuron Substances 0.000 claims description 3
- 239000005815 Penflufen Substances 0.000 claims description 3
- 239000005823 Propineb Substances 0.000 claims description 3
- 239000005828 Pyrimethanil Substances 0.000 claims description 3
- 239000005835 Silthiofam Substances 0.000 claims description 3
- 239000005837 Spiroxamine Substances 0.000 claims description 3
- 239000005840 Tetraconazole Substances 0.000 claims description 3
- 239000005842 Thiophanate-methyl Substances 0.000 claims description 3
- 239000005843 Thiram Substances 0.000 claims description 3
- 239000005845 Tolclofos-methyl Substances 0.000 claims description 3
- 239000005846 Triadimenol Substances 0.000 claims description 3
- 239000005847 Triazoxide Substances 0.000 claims description 3
- 229930195482 Validamycin Natural products 0.000 claims description 3
- 239000005870 Ziram Substances 0.000 claims description 3
- 239000005863 Zoxamide Substances 0.000 claims description 3
- 239000011717 all-trans-retinol Substances 0.000 claims description 3
- 235000019169 all-trans-retinol Nutrition 0.000 claims description 3
- GGKQIOFASHYUJZ-UHFFFAOYSA-N ametoctradin Chemical compound NC1=C(CCCCCCCC)C(CC)=NC2=NC=NN21 GGKQIOFASHYUJZ-UHFFFAOYSA-N 0.000 claims description 3
- BREATYVWRHIPIY-UHFFFAOYSA-N amisulbrom Chemical compound CN(C)S(=O)(=O)N1C=NC(S(=O)(=O)N2C3=CC(F)=CC=C3C(Br)=C2C)=N1 BREATYVWRHIPIY-UHFFFAOYSA-N 0.000 claims description 3
- IMHBYKMAHXWHRP-UHFFFAOYSA-N anilazine Chemical compound ClC1=CC=CC=C1NC1=NC(Cl)=NC(Cl)=N1 IMHBYKMAHXWHRP-UHFFFAOYSA-N 0.000 claims description 3
- LJOZMWRYMKECFF-UHFFFAOYSA-N benodanil Chemical compound IC1=CC=CC=C1C(=O)NC1=CC=CC=C1 LJOZMWRYMKECFF-UHFFFAOYSA-N 0.000 claims description 3
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 claims description 3
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 claims description 3
- 235000010290 biphenyl Nutrition 0.000 claims description 3
- 239000004305 biphenyl Substances 0.000 claims description 3
- OIPMQULDKWSNGX-UHFFFAOYSA-N bis[[ethoxy(oxo)phosphaniumyl]oxy]alumanyloxy-ethoxy-oxophosphanium Chemical compound [Al+3].CCO[P+]([O-])=O.CCO[P+]([O-])=O.CCO[P+]([O-])=O OIPMQULDKWSNGX-UHFFFAOYSA-N 0.000 claims description 3
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 claims description 3
- DSKJPMWIHSOYEA-UHFFFAOYSA-N bupirimate Chemical compound CCCCC1=C(C)N=C(NCC)N=C1OS(=O)(=O)N(C)C DSKJPMWIHSOYEA-UHFFFAOYSA-N 0.000 claims description 3
- JHRWWRDRBPCWTF-OLQVQODUSA-N captafol Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)C(Cl)Cl)C(=O)[C@H]21 JHRWWRDRBPCWTF-OLQVQODUSA-N 0.000 claims description 3
- 229940117949 captan Drugs 0.000 claims description 3
- GYSSRZJIHXQEHQ-UHFFFAOYSA-N carboxin Chemical compound S1CCOC(C)=C1C(=O)NC1=CC=CC=C1 GYSSRZJIHXQEHQ-UHFFFAOYSA-N 0.000 claims description 3
- RXDMAYSSBPYBFW-UHFFFAOYSA-N carpropamid Chemical compound C=1C=C(Cl)C=CC=1C(C)NC(=O)C1(CC)C(C)C1(Cl)Cl RXDMAYSSBPYBFW-UHFFFAOYSA-N 0.000 claims description 3
- PFIADAMVCJPXSF-UHFFFAOYSA-N chloroneb Chemical compound COC1=CC(Cl)=C(OC)C=C1Cl PFIADAMVCJPXSF-UHFFFAOYSA-N 0.000 claims description 3
- YXKMMRDKEKCERS-UHFFFAOYSA-N cyazofamid Chemical compound CN(C)S(=O)(=O)N1C(C#N)=NC(Cl)=C1C1=CC=C(C)C=C1 YXKMMRDKEKCERS-UHFFFAOYSA-N 0.000 claims description 3
- HAORKNGNJCEJBX-UHFFFAOYSA-N cyprodinil Chemical compound N=1C(C)=CC(C2CC2)=NC=1NC1=CC=CC=C1 HAORKNGNJCEJBX-UHFFFAOYSA-N 0.000 claims description 3
- 125000004472 dialkylaminosulfonyl group Chemical group 0.000 claims description 3
- WURGXGVFSMYFCG-UHFFFAOYSA-N dichlofluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=CC=C1 WURGXGVFSMYFCG-UHFFFAOYSA-N 0.000 claims description 3
- BIXZHMJUSMUDOQ-UHFFFAOYSA-N dichloran Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl BIXZHMJUSMUDOQ-UHFFFAOYSA-N 0.000 claims description 3
- YEJGPFZQLRMXOI-PKEIRNPWSA-N diclocymet Chemical compound N#CC(C(C)(C)C)C(=O)N[C@H](C)C1=CC=C(Cl)C=C1Cl YEJGPFZQLRMXOI-PKEIRNPWSA-N 0.000 claims description 3
- UWQMKVBQKFHLCE-UHFFFAOYSA-N diclomezine Chemical compound C1=C(Cl)C(C)=C(Cl)C=C1C1=NNC(=O)C=C1 UWQMKVBQKFHLCE-UHFFFAOYSA-N 0.000 claims description 3
- 229940004812 dicloran Drugs 0.000 claims description 3
- LNJNFVJKDJYTEU-UHFFFAOYSA-N diethofencarb Chemical compound CCOC1=CC=C(NC(=O)OC(C)C)C=C1OCC LNJNFVJKDJYTEU-UHFFFAOYSA-N 0.000 claims description 3
- CJHXCRMKMMBYJQ-UHFFFAOYSA-N dimethirimol Chemical compound CCCCC1=C(C)NC(N(C)C)=NC1=O CJHXCRMKMMBYJQ-UHFFFAOYSA-N 0.000 claims description 3
- PYZSVQVRHDXQSL-UHFFFAOYSA-N dithianon Chemical compound S1C(C#N)=C(C#N)SC2=C1C(=O)C1=CC=CC=C1C2=O PYZSVQVRHDXQSL-UHFFFAOYSA-N 0.000 claims description 3
- JMXKCYUTURMERF-UHFFFAOYSA-N dodemorph Chemical compound C1C(C)OC(C)CN1C1CCCCCCCCCCC1 JMXKCYUTURMERF-UHFFFAOYSA-N 0.000 claims description 3
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 claims description 3
- 229960002125 enilconazole Drugs 0.000 claims description 3
- BBXXLROWFHWFQY-UHFFFAOYSA-N ethirimol Chemical compound CCCCC1=C(C)NC(NCC)=NC1=O BBXXLROWFHWFQY-UHFFFAOYSA-N 0.000 claims description 3
- IGUYEXXAGBDLLX-UHFFFAOYSA-N ethyl 3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1C(C(=O)OCC)(C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 IGUYEXXAGBDLLX-UHFFFAOYSA-N 0.000 claims description 3
- LMVPQMGRYSRMIW-KRWDZBQOSA-N fenamidone Chemical compound O=C([C@@](C)(N=C1SC)C=2C=CC=CC=2)N1NC1=CC=CC=C1 LMVPQMGRYSRMIW-KRWDZBQOSA-N 0.000 claims description 3
- JFSPBVWPKOEZCB-UHFFFAOYSA-N fenfuram Chemical compound O1C=CC(C(=O)NC=2C=CC=CC=2)=C1C JFSPBVWPKOEZCB-UHFFFAOYSA-N 0.000 claims description 3
- VDLGAVXLJYLFDH-UHFFFAOYSA-N fenhexamid Chemical compound C=1C=C(O)C(Cl)=C(Cl)C=1NC(=O)C1(C)CCCCC1 VDLGAVXLJYLFDH-UHFFFAOYSA-N 0.000 claims description 3
- FKLFBQCQQYDUAM-UHFFFAOYSA-N fenpiclonil Chemical compound ClC1=CC=CC(C=2C(=CNC=2)C#N)=C1Cl FKLFBQCQQYDUAM-UHFFFAOYSA-N 0.000 claims description 3
- UTOHZQYBSYOOGC-UHFFFAOYSA-N fenpyrazamine Chemical compound O=C1N(C(C)C)N(C(=O)SCC=C)C(N)=C1C1=CC=CC=C1C UTOHZQYBSYOOGC-UHFFFAOYSA-N 0.000 claims description 3
- WDQNIWFZKXZFAY-UHFFFAOYSA-M fentin acetate Chemical compound CC([O-])=O.C1=CC=CC=C1[Sn+](C=1C=CC=CC=1)C1=CC=CC=C1 WDQNIWFZKXZFAY-UHFFFAOYSA-M 0.000 claims description 3
- NJVOZLGKTAPUTQ-UHFFFAOYSA-M fentin chloride Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 NJVOZLGKTAPUTQ-UHFFFAOYSA-M 0.000 claims description 3
- WHDGWKAJBYRJJL-UHFFFAOYSA-K ferbam Chemical compound [Fe+3].CN(C)C([S-])=S.CN(C)C([S-])=S.CN(C)C([S-])=S WHDGWKAJBYRJJL-UHFFFAOYSA-K 0.000 claims description 3
- GOWLARCWZRESHU-AQTBWJFISA-N ferimzone Chemical compound C=1C=CC=C(C)C=1C(/C)=N\NC1=NC(C)=CC(C)=N1 GOWLARCWZRESHU-AQTBWJFISA-N 0.000 claims description 3
- 238000007667 floating Methods 0.000 claims description 3
- UZCGKGPEKUCDTF-UHFFFAOYSA-N fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 claims description 3
- MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 claims description 3
- GBOYJIHYACSLGN-UHFFFAOYSA-N fluopicolide Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CNC(=O)C1=C(Cl)C=CC=C1Cl GBOYJIHYACSLGN-UHFFFAOYSA-N 0.000 claims description 3
- IPENDKRRWFURRE-UHFFFAOYSA-N fluoroimide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(Cl)=C(Cl)C1=O IPENDKRRWFURRE-UHFFFAOYSA-N 0.000 claims description 3
- UFEODZBUAFNAEU-NLRVBDNBSA-N fluoxastrobin Chemical compound C=1C=CC=C(OC=2C(=C(OC=3C(=CC=CC=3)Cl)N=CN=2)F)C=1C(=N/OC)\C1=NOCCO1 UFEODZBUAFNAEU-NLRVBDNBSA-N 0.000 claims description 3
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 claims description 3
- GNVDAZSPJWCIQZ-UHFFFAOYSA-N flusulfamide Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1NS(=O)(=O)C1=CC=C(Cl)C(C(F)(F)F)=C1 GNVDAZSPJWCIQZ-UHFFFAOYSA-N 0.000 claims description 3
- KGXUEPOHGFWQKF-ZCXUNETKSA-N flutianil Chemical compound COC1=CC=CC=C1N(CCS\1)C/1=C(C#N)/SC1=CC(C(F)(F)F)=CC=C1F KGXUEPOHGFWQKF-ZCXUNETKSA-N 0.000 claims description 3
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 claims description 3
- HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 claims description 3
- 125000004461 halocycloalkylalkyl group Chemical group 0.000 claims description 3
- KGVPNLBXJKTABS-UHFFFAOYSA-N hymexazol Chemical compound CC1=CC(O)=NO1 KGVPNLBXJKTABS-UHFFFAOYSA-N 0.000 claims description 3
- AGKSTYPVMZODRV-UHFFFAOYSA-N imibenconazole Chemical compound C1=CC(Cl)=CC=C1CSC(CN1N=CN=C1)=NC1=CC=C(Cl)C=C1Cl AGKSTYPVMZODRV-UHFFFAOYSA-N 0.000 claims description 3
- FCOAHACKGGIURQ-UHFFFAOYSA-N iprobenfos Chemical compound CC(C)OP(=O)(OC(C)C)SCC1=CC=CC=C1 FCOAHACKGGIURQ-UHFFFAOYSA-N 0.000 claims description 3
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 claims description 3
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 claims description 3
- WLPCAERCXQSYLQ-UHFFFAOYSA-N isotianil Chemical compound ClC1=NSC(C(=O)NC=2C(=CC=CC=2)C#N)=C1Cl WLPCAERCXQSYLQ-UHFFFAOYSA-N 0.000 claims description 3
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 claims description 3
- YKSNLCVSTHTHJA-UHFFFAOYSA-L maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 claims description 3
- 229920000940 maneb Polymers 0.000 claims description 3
- CIFWZNRJIBNXRE-UHFFFAOYSA-N mepanipyrim Chemical compound CC#CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 CIFWZNRJIBNXRE-UHFFFAOYSA-N 0.000 claims description 3
- BCTQJXQXJVLSIG-UHFFFAOYSA-N mepronil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C)=C1 BCTQJXQXJVLSIG-UHFFFAOYSA-N 0.000 claims description 3
- IXJOSTZEBSTPAG-UHFFFAOYSA-N methasulfocarb Chemical compound CNC(=O)SC1=CC=C(OS(C)(=O)=O)C=C1 IXJOSTZEBSTPAG-UHFFFAOYSA-N 0.000 claims description 3
- CJPQIRJHIZUAQP-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)alaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-UHFFFAOYSA-N 0.000 claims description 3
- CIEXPHRYOLIQQD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-2-furoylalaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)C1=CC=CO1 CIEXPHRYOLIQQD-UHFFFAOYSA-N 0.000 claims description 3
- 229920000257 metiram Polymers 0.000 claims description 3
- IWWKIOTVAJOMJT-UHFFFAOYSA-N n-(2,2,2-trichloro-1-morpholin-4-ylethyl)formamide Chemical compound O=CNC(C(Cl)(Cl)Cl)N1CCOCC1 IWWKIOTVAJOMJT-UHFFFAOYSA-N 0.000 claims description 3
- OZGNYLLQHRPOBR-DHZHZOJOSA-N naftifine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)C\C=C\C1=CC=CC=C1 OZGNYLLQHRPOBR-DHZHZOJOSA-N 0.000 claims description 3
- 229960004313 naftifine Drugs 0.000 claims description 3
- 125000006574 non-aromatic ring group Chemical group 0.000 claims description 3
- JHIPUJPTQJYEQK-ZLHHXESBSA-N orysastrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1CO\N=C(/C)\C(=N\OC)\C(\C)=N\OC JHIPUJPTQJYEQK-ZLHHXESBSA-N 0.000 claims description 3
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 claims description 3
- 229960000321 oxolinic acid Drugs 0.000 claims description 3
- AMEKQAFGQBKLKX-UHFFFAOYSA-N oxycarboxin Chemical compound O=S1(=O)CCOC(C)=C1C(=O)NC1=CC=CC=C1 AMEKQAFGQBKLKX-UHFFFAOYSA-N 0.000 claims description 3
- 229960000625 oxytetracycline Drugs 0.000 claims description 3
- 235000019366 oxytetracycline Nutrition 0.000 claims description 3
- OGYFATSSENRIKG-UHFFFAOYSA-N pencycuron Chemical compound C1=CC(Cl)=CC=C1CN(C(=O)NC=1C=CC=CC=1)C1CCCC1 OGYFATSSENRIKG-UHFFFAOYSA-N 0.000 claims description 3
- WBTYBAGIHOISOQ-UHFFFAOYSA-N pent-4-en-1-yl 2-[(2-furylmethyl)(imidazol-1-ylcarbonyl)amino]butanoate Chemical compound C1=CN=CN1C(=O)N(C(CC)C(=O)OCCCC=C)CC1=CC=CO1 WBTYBAGIHOISOQ-UHFFFAOYSA-N 0.000 claims description 3
- LKPLKUMXSAEKID-UHFFFAOYSA-N pentachloronitrobenzene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LKPLKUMXSAEKID-UHFFFAOYSA-N 0.000 claims description 3
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 claims description 3
- QXJKBPAVAHBARF-BETUJISGSA-N procymidone Chemical compound O=C([C@]1(C)C[C@@]1(C1=O)C)N1C1=CC(Cl)=CC(Cl)=C1 QXJKBPAVAHBARF-BETUJISGSA-N 0.000 claims description 3
- KKMLIVYBGSAJPM-UHFFFAOYSA-L propineb Chemical compound [Zn+2].[S-]C(=S)NC(C)CNC([S-])=S KKMLIVYBGSAJPM-UHFFFAOYSA-L 0.000 claims description 3
- YRRBXJLFCBCKNW-UHFFFAOYSA-N prothiocarb Chemical compound CCSC(=O)NCCCN(C)C YRRBXJLFCBCKNW-UHFFFAOYSA-N 0.000 claims description 3
- JOOMJVFZQRQWKR-UHFFFAOYSA-N pyrazophos Chemical compound N1=C(C)C(C(=O)OCC)=CN2N=C(OP(=S)(OCC)OCC)C=C21 JOOMJVFZQRQWKR-UHFFFAOYSA-N 0.000 claims description 3
- CRFYLQMIDWBKRT-LPYMAVHISA-N pyribencarb Chemical compound C1=C(Cl)C(CNC(=O)OC)=CC(C(\C)=N\OCC=2N=C(C)C=CC=2)=C1 CRFYLQMIDWBKRT-LPYMAVHISA-N 0.000 claims description 3
- VTRWMTJQBQJKQH-UHFFFAOYSA-N pyributicarb Chemical compound COC1=CC=CC(N(C)C(=S)OC=2C=C(C=CC=2)C(C)(C)C)=N1 VTRWMTJQBQJKQH-UHFFFAOYSA-N 0.000 claims description 3
- ZLIBICFPKPWGIZ-UHFFFAOYSA-N pyrimethanil Chemical compound CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 ZLIBICFPKPWGIZ-UHFFFAOYSA-N 0.000 claims description 3
- DHTJFQWHCVTNRY-OEMAIJDKSA-N pyrisoxazole Chemical compound C1([C@@]2(C)CC(ON2C)C=2C=CC(Cl)=CC=2)=CC=CN=C1 DHTJFQWHCVTNRY-OEMAIJDKSA-N 0.000 claims description 3
- XRJLAOUDSILTFT-UHFFFAOYSA-N pyroquilon Chemical compound O=C1CCC2=CC=CC3=C2N1CC3 XRJLAOUDSILTFT-UHFFFAOYSA-N 0.000 claims description 3
- 229960002132 pyrrolnitrin Drugs 0.000 claims description 3
- MXMXHPPIGKYTAR-UHFFFAOYSA-N silthiofam Chemical compound CC=1SC([Si](C)(C)C)=C(C(=O)NCC=C)C=1C MXMXHPPIGKYTAR-UHFFFAOYSA-N 0.000 claims description 3
- 229960005322 streptomycin Drugs 0.000 claims description 3
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- LWLJEQHTPVPKSJ-UHFFFAOYSA-N tebufloquin Chemical compound C1=C(C(C)(C)C)C=C2C(OC(=O)C)=C(C)C(C)=NC2=C1F LWLJEQHTPVPKSJ-UHFFFAOYSA-N 0.000 claims description 3
- XQTLDIFVVHJORV-UHFFFAOYSA-N tecnazene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl XQTLDIFVVHJORV-UHFFFAOYSA-N 0.000 claims description 3
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 claims description 3
- 229960002722 terbinafine Drugs 0.000 claims description 3
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 claims description 3
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 claims description 3
- 239000004308 thiabendazole Substances 0.000 claims description 3
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 claims description 3
- 229960004546 thiabendazole Drugs 0.000 claims description 3
- 235000010296 thiabendazole Nutrition 0.000 claims description 3
- WOSNCVAPUOFXEH-UHFFFAOYSA-N thifluzamide Chemical compound S1C(C)=NC(C(F)(F)F)=C1C(=O)NC1=C(Br)C=C(OC(F)(F)F)C=C1Br WOSNCVAPUOFXEH-UHFFFAOYSA-N 0.000 claims description 3
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical compound COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 claims description 3
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 claims description 3
- 229960002447 thiram Drugs 0.000 claims description 3
- VJQYLJSMBWXGDV-UHFFFAOYSA-N tiadinil Chemical compound N1=NSC(C(=O)NC=2C=C(Cl)C(C)=CC=2)=C1C VJQYLJSMBWXGDV-UHFFFAOYSA-N 0.000 claims description 3
- OBZIQQJJIKNWNO-UHFFFAOYSA-N tolclofos-methyl Chemical compound COP(=S)(OC)OC1=C(Cl)C=C(C)C=C1Cl OBZIQQJJIKNWNO-UHFFFAOYSA-N 0.000 claims description 3
- HYVWIQDYBVKITD-UHFFFAOYSA-N tolylfluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=C(C)C=C1 HYVWIQDYBVKITD-UHFFFAOYSA-N 0.000 claims description 3
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 claims description 3
- IQGKIPDJXCAMSM-UHFFFAOYSA-N triazoxide Chemical compound N=1C2=CC=C(Cl)C=C2[N+]([O-])=NC=1N1C=CN=C1 IQGKIPDJXCAMSM-UHFFFAOYSA-N 0.000 claims description 3
- RROQIUMZODEXOR-UHFFFAOYSA-N triforine Chemical compound O=CNC(C(Cl)(Cl)Cl)N1CCN(C(NC=O)C(Cl)(Cl)Cl)CC1 RROQIUMZODEXOR-UHFFFAOYSA-N 0.000 claims description 3
- JARYYMUOCXVXNK-IMTORBKUSA-N validamycin Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-IMTORBKUSA-N 0.000 claims description 3
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 claims description 3
- FJBGIXKIXPUXBY-UHFFFAOYSA-N {2-[3-(4-chlorophenyl)propyl]-2,4,4-trimethyl-1,3-oxazolidin-3-yl}(imidazol-1-yl)methanone Chemical compound C1=CN=CN1C(=O)N1C(C)(C)COC1(C)CCCC1=CC=C(Cl)C=C1 FJBGIXKIXPUXBY-UHFFFAOYSA-N 0.000 claims description 3
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims description 2
- 125000006729 (C2-C5) alkenyl group Chemical group 0.000 claims description 2
- 125000006730 (C2-C5) alkynyl group Chemical group 0.000 claims description 2
- PQQRHWFRZHFGFM-UHFFFAOYSA-N 1,3-thiazole-4-carboxamide Chemical compound NC(=O)C1=CSC=N1 PQQRHWFRZHFGFM-UHFFFAOYSA-N 0.000 claims description 2
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 2
- JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical group F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000005858 Triflumizole Substances 0.000 claims description 2
- AKNQMEBLVAMSNZ-UHFFFAOYSA-N azaconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCCO1 AKNQMEBLVAMSNZ-UHFFFAOYSA-N 0.000 claims description 2
- 229950000294 azaconazole Drugs 0.000 claims description 2
- 125000005167 cycloalkylaminocarbonyl group Chemical group 0.000 claims description 2
- 125000005169 cycloalkylcarbonylamino group Chemical group 0.000 claims description 2
- 125000005202 dialkylaminocarbonyloxy group Chemical group 0.000 claims description 2
- 125000004995 haloalkylthio group Chemical group 0.000 claims description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 2
- HSMVPDGQOIQYSR-KGENOOAVSA-N triflumizole Chemical compound C1=CN=CN1C(/COCCC)=N/C1=CC=C(Cl)C=C1C(F)(F)F HSMVPDGQOIQYSR-KGENOOAVSA-N 0.000 claims description 2
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 claims description 2
- 239000005794 Hymexazol Substances 0.000 claims 1
- XFOXDUJCOHBXRC-UHFFFAOYSA-N N-Ethyl-N-methyl-4-(trifluoromethyl)-2-(3,4-dimethoxyphenyl)benzamide Chemical compound CCN(C)C(=O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C(OC)C(OC)=C1 XFOXDUJCOHBXRC-UHFFFAOYSA-N 0.000 claims 1
- 239000005821 Propamocarb Substances 0.000 claims 1
- MKIMSXGUTQTKJU-UHFFFAOYSA-N Propamocarb hydrochloride Chemical compound [Cl-].CCCOC(=O)NCCC[NH+](C)C MKIMSXGUTQTKJU-UHFFFAOYSA-N 0.000 claims 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 claims 1
- 229960004022 clotrimazole Drugs 0.000 claims 1
- 150000001879 copper Chemical class 0.000 claims 1
- 125000006448 cycloalkyl cycloalkyl group Chemical group 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- BFWMWWXRWVJXSE-UHFFFAOYSA-M fentin hydroxide Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(O)C1=CC=CC=C1 BFWMWWXRWVJXSE-UHFFFAOYSA-M 0.000 claims 1
- ZEYJIQLVKGBLEM-UHFFFAOYSA-N fuberidazole Chemical compound C1=COC(C=2N=C3[CH]C=CC=C3N=2)=C1 ZEYJIQLVKGBLEM-UHFFFAOYSA-N 0.000 claims 1
- 125000004440 haloalkylsulfinyl group Chemical group 0.000 claims 1
- 125000001841 imino group Chemical group [H]N=* 0.000 claims 1
- QTRHQIVJJBABOF-UHFFFAOYSA-N methyl 4-(3,3,3-trifluoro-2,2-dihydroxypropoxy)benzoate Chemical compound FC(C(COC1=CC=C(C=C1)C(=O)OC)(O)O)(F)F QTRHQIVJJBABOF-UHFFFAOYSA-N 0.000 claims 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 claims 1
- 150000003881 polyketide derivatives Polymers 0.000 claims 1
- WZZLDXDUQPOXNW-UHFFFAOYSA-N propamocarb Chemical compound CCCOC(=O)NCCCN(C)C WZZLDXDUQPOXNW-UHFFFAOYSA-N 0.000 claims 1
- ROZUQUDEWZIBHV-UHFFFAOYSA-N tecloftalam Chemical compound OC(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C(=O)NC1=CC=CC(Cl)=C1Cl ROZUQUDEWZIBHV-UHFFFAOYSA-N 0.000 claims 1
- 244000000004 fungal plant pathogen Species 0.000 abstract description 9
- 241000196324 Embryophyta Species 0.000 description 67
- 150000001721 carbon Chemical group 0.000 description 45
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 41
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 36
- 238000002360 preparation method Methods 0.000 description 33
- 241000233866 Fungi Species 0.000 description 30
- 230000002829 reductive effect Effects 0.000 description 26
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 24
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 24
- 239000000460 chlorine Substances 0.000 description 24
- 239000000243 solution Substances 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 23
- 230000012010 growth Effects 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 22
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 22
- ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- 238000005481 NMR spectroscopy Methods 0.000 description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 239000011541 reaction mixture Substances 0.000 description 20
- 239000000463 material Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 14
- 150000002576 ketones Chemical class 0.000 description 14
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 229930182558 Sterol Natural products 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 12
- 235000019341 magnesium sulphate Nutrition 0.000 description 12
- 239000012044 organic layer Substances 0.000 description 12
- 150000003432 sterols Chemical class 0.000 description 12
- 235000003702 sterols Nutrition 0.000 description 12
- 238000006467 substitution reaction Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000004293 19F NMR spectroscopy Methods 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 230000000875 corresponding effect Effects 0.000 description 11
- 238000011161 development Methods 0.000 description 11
- 230000018109 developmental process Effects 0.000 description 11
- 230000002538 fungal effect Effects 0.000 description 11
- 229910000027 potassium carbonate Inorganic materials 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 125000003320 C2-C6 alkenyloxy group Chemical group 0.000 description 8
- 229910000024 caesium carbonate Inorganic materials 0.000 description 8
- 230000006540 mitochondrial respiration Effects 0.000 description 8
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 8
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 7
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 7
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 7
- 210000002421 cell wall Anatomy 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 238000010898 silica gel chromatography Methods 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 6
- 125000006766 (C2-C6) alkynyloxy group Chemical group 0.000 description 6
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 6
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 description 6
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 102000029749 Microtubule Human genes 0.000 description 6
- 108091022875 Microtubule Proteins 0.000 description 6
- NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 210000004688 microtubule Anatomy 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 125000004430 oxygen atom Chemical group O* 0.000 description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 description 6
- PWWPULQZEAPTTB-UHFFFAOYSA-N (4-phenoxyphenyl)methyl 2-amino-6-methylpyridine-3-carboxylate Chemical compound NC1=NC(C)=CC=C1C(=O)OCC(C=C1)=CC=C1OC1=CC=CC=C1 PWWPULQZEAPTTB-UHFFFAOYSA-N 0.000 description 5
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 description 5
- ZNBJSAAROMDHOX-UHFFFAOYSA-N 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine Chemical compound C=1C=CC=CC=1C=1C(C)=NN=C(Cl)C=1C1=C(F)C=CC=C1F ZNBJSAAROMDHOX-UHFFFAOYSA-N 0.000 description 5
- 102000015782 Electron Transport Complex III Human genes 0.000 description 5
- 108010024882 Electron Transport Complex III Proteins 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 5
- 125000002837 carbocyclic group Chemical group 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 238000004891 communication Methods 0.000 description 5
- 244000038559 crop plants Species 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- OSFBJERFMQCEQY-UHFFFAOYSA-N propylidene Chemical compound [CH]CC OSFBJERFMQCEQY-UHFFFAOYSA-N 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 230000032258 transport Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- WYRSGXAIHNMKOL-UHFFFAOYSA-N $l^{1}-sulfanylethane Chemical compound CC[S] WYRSGXAIHNMKOL-UHFFFAOYSA-N 0.000 description 4
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 4
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 4
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 4
- CUTZZBQQGUIEGT-UHFFFAOYSA-N 3-[(3,4-dichloro-1,2-thiazol-5-yl)methoxy]-1,2-benzothiazole 1,1-dioxide Chemical compound ClC1=NSC(COC=2C3=CC=CC=C3S(=O)(=O)N=2)=C1Cl CUTZZBQQGUIEGT-UHFFFAOYSA-N 0.000 description 4
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 4
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 4
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 4
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 4
- 241000221785 Erysiphales Species 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 125000004471 alkyl aminosulfonyl group Chemical group 0.000 description 4
- 230000032823 cell division Effects 0.000 description 4
- 239000012230 colorless oil Substances 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- FPKXBFWMIYHCID-UHFFFAOYSA-N dipymetitrone Chemical compound S1C=2C(=O)N(C)C(=O)C=2SC2=C1C(=O)N(C)C2=O FPKXBFWMIYHCID-UHFFFAOYSA-N 0.000 description 4
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- QGTOTYJSCYHYFK-RBODFLQRSA-N fenpicoxamid Chemical compound COC1=CC=NC(C(=O)N[C@@H]2C(O[C@@H](C)[C@H](OC(=O)C(C)C)[C@@H](CC=3C=CC=CC=3)C(=O)OC2)=O)=C1OCOC(=O)C(C)C QGTOTYJSCYHYFK-RBODFLQRSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- IBBMAWULFFBRKK-UHFFFAOYSA-N picolinamide Chemical compound NC(=O)C1=CC=CC=N1 IBBMAWULFFBRKK-UHFFFAOYSA-N 0.000 description 4
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 4
- 150000003254 radicals Chemical group 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 125000006413 ring segment Chemical group 0.000 description 4
- 230000019491 signal transduction Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- RSOBJVBYZCMJOS-CYBMUJFWSA-N tolprocarb Chemical compound FC(F)(F)COC(=O)N[C@@H](C(C)C)CNC(=O)C1=CC=C(C)C=C1 RSOBJVBYZCMJOS-CYBMUJFWSA-N 0.000 description 4
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 4
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- QSLPNSWXUQHVLP-UHFFFAOYSA-N $l^{1}-sulfanylmethane Chemical compound [S]C QSLPNSWXUQHVLP-UHFFFAOYSA-N 0.000 description 3
- VUEGYUOUAAVYAS-JGGQBBKZSA-N (6ar,9s,10ar)-9-(dimethylsulfamoylamino)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline Chemical compound C1=CC([C@H]2C[C@@H](CN(C)[C@@H]2C2)NS(=O)(=O)N(C)C)=C3C2=CNC3=C1 VUEGYUOUAAVYAS-JGGQBBKZSA-N 0.000 description 3
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 description 3
- SWTPIYGGSMJRTB-UHFFFAOYSA-N 4,4-difluoro-3,3-dimethyl-1-quinolin-3-ylisoquinoline Chemical compound C12=CC=CC=C2C(F)(F)C(C)(C)N=C1C1=CN=C(C=CC=C2)C2=C1 SWTPIYGGSMJRTB-UHFFFAOYSA-N 0.000 description 3
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 3
- GVCLNACSYKYUHP-UHFFFAOYSA-N 4-amino-7-(2-hydroxyethoxymethyl)pyrrolo[2,3-d]pyrimidine-5-carbothioamide Chemical compound C1=NC(N)=C2C(C(=S)N)=CN(COCCO)C2=N1 GVCLNACSYKYUHP-UHFFFAOYSA-N 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000005964 Acibenzolar-S-methyl Substances 0.000 description 3
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 102000018832 Cytochromes Human genes 0.000 description 3
- 108010052832 Cytochromes Proteins 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- YSVSUCSNKUVUFZ-UHFFFAOYSA-N N-[2-[2-chloro-4-(trifluoromethyl)phenoxy]phenyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound ClC1=C(OC2=C(C=CC=C2)NC(=O)C=2C(=NN(C=2)C)C(F)F)C=CC(=C1)C(F)(F)F YSVSUCSNKUVUFZ-UHFFFAOYSA-N 0.000 description 3
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 3
- 241000233654 Oomycetes Species 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 244000153955 Reynoutria sachalinensis Species 0.000 description 3
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 3
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 3
- DKVNPHBNOWQYFE-UHFFFAOYSA-N carbamodithioic acid Chemical compound NC(S)=S DKVNPHBNOWQYFE-UHFFFAOYSA-N 0.000 description 3
- 150000003857 carboxamides Chemical class 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- APEJMQOBVMLION-UHFFFAOYSA-N cinnamamide Chemical compound NC(=O)C=CC1=CC=CC=C1 APEJMQOBVMLION-UHFFFAOYSA-N 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000012024 dehydrating agents Substances 0.000 description 3
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 3
- 239000012990 dithiocarbamate Substances 0.000 description 3
- OCJKUQIPRNZDTK-UHFFFAOYSA-N ethyl 4,4,4-trifluoro-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)C(F)(F)F OCJKUQIPRNZDTK-UHFFFAOYSA-N 0.000 description 3
- ATZHVIVDMUCBEY-HOTGVXAUSA-N florylpicoxamid Chemical compound C(C)(=O)OC=1C(=NC=CC=1OC)C(=O)N[C@H](C(=O)O[C@H](C(C1=CC=C(C=C1)F)C1=CC=C(C=C1)F)C)C ATZHVIVDMUCBEY-HOTGVXAUSA-N 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 235000019256 formaldehyde Nutrition 0.000 description 3
- 238000007429 general method Methods 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- DSXOWZNZGWXWMX-UHFFFAOYSA-N ipflufenoquin Chemical compound CC1=NC2=C(F)C(F)=CC=C2C=C1OC1=CC=CC(F)=C1C(C)(C)O DSXOWZNZGWXWMX-UHFFFAOYSA-N 0.000 description 3
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 3
- XUQQRGKFXLAPNV-UHFFFAOYSA-N metyltetraprole Chemical compound CC1=CC=CC(N2C(N(C)N=N2)=O)=C1COC(=N1)C=CN1C1=CC=C(Cl)C=C1 XUQQRGKFXLAPNV-UHFFFAOYSA-N 0.000 description 3
- 230000011278 mitosis Effects 0.000 description 3
- 125000002524 organometallic group Chemical group 0.000 description 3
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 235000007586 terpenes Nutrition 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 3
- 150000003573 thiols Chemical class 0.000 description 3
- MYUPFXPCYUISAG-UHFFFAOYSA-N (2,4-dichlorophenyl)(phenyl)pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC(Cl)=CC=1)Cl)(O)C1=CC=CC=C1 MYUPFXPCYUISAG-UHFFFAOYSA-N 0.000 description 2
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 2
- IMLJLCJZQLGHJS-JEKSYDDFSA-N (4s,4ar,5s,5ar,6s,12ar)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;dihydrate Chemical compound O.O.C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O IMLJLCJZQLGHJS-JEKSYDDFSA-N 0.000 description 2
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 description 2
- 125000006528 (C2-C6) alkyl group Chemical group 0.000 description 2
- 125000006643 (C2-C6) haloalkenyl group Chemical group 0.000 description 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 2
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 2
- MAUMSNABMVEOGP-UHFFFAOYSA-N (methyl-$l^{2}-azanyl)methane Chemical compound C[N]C MAUMSNABMVEOGP-UHFFFAOYSA-N 0.000 description 2
- FNQJDLTXOVEEFB-UHFFFAOYSA-N 1,2,3-benzothiadiazole Chemical compound C1=CC=C2SN=NC2=C1 FNQJDLTXOVEEFB-UHFFFAOYSA-N 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 2
- YGTAZGSLCXNBQL-UHFFFAOYSA-N 1,2,4-thiadiazole Chemical compound C=1N=CSN=1 YGTAZGSLCXNBQL-UHFFFAOYSA-N 0.000 description 2
- CSNIZNHTOVFARY-UHFFFAOYSA-N 1,2-benzothiazole Chemical compound C1=CC=C2C=NSC2=C1 CSNIZNHTOVFARY-UHFFFAOYSA-N 0.000 description 2
- JLHMJWHSBYZWJJ-UHFFFAOYSA-N 1,2-thiazole 1-oxide Chemical class O=S1C=CC=N1 JLHMJWHSBYZWJJ-UHFFFAOYSA-N 0.000 description 2
- FXVNBZGTAWLLNE-UHFFFAOYSA-N 1,3-thiazole;zinc Chemical compound [Zn].C1=CSC=N1 FXVNBZGTAWLLNE-UHFFFAOYSA-N 0.000 description 2
- IAQLCKZJGNTRDO-UHFFFAOYSA-N 1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone Chemical compound CC1=CC(C(F)(F)F)=NN1CC(=O)N1CCC(C=2SC=C(N=2)C=2CC(ON=2)C=2C(=CC=CC=2F)F)CC1 IAQLCKZJGNTRDO-UHFFFAOYSA-N 0.000 description 2
- VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical compound CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 2
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 2
- QMQZIXCNLUPEIN-UHFFFAOYSA-N 1h-imidazole-2-carbonitrile Chemical compound N#CC1=NC=CN1 QMQZIXCNLUPEIN-UHFFFAOYSA-N 0.000 description 2
- ZVXKYWHJBYIYNI-UHFFFAOYSA-N 1h-pyrazole-4-carboxamide Chemical compound NC(=O)C=1C=NNC=1 ZVXKYWHJBYIYNI-UHFFFAOYSA-N 0.000 description 2
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical class C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 description 2
- PWQSMBODNGQNOZ-UHFFFAOYSA-N 2,2,2-trifluoroethylcarbamic acid Chemical compound OC(=O)NCC(F)(F)F PWQSMBODNGQNOZ-UHFFFAOYSA-N 0.000 description 2
- GXHYWPWPQSPOJY-UHFFFAOYSA-N 2-(2-pyridin-2-ylethyl)benzamide Chemical compound NC(=O)C1=CC=CC=C1CCC1=CC=CC=N1 GXHYWPWPQSPOJY-UHFFFAOYSA-N 0.000 description 2
- AQZRARFZZMGLHL-UHFFFAOYSA-N 2-(trifluoromethyl)oxirane Chemical compound FC(F)(F)C1CO1 AQZRARFZZMGLHL-UHFFFAOYSA-N 0.000 description 2
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 2
- ZEXXEODAXHSRDJ-UHFFFAOYSA-N 2-[(ethanesulfonyl)amino]-5-fluoro-4-[4-methyl-5-oxo-3-(trifluoromethyl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzene-1-carbothioamide Chemical compound CS(=O)(=O)OC1=CC=CC(Cl)=C1C1ON=C(C=2N=C(SC=2)C2CCN(CC2)C(=O)CN2C(=CC(=N2)C(F)F)C(F)F)C1 ZEXXEODAXHSRDJ-UHFFFAOYSA-N 0.000 description 2
- JERZEQUMJNCPRJ-UHFFFAOYSA-N 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol Chemical compound C=1C=C(OC=2C=CC(Cl)=CC=2)C=C(C(F)(F)F)C=1C(O)(C)CN1C=NC=N1 JERZEQUMJNCPRJ-UHFFFAOYSA-N 0.000 description 2
- JBYRSSMFLXQHKH-UHFFFAOYSA-N 2-amino-1h-pyrazol-3-one Chemical class NN1NC=CC1=O JBYRSSMFLXQHKH-UHFFFAOYSA-N 0.000 description 2
- MTEZLAATISORQK-UHFFFAOYSA-N 2-methoxyacetamide Chemical compound COCC(N)=O MTEZLAATISORQK-UHFFFAOYSA-N 0.000 description 2
- GTKIGDZXPDCIKR-UHFFFAOYSA-N 2-phenylbenzamide Chemical compound NC(=O)C1=CC=CC=C1C1=CC=CC=C1 GTKIGDZXPDCIKR-UHFFFAOYSA-N 0.000 description 2
- PDPWCKVFIFAQIQ-UHFFFAOYSA-N 2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide Chemical compound CNC(=O)C(OC)C1=CC=CC=C1COC1=CC(C)=CC=C1C PDPWCKVFIFAQIQ-UHFFFAOYSA-N 0.000 description 2
- WAIIVJKIXMLKTR-UHFFFAOYSA-N 2h-triazole-4-sulfonamide Chemical compound NS(=O)(=O)C1=CNN=N1 WAIIVJKIXMLKTR-UHFFFAOYSA-N 0.000 description 2
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 2
- OVFHHJZHXHZIHT-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)quinazolin-4-one Chemical compound ClC1=CC(Cl)=CC=C1N1C(=O)C2=CC=CC=C2N=C1N1N=CN=C1 OVFHHJZHXHZIHT-UHFFFAOYSA-N 0.000 description 2
- JHQONOCFAYZOEQ-UHFFFAOYSA-N 3-(bromomethyl)phenol Chemical compound OC1=CC=CC(CBr)=C1 JHQONOCFAYZOEQ-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- NMWKWBPNKPGATC-UHFFFAOYSA-N 4,5,6,7-tetrachloro-2-benzofuran-1(3H)-one Chemical compound ClC1=C(Cl)C(Cl)=C2COC(=O)C2=C1Cl NMWKWBPNKPGATC-UHFFFAOYSA-N 0.000 description 2
- ZALZMUXMSIVXKA-UHFFFAOYSA-N 5-fluoro-2-[(4-fluorophenyl)methoxy]pyrimidin-4-amine Chemical compound C1=C(F)C(N)=NC(OCC=2C=CC(F)=CC=2)=N1 ZALZMUXMSIVXKA-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000235349 Ascomycota Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 2
- 241000194106 Bacillus mycoides Species 0.000 description 2
- 241000221198 Basidiomycota Species 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- ZZVVDIVWGXTDRQ-BSYVCWPDSA-N Buthiobate Chemical compound C=1C=CN=CC=1\N=C(/SCCCC)SCC1=CC=C(C(C)(C)C)C=C1 ZZVVDIVWGXTDRQ-BSYVCWPDSA-N 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- 239000005752 Copper oxychloride Substances 0.000 description 2
- 102000008013 Electron Transport Complex I Human genes 0.000 description 2
- 108010089760 Electron Transport Complex I Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- 239000005656 Fenazaquin Substances 0.000 description 2
- 239000005792 Geraniol Substances 0.000 description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 108010072039 Histidine kinase Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- FKWDSATZSMJRLC-UHFFFAOYSA-N Iminoctadine acetate Chemical compound CC([O-])=O.CC([O-])=O.CC([O-])=O.NC([NH3+])=NCCCCCCCC[NH2+]CCCCCCCCN=C(N)[NH3+] FKWDSATZSMJRLC-UHFFFAOYSA-N 0.000 description 2
- 239000005798 Isofetamid Substances 0.000 description 2
- 239000005717 Laminarin Substances 0.000 description 2
- 229920001543 Laminarin Polymers 0.000 description 2
- 108010028921 Lipopeptides Proteins 0.000 description 2
- 241000219745 Lupinus Species 0.000 description 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 2
- 239000005803 Mandestrobin Substances 0.000 description 2
- 241000366182 Melaleuca alternifolia Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- FHFBSBQYPLFMHC-TURZUDJPSA-N N-[(2Z)-2-[2-chloro-4-(2-cyclopropylethynyl)phenyl]-2-propan-2-yloxyiminoethyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound CC(C)O\N=C(/CNC(=O)c1cn(C)nc1C(F)F)c1ccc(cc1Cl)C#CC1CC1 FHFBSBQYPLFMHC-TURZUDJPSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 239000005812 Oxathiapiprolin Substances 0.000 description 2
- 206010034133 Pathogen resistance Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000425347 Phyla <beetle> Species 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 241001533598 Septoria Species 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- STSCVKRWJPWALQ-UHFFFAOYSA-N TRIFLUOROACETIC ACID ETHYL ESTER Chemical compound CCOC(=O)C(F)(F)F STSCVKRWJPWALQ-UHFFFAOYSA-N 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- 102100029677 Trehalase Human genes 0.000 description 2
- 108010087472 Trehalase Proteins 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- FMPFURNXXAKYNE-UHFFFAOYSA-N [2-ethyl-3,7-dimethyl-6-[4-(trifluoromethoxy)phenoxy]quinolin-4-yl] methyl carbonate Chemical compound C1=C2C(OC(=O)OC)=C(C)C(CC)=NC2=CC(C)=C1OC1=CC=C(OC(F)(F)F)C=C1 FMPFURNXXAKYNE-UHFFFAOYSA-N 0.000 description 2
- ZWUDYGSKBLLKBW-UHFFFAOYSA-N [3-(bromomethyl)phenyl] acetate Chemical compound CC(=O)OC1=CC=CC(CBr)=C1 ZWUDYGSKBLLKBW-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical group CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 229930188620 butyrolactone Natural products 0.000 description 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- HKMOPYJWSFRURD-UHFFFAOYSA-N chloro hypochlorite;copper Chemical compound [Cu].ClOCl HKMOPYJWSFRURD-UHFFFAOYSA-N 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- CWVRPJSBNHNJSI-XQNSMLJCSA-N coumoxystrobin Chemical compound C1=C2OC(=O)C(CCCC)=C(C)C2=CC=C1OCC1=CC=CC=C1\C(=C/OC)C(=O)OC CWVRPJSBNHNJSI-XQNSMLJCSA-N 0.000 description 2
- AIMMVWOEOZMVMS-UHFFFAOYSA-N cyclopropanecarboxamide Chemical compound NC(=O)C1CC1 AIMMVWOEOZMVMS-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229960003913 econazole Drugs 0.000 description 2
- 125000006575 electron-withdrawing group Chemical group 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- DWRKFAJEBUWTQM-UHFFFAOYSA-N etaconazole Chemical compound O1C(CC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 DWRKFAJEBUWTQM-UHFFFAOYSA-N 0.000 description 2
- YKRQBWKLHCEKQH-KHPPLWFESA-N ethyl (z)-3-amino-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C(/N)C1=CC=CC=C1 YKRQBWKLHCEKQH-KHPPLWFESA-N 0.000 description 2
- 241001233957 eudicotyledons Species 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- RBWGTZRSEOIHFD-UHUFKFKFSA-N fenaminstrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1CO\N=C(/C)\C=C\C1=C(Cl)C=CC=C1Cl RBWGTZRSEOIHFD-UHUFKFKFSA-N 0.000 description 2
- DMYHGDXADUDKCQ-UHFFFAOYSA-N fenazaquin Chemical compound C1=CC(C(C)(C)C)=CC=C1CCOC1=NC=NC2=CC=CC=C12 DMYHGDXADUDKCQ-UHFFFAOYSA-N 0.000 description 2
- 244000037666 field crops Species 0.000 description 2
- MBHXIQDIVCJZTD-RVDMUPIBSA-N flufenoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=C(C(F)(F)F)C=C1Cl MBHXIQDIVCJZTD-RVDMUPIBSA-N 0.000 description 2
- DNJKFZQFTZJKDK-UHFFFAOYSA-N fluopimomide Chemical compound FC1=C(F)C(OC)=C(F)C(F)=C1C(=O)NCC1=NC=C(C(F)(F)F)C=C1Cl DNJKFZQFTZJKDK-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- UYJUZNLFJAWNEZ-UHFFFAOYSA-N fuberidazole Chemical compound C1=COC(C=2NC3=CC=CC=C3N=2)=C1 UYJUZNLFJAWNEZ-UHFFFAOYSA-N 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- TVFIYRKPCACCNL-UHFFFAOYSA-N furan-2-carboxamide Chemical compound NC(=O)C1=CC=CO1 TVFIYRKPCACCNL-UHFFFAOYSA-N 0.000 description 2
- 229940113087 geraniol Drugs 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 125000006809 haloalkylaminocarbonyl group Chemical group 0.000 description 2
- 150000003944 halohydrins Chemical class 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- YTCIYOXHHQLDEI-SNVBAGLBSA-N inpyrfluxam Chemical compound C([C@H](C=12)C)C(C)(C)C2=CC=CC=1NC(=O)C1=CN(C)N=C1C(F)F YTCIYOXHHQLDEI-SNVBAGLBSA-N 0.000 description 2
- WMKZDPFZIZQROT-UHFFFAOYSA-N isofetamid Chemical compound CC1=CC(OC(C)C)=CC=C1C(=O)C(C)(C)NC(=O)C1=C(C)C=CS1 WMKZDPFZIZQROT-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 150000002545 isoxazoles Chemical class 0.000 description 2
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- BYFVQGSSOPBYMR-UHFFFAOYSA-N methoxycarbamic acid Chemical compound CONC(O)=O BYFVQGSSOPBYMR-UHFFFAOYSA-N 0.000 description 2
- BSDQITJYKQHXQR-UHFFFAOYSA-N methyl prop-2-eneperoxoate Chemical compound COOC(=O)C=C BSDQITJYKQHXQR-UHFFFAOYSA-N 0.000 description 2
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 description 2
- 210000001700 mitochondrial membrane Anatomy 0.000 description 2
- JEFUQUGZXLEHLD-UHFFFAOYSA-N n-[(5-chloro-2-propan-2-ylphenyl)methyl]-n-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methylpyrazole-4-carboxamide Chemical compound CC(C)C1=CC=C(Cl)C=C1CN(C(=O)C=1C(=NN(C)C=1F)C(F)F)C1CC1 JEFUQUGZXLEHLD-UHFFFAOYSA-N 0.000 description 2
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- IMTNSEPDLICZMZ-UHFFFAOYSA-N oxathiine-3-carboxamide Chemical compound NC(=O)C1=CC=COS1 IMTNSEPDLICZMZ-UHFFFAOYSA-N 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- URHWNXDZOULUHC-ULJHMMPZSA-N picarbutrazox Chemical compound CN1N=NN=C1\C(C=1C=CC=CC=1)=N/OCC1=CC=CC(NC(=O)OC(C)(C)C)=N1 URHWNXDZOULUHC-ULJHMMPZSA-N 0.000 description 2
- 150000004885 piperazines Chemical class 0.000 description 2
- 229960005235 piperonyl butoxide Drugs 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- KKEJMLAPZVXPOF-UHFFFAOYSA-N pyraziflumid Chemical compound C1=C(F)C(F)=CC=C1C1=CC=CC=C1NC(=O)C1=NC=CN=C1C(F)(F)F KKEJMLAPZVXPOF-UHFFFAOYSA-N 0.000 description 2
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- BAUQXSYUDSNRHL-UHFFFAOYSA-N pyrimorph Chemical compound C1=CC(C(C)(C)C)=CC=C1C(C=1C=NC(Cl)=CC=1)=CC(=O)N1CCOCC1 BAUQXSYUDSNRHL-UHFFFAOYSA-N 0.000 description 2
- WUKKREVJKMPFTB-UHFFFAOYSA-N pyrrolo[2,3-h]quinolin-2-one Chemical compound C1=C2N=CC=C2C2=NC(=O)C=CC2=C1 WUKKREVJKMPFTB-UHFFFAOYSA-N 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 2
- 150000003457 sulfones Chemical class 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- INWVNNCOIIHEPX-UHFFFAOYSA-N thiadiazole-4-carboxamide Chemical compound NC(=O)C1=CSN=N1 INWVNNCOIIHEPX-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- WPALTCMYPARVNV-UHFFFAOYSA-N tolfenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(OC=3C=CC(C)=CC=3)=CC=2)=C1Cl WPALTCMYPARVNV-UHFFFAOYSA-N 0.000 description 2
- 150000003852 triazoles Chemical class 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- QFNFRZHOXWNWAQ-UHFFFAOYSA-N triclopyricarb Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NC(Cl)=C(Cl)C=C1Cl QFNFRZHOXWNWAQ-UHFFFAOYSA-N 0.000 description 2
- 125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 description 2
- MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 2
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 2
- NRHFWOJROOQKBK-UHFFFAOYSA-N triphenyltin;hydrate Chemical compound O.C1=CC=CC=C1[Sn](C=1C=CC=CC=1)C1=CC=CC=C1 NRHFWOJROOQKBK-UHFFFAOYSA-N 0.000 description 2
- YNWVFADWVLCOPU-MAUPQMMJSA-N uniconazole P Chemical compound C1=NC=NN1/C([C@@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MAUPQMMJSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- XDEHMKQLKPZERH-BYPYZUCNSA-N (2s)-2-amino-3-methylbutanamide Chemical compound CC(C)[C@H](N)C(N)=O XDEHMKQLKPZERH-BYPYZUCNSA-N 0.000 description 1
- 125000004455 (C1-C3) alkylthio group Chemical group 0.000 description 1
- 125000004768 (C1-C4) alkylsulfinyl group Chemical group 0.000 description 1
- 125000004771 (C1-C4) haloalkylsulfinyl group Chemical group 0.000 description 1
- COLOHWPRNRVWPI-UHFFFAOYSA-N 1,1,1-trifluoroethane Chemical compound [CH2]C(F)(F)F COLOHWPRNRVWPI-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- IMLSAISZLJGWPP-UHFFFAOYSA-N 1,3-dithiolane Chemical compound C1CSCS1 IMLSAISZLJGWPP-UHFFFAOYSA-N 0.000 description 1
- OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 1
- BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 1
- SQAINHDHICKHLX-UHFFFAOYSA-N 1-naphthaldehyde Chemical compound C1=CC=C2C(C=O)=CC=CC2=C1 SQAINHDHICKHLX-UHFFFAOYSA-N 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- MQLACMBJVPINKE-UHFFFAOYSA-N 10-[(3-hydroxy-4-methoxyphenyl)methylidene]anthracen-9-one Chemical compound C1=C(O)C(OC)=CC=C1C=C1C2=CC=CC=C2C(=O)C2=CC=CC=C21 MQLACMBJVPINKE-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BNYCHCAYYYRJSH-UHFFFAOYSA-N 1h-pyrazole-5-carboxamide Chemical class NC(=O)C1=CC=NN1 BNYCHCAYYYRJSH-UHFFFAOYSA-N 0.000 description 1
- SFFUEHODRAXXIA-UHFFFAOYSA-N 2,2,2-trifluoroacetonitrile Chemical compound FC(F)(F)C#N SFFUEHODRAXXIA-UHFFFAOYSA-N 0.000 description 1
- SNTWKPAKVQFCCF-UHFFFAOYSA-N 2,3-dihydro-1h-triazole Chemical compound N1NC=CN1 SNTWKPAKVQFCCF-UHFFFAOYSA-N 0.000 description 1
- QFUSCYRJMXLNRB-UHFFFAOYSA-N 2,6-dinitroaniline Chemical class NC1=C([N+]([O-])=O)C=CC=C1[N+]([O-])=O QFUSCYRJMXLNRB-UHFFFAOYSA-N 0.000 description 1
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 1
- DBTWOTKWIVISQR-UHFFFAOYSA-N 2-bromopropan-1-ol Chemical compound CC(Br)CO DBTWOTKWIVISQR-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- KNXINOHLQFUXLB-UHFFFAOYSA-N 2-quinolin-4-ylacetic acid Chemical class C1=CC=C2C(CC(=O)O)=CC=NC2=C1 KNXINOHLQFUXLB-UHFFFAOYSA-N 0.000 description 1
- MBMDRPGKRRJGSQ-UHFFFAOYSA-N 3,4-dihydrodioxazine Chemical compound C1NOOC=C1 MBMDRPGKRRJGSQ-UHFFFAOYSA-N 0.000 description 1
- RQFUZUMFPRMVDX-UHFFFAOYSA-N 3-Bromo-1-propanol Chemical compound OCCCBr RQFUZUMFPRMVDX-UHFFFAOYSA-N 0.000 description 1
- RSIABUHRZDERKI-UHFFFAOYSA-N 4-(ethylamino)-1,3-thiazole-2-carboxamide Chemical class CCNC1=CSC(C(N)=O)=N1 RSIABUHRZDERKI-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 description 1
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
- GBRSPKXOFRTAHS-UHFFFAOYSA-N 5-(4-nitrophenyl)-1,2-oxazole-3-carboxylic acid Chemical compound O1N=C(C(=O)O)C=C1C1=CC=C([N+]([O-])=O)C=C1 GBRSPKXOFRTAHS-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- UHYISDCXHNDRHZ-UHFFFAOYSA-N 7h-[1,3]thiazolo[5,4-e]benzotriazole Chemical compound C1=CC2=NCSC2=C2N=NN=C21 UHYISDCXHNDRHZ-UHFFFAOYSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000055025 Adenosine deaminases Human genes 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- 239000005739 Bordeaux mixture Substances 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 102000005469 Chitin Synthase Human genes 0.000 description 1
- 108700040089 Chitin synthases Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 244000299507 Gossypium hirsutum Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- DBTDEFJAFBUGPP-UHFFFAOYSA-N Methanethial Chemical compound S=C DBTDEFJAFBUGPP-UHFFFAOYSA-N 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 102100032199 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 Human genes 0.000 description 1
- 241000221961 Neurospora crassa Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 1
- 241000233679 Peronosporaceae Species 0.000 description 1
- 241000682645 Phakopsora pachyrhizi Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 108010030975 Polyketide Synthases Proteins 0.000 description 1
- 241000221300 Puccinia Species 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 241000592344 Spermatophyta Species 0.000 description 1
- 102000005782 Squalene Monooxygenase Human genes 0.000 description 1
- 108020003891 Squalene monooxygenase Proteins 0.000 description 1
- 229930182692 Strobilurin Natural products 0.000 description 1
- 101710183280 Topoisomerase Proteins 0.000 description 1
- 239000005848 Tribasic copper sulfate Substances 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- 101710175177 Very-long-chain 3-oxoacyl-CoA reductase Proteins 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 241000758405 Zoopagomycotina Species 0.000 description 1
- AOBHTXFZZPUOGU-UHFFFAOYSA-N [2-(trifluoromethyl)-1,3-dioxolan-2-yl]methanol Chemical compound OCC1(C(F)(F)F)OCCO1 AOBHTXFZZPUOGU-UHFFFAOYSA-N 0.000 description 1
- JEDZLBFUGJTJGQ-UHFFFAOYSA-N [Na].COCCO[AlH]OCCOC Chemical compound [Na].COCCO[AlH]OCCOC JEDZLBFUGJTJGQ-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000009418 agronomic effect Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000007854 aminals Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940054066 benzamide antipsychotics Drugs 0.000 description 1
- 150000003936 benzamides Chemical class 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- RRIWSQXXBIFKQM-UHFFFAOYSA-N benzylcarbamic acid Chemical class OC(=O)NCC1=CC=CC=C1 RRIWSQXXBIFKQM-UHFFFAOYSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- HJZVHUQSQGITAM-UHFFFAOYSA-N butanamide Chemical compound CC[CH]C(N)=O HJZVHUQSQGITAM-UHFFFAOYSA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000005569 butenylene group Chemical group 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005622 butynylene group Chemical class 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000012677 causal agent Substances 0.000 description 1
- 108010040093 cellulose synthase Proteins 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- OMZSGWSJDCOLKM-UHFFFAOYSA-N copper(II) sulfide Chemical compound [S-2].[Cu+2] OMZSGWSJDCOLKM-UHFFFAOYSA-N 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002933 cyclohexyloxy group Chemical group C1(CCCCC1)O* 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000006638 cyclopentyl carbonyl group Chemical group 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001887 cyclopentyloxy group Chemical group C1(CCCC1)O* 0.000 description 1
- 125000006255 cyclopropyl carbonyl group Chemical group [H]C1([H])C([H])([H])C1([H])C(*)=O 0.000 description 1
- 125000006450 cyclopropyl cyclopropyl group Chemical group 0.000 description 1
- 125000004859 cyclopropyloxymethyl group Chemical group C1(CC1)OC* 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- YDVNLQGCLLPHAH-UHFFFAOYSA-N dichloromethane;hydrate Chemical compound O.ClCCl YDVNLQGCLLPHAH-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 150000004683 dihydrates Chemical group 0.000 description 1
- FFHWGQQFANVOHV-UHFFFAOYSA-N dimethyldioxirane Chemical compound CC1(C)OO1 FFHWGQQFANVOHV-UHFFFAOYSA-N 0.000 description 1
- 150000004844 dioxiranes Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 150000004863 dithiolanes Chemical class 0.000 description 1
- UZZWBUYVTBPQIV-UHFFFAOYSA-N dme dimethoxyethane Chemical compound COCCOC.COCCOC UZZWBUYVTBPQIV-UHFFFAOYSA-N 0.000 description 1
- 238000007350 electrophilic reaction Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000006437 ethyl cyclopropyl group Chemical group 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000000806 fluorine-19 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000002373 hemiacetals Chemical class 0.000 description 1
- 150000002374 hemiaminals Chemical class 0.000 description 1
- VBZWSGALLODQNC-UHFFFAOYSA-N hexafluoroacetone Chemical class FC(F)(F)C(=O)C(F)(F)F VBZWSGALLODQNC-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- NDJGGFVLWCNXSH-UHFFFAOYSA-N hydroxy(trimethoxy)silane Chemical compound CO[Si](O)(OC)OC NDJGGFVLWCNXSH-UHFFFAOYSA-N 0.000 description 1
- RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 125000003971 isoxazolinyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- MAGPZHKLEZXLNU-UHFFFAOYSA-N mandelamide Chemical compound NC(=O)C(O)C1=CC=CC=C1 MAGPZHKLEZXLNU-UHFFFAOYSA-N 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 150000002780 morpholines Chemical class 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000037023 motor activity Effects 0.000 description 1
- AEXITZJSLGALNH-UHFFFAOYSA-N n'-hydroxyethanimidamide Chemical compound CC(N)=NO AEXITZJSLGALNH-UHFFFAOYSA-N 0.000 description 1
- JHBTVPLZRMXZKD-UHFFFAOYSA-N n-(pyridin-2-ylmethyl)benzamide Chemical class C=1C=CC=CC=1C(=O)NCC1=CC=CC=N1 JHBTVPLZRMXZKD-UHFFFAOYSA-N 0.000 description 1
- BOBIZDGUDNVINH-UHFFFAOYSA-N n-[2-[4-[3-(4-chlorophenyl)prop-2-ynoxy]-3-methoxyphenyl]ethyl]-2-(methanesulfonamido)-3-methylbutanamide Chemical compound COC1=CC(CCNC(=O)C(NS(C)(=O)=O)C(C)C)=CC=C1OCC#CC1=CC=C(Cl)C=C1 BOBIZDGUDNVINH-UHFFFAOYSA-N 0.000 description 1
- 229960003255 natamycin Drugs 0.000 description 1
- 235000010298 natamycin Nutrition 0.000 description 1
- 239000004311 natamycin Substances 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 238000007344 nucleophilic reaction Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 238000010653 organometallic reaction Methods 0.000 description 1
- COWNFYYYZFRNOY-UHFFFAOYSA-N oxazolidinedione Chemical compound O=C1COC(=O)N1 COWNFYYYZFRNOY-UHFFFAOYSA-N 0.000 description 1
- 150000001475 oxazolidinediones Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N pentanoic acid group Chemical class C(CCCC)(=O)O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- GCSHUYKULREZSJ-UHFFFAOYSA-N phenyl(pyridin-2-yl)methanone Chemical class C=1C=CC=NC=1C(=O)C1=CC=CC=C1 GCSHUYKULREZSJ-UHFFFAOYSA-N 0.000 description 1
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229960005206 pyrazinamide Drugs 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- LJXQPZWIHJMPQQ-UHFFFAOYSA-N pyrimidin-2-amine Chemical class NC1=NC=CC=N1 LJXQPZWIHJMPQQ-UHFFFAOYSA-N 0.000 description 1
- QDGHXQFTWKRQTG-UHFFFAOYSA-N pyrimidin-2-ylhydrazine Chemical class NNC1=NC=CC=N1 QDGHXQFTWKRQTG-UHFFFAOYSA-N 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 108010010116 scytalone dehydratase Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000012419 sodium bis(2-methoxyethoxy)aluminum hydride Substances 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 108010025009 spectrin-like proteins Proteins 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- LITQZINTSYBKIU-UHFFFAOYSA-F tetracopper;hexahydroxide;sulfate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Cu+2].[Cu+2].[Cu+2].[Cu+2].[O-]S([O-])(=O)=O LITQZINTSYBKIU-UHFFFAOYSA-F 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 150000003548 thiazolidines Chemical class 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 150000003558 thiocarbamic acid derivatives Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 125000005490 tosylate group Chemical group 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 238000005583 trifluoroacetylation reaction Methods 0.000 description 1
- 238000006692 trifluoromethylation reaction Methods 0.000 description 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- 108010013280 ubiquinol oxidase Proteins 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/06—Unsaturated carboxylic acids or thio analogues thereof; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
- A01N37/32—Cyclic imides of polybasic carboxylic acids or thio analogues thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/34—Nitriles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
- A01N37/38—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system
- A01N37/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system having at least one carboxylic group or a thio analogue, or a derivative thereof, and one oxygen or sulfur atom attached to the same aromatic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/24—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
- A01N43/26—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings
- A01N43/28—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings with two hetero atoms in positions 1,3
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/44—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom three- or four-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
- A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/713—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with four or more nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
- A01N43/76—1,3-Oxazoles; Hydrogenated 1,3-oxazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
- A01N43/78—1,3-Thiazoles; Hydrogenated 1,3-thiazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/82—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
- A01N47/12—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring
- A01N47/14—Di-thio analogues thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
Definitions
- This invention relates to certain halomethyl ketone and hydrate derivatives, their A-oxidcs and salts, and to mixtures and compositions comprising such halomethyl ketone and hydrate derivatives and methods for using such derivatives and their mixtures and compositions as fungicides.
- This invention relates to a fungicidal composition (i.e. combination, mixture) comprising
- T is selected from the group consisting of: wherein the bond extending to the left is attached to A;
- R 1 is CF 3 , CHF 2 , CC1 3 , CHC1 2 , CF 2 C1, CFC1 2 or CHFC1;
- W is O, S or NR 3 ;
- R 3a is H, benzyl, C 4 -C 4 alkyl, C 2 -C 4 alkylcarbonyl or C 2 -C 4 haloalkylcarbonyl;
- R 3b is H, C 4 -C 4 alkyl, C 2 -C 4 alkylcarbonyl or C 2 -C 4 haloalkylcarbonyl;
- R 3C is H or C 4 -C 4 alkyl
- R 3b and R 3c are taken together to form a 4- to 6-membered fully saturated heterocyclic ring, each ring containing ring members, in addition to the connecting nitrogen atom, selected from carbon atoms and up to 2 heteroatoms independently selected from up to 2 O, up to 2 S and up to 2 N atoms, each ring optionally substituted with up to 2 methyl groups;
- X is O, S or NR 5a ;
- Y is O, S or NR 5b ;
- R 5a and R 5b are each independently H, hydroxy or C 4 -C 4 alkyl
- R 2a and R 2b are each independently H, C 4 -C 4 alkyl, C 2 -C 4 alkenyl, C 3 -C
- R 2C is C 4 -C 4 alkyl, C 4 -C 4 haloalkyl, C 2 -C 4 alkenyl, C 2 -C 4 haloalkenyl, C 2 -C 4 alkynyl, C 2 -C 4 haloalkynyl or trifluoromethylsulfonyl, each optionally substituted with up 2 substituents independently selected from cyano, hydroxy, SCoN and C
- R 2d is H, cyano, halogen or C1-C4 alkyl; each R 4a and R 4b is independently H or C4-C4 alkyl;
- p is 2 or 3; when T is T-l or T-2, then A is A 1 -A 2 -CR 6a R 6b , wherein A 1 is connected to J, and CR 6a R 6b is connected to T; when T is T-3, then A is A ! -A 2 , wherein A 1
- a 2 is a direct bond, CR 6e R 6f , N(R 7b ), O or S;
- J is selected from the group consisting of:
- each R 8 is independently F, Cl, I, Br, cyano, methyl, trifluoromethyl or methoxy; q is 0, 1, 2, 3 or 4;
- L is (CR 9a R 9b ) n ; each R 9a and R 9b is independently H, halogen, cyano, hydroxy, nitro, C 1 -C3 alkyl, C 3 -C3 haloalkyl, C 3 -C3 alkoxy or C 3 -C3 haloalkoxy; haloalkyl; or
- each R l la is independently halogen, hydroxy, cyano, amino, nitro, C 4 -C 4 alkyl, C 4 -C 4 haloalkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl
- E 2 is G-Z, wherein Z is attached to L;
- G is phenyl optionally substituted with up to 3 substituents independently selected from R 13 ; or
- G is a 5- to 6-membered heteroaromatic ring, each ring containing ring members selected from carbon atoms and 1 to 4 heteroatoms independently selected from up to 2 O, up to 2 S and up to 4 N atoms, each ring optionally substituted with up to 3 substituents independently selected from R 13 ; or
- R 18a and R 18b are taken together to form a 5- to 6-membered fully saturated heterocyclic ring, each ring containing ring members, in addition to the connecting nitrogen atom, selected from carbon atoms and up to 2 heteroatoms independently selected from up to 2 O, up to 2 S and up to 2 N atoms, each ring optionally substituted with up to 2 methyl groups; each R 19 is independently amino, cyano, halogen, hydroxy, nitro, -SH, C 4 -C 4 alkyl, C 4 -C 4 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C 4 -C 4 alkoxy, C 4 -C 4 haloalkoxy, C 2 -C 4 alkoxyalkoxy, C 1 -C 4 alkylthio, C 4 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 4 -C
- each R 22 is independently H, C 3 -C5 alkyl, C 3 -C5 haloalkyl, C 2 -C5 alkenyl, C 2 -C5 haloalkenyl, C 2 -C5 alkynyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C 2 -C5 alkylcarbonyl or C 2 -C5 alkoxycarbonyl; or each R 22 is phenyl optionally substituted with up to 2 substituents independently selected halogen and C 3 -C3 alkyl; or a 5- to 6-membered fully saturated heterocyclic ring, each ring containing ring members selected from carbon atoms and up to 2 heteroatoms independently selected from up to 2 O, up
- This invention also relates to a composition
- a composition comprising: (a) at least one compound selected from the compounds of Formula 1 described above, /V-oxides, and salts thereof; and at least one invertebrate pest control compound or agent.
- This invention also relates to a composition
- a composition comprising one of the aforesaid compositions comprising component (a) and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.
- This invention also relates to a method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof, or to the plant seed, a fungicidally effective amount of one of the aforesaid compositions.
- the aforedescribed method can also be described as a method for protecting a plant or plant seed from diseases caused by fungal pathogens comprising applying a fungicidally effective amount of one of the aforesaid compositions to the plant (or portion thereof) or plant seed (directly or through the environment (e.g., growing medium) of the plant or plant seed).
- This invention also relates to a compound of Formula 1 described above, a tautomer, an A-oxidc or salt thereof.
- compositions comprising, “comprising,” “includes,” “including,” “has,” “having,” “contains,” “containing,” “characterized by” or any other variation thereof, are intended to cover a non-exclusive inclusion, subject to any limitation explicitly indicated.
- a composition, mixture, process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, mixture, process, method, article, or apparatus.
- transitional phrase “consisting essentially of’ is used to define a composition, method or apparatus that includes materials, steps, features, components, or elements, in addition to those literally disclosed, provided that these additional materials, steps, features, components, or elements do not materially affect the basic and novel characteristic(s) of the claimed invention.
- the term “consisting essentially of’ occupies a middle ground between “comprising” and “consisting of’.
- agronomic refers to the production of field crops such as for food and fiber and includes the growth of maize or corn, soybeans and other legumes, rice, cereal (e.g., wheat, oats, barley, rye and rice), leafy vegetables (e.g., lettuce, cabbage, and other cole crops), fruiting vegetables (e.g., tomatoes, pepper, eggplant, crucifers and cucurbits), potatoes, sweet potatoes, grapes, cotton, tree fruits (e.g., pome, stone and citrus), small fruit (e.g., berries and cherries) and other specialty crops (e.g., canola, sunflower and olives).
- wheat e.g., wheat, oats, barley, rye and rice
- leafy vegetables e.g., lettuce, cabbage, and other cole crops
- fruiting vegetables e.g., tomatoes, pepper, eggplant, crucifers and cucurbits
- potatoes e.g., sweet potatoes, grapes, cotton, tree fruits (e
- nonagronomic refers to other than field crops, such as horticultural crops (e.g., greenhouse, nursery or ornamental plants not grown in a field), residential, agricultural, commercial and industrial structures, turf (e.g., sod farm, pasture, golf course, lawn, sports field, etc.), wood products, stored product, agro-forestry and vegetation management, public health (i.e. human) and animal health (e.g., domesticated animals such as pets, livestock and poultry, undomesticated animals such as wildlife) applications.
- horticultural crops e.g., greenhouse, nursery or ornamental plants not grown in a field
- turf e.g., sod farm, pasture, golf course, lawn, sports field, etc.
- wood products e.g., stored product, agro-forestry and vegetation management
- public health i.e. human
- animal health e.g., domesticated animals such as pets, livestock and poultry, undomesticated animals such as wildlife
- crop vigor refers to rate of growth or biomass accumulation of a crop plant.
- An “increase in vigor” refers to an increase in growth or biomass accumulation in a crop plant relative to an untreated control crop plant.
- the term “crop yield” refers to the return on crop material, in terms of both quantity and quality, obtained after harvesting a crop plant.
- An “increase in crop yield” refers to an increase in crop yield relative to an untreated control crop plant.
- biologically effective amount refers to the amount of a biologically active compound (e.g., a compound of Formula 1 or a mixture with at least one other fungicidal compound) sufficient to produce the desired biological effect when applied to (i.e. contacted with) a fungus to be controlled or its environment, or to a plant, the seed from which the plant is grown, or the locus of the plant (e.g., growth medium) to protect the plant from injury by the fungal disease or for other desired effect (e.g., increasing plant vigor).
- a biologically active compound e.g., a compound of Formula 1 or a mixture with at least one other fungicidal compound
- plant includes members of Kingdom Plantae, particularly seed plants (Spermatopsida), at all life stages, including young plants (e.g., germinating seeds developing into seedlings) and mature, reproductive stages (e.g., plants producing flowers and seeds).
- Portions of plants include geotropic members typically growing beneath the surface of the growing medium (e.g., soil), such as roots, tubers, bulbs and corms, and also members growing above the growing medium, such as foliage (including stems and leaves), flowers, fruits and seeds.
- seedling used either alone or in a combination of words means a young plant developing from the embryo of a seed.
- narrowleaf used either alone or in words such as “broadleaf crop” means dicot or dicotyledon, a term used to describe a group of angiosperms characterized by embryos having two cotyledons.
- fungal pathogen and “fungal plant pathogen” include pathogens in the Ascomycota, Basidiomycota and Zygomycota phyla, and the fungal-like Oomycota class that are the causal agents of a broad spectrum of plant diseases of economic importance, affecting ornamental, turf, vegetable, field, cereal and fruit crops.
- “protecting a plant from disease” or “control of a plant disease” includes preventative action (interruption of the fungal cycle of infection, colonization, symptom development and spore production) and/or curative action (inhibition of colonization of plant host tissues).
- MO A mode of action
- FRAC Fungicide Resistance Action Committee
- FRAC-defined modes of actions include (A) nucleic acids metabolism, (B) cytoskeleton and motor protein, (C) respiration, (D) amino acids and protein synthesis, (E) signal transduction, (F) lipid synthesis or transport and membrane integrity or function, (G) sterol biosynthesis in membranes, (H) cell wall biosynthesis, (I) melanin synthesis in cell wall, (P) host plant defense induction, (U) unknown mode of action, (M) chemicals with multi-site activity and (BM) biologicals with multiple modes of action.
- Each mode of action i.e.
- letters A through BM) contain one or more subgroups (e.g., A includes subgroups Al, A2, A3 and A4) based either on individual validated target sites of action, or in cases where the precise target site is unknown, based on cross resistance profiles within a group or in relation to other groups.
- Each of these subgroups e.g., Al, A2, A3 and A4 is assigned a FRAC code which is a number and/or letter.
- the FRAC code for subgroup Al is 4. Additional information on target sites and FRAC codes can be obtained from publicly available databases maintained, for example, by FRAC.
- cross resistance refers to the phenomenon that occurs when a pathogen develops resistance to one fungicide and simultaneously becomes resistant to one or more other fungicides. These other fungicides are typically, but not always, in the same chemical class or have the same target site of action, or can be detoxified by the same mechanism.
- alkyl used either alone or in compound words such as “alkylthio” or “haloalkyl” includes straight-chain and branched alkyl, such as, methyl, ethyl, n -propyl, /-propyl, and the different butyl, pentyl and hexyl isomers.
- Alkenyl includes straight- chain and branched alkenes such as ethenyl, 1-propenyl, 2-propenyl, and the different butenyl, pentenyl and hexenyl isomers.
- Alkenyl also includes polyenes such as 1,2-propadienyl and 2,4-hexadienyl.
- Alkynyl includes straight-chain and branched alkynes such as ethynyl, 1-propynyl, 2-propynyl, and the different butynyl, pentynyl and hexynyl isomers.
- Alkynyl can also include moieties comprised of multiple triple bonds such as 2,5-hexadiynyl.
- Alkylene denotes a straight-chain or branched alkanediyl.
- alkylene examples include CH2, CH2CH2, CH(CH3), CH2CH2CH2, CH2CH(CH3), and the different butylene isomers.
- Alkynylene denotes a straight-chain or branched alkynediyl containing one triple bond.
- alkynylene examples include CH2CoC, CoCCH2, and the different butynylene, pentynylene or hexynylene isomers.
- cycloalkylene denotes a cycloalkanediyl ring.
- examples of “cycloalkylene” include cyclobutanediyl, cyclopentanediyl and cyclohexanediyl.
- cycloalkenylene denotes a cycloalkenediyl ring containing one olefinic bond. Examples of “cycloalkenylene” include cyclopropenediyl and cyclopentenediyl.
- Alkoxy includes, for example, methoxy, ethoxy, 77-propyloxy, /-propyloxy, and the different butoxy, pentoxy and hexyloxy isomers.
- Alkynyloxy includes straight-chain and branched alkynyl attached to and linked through an oxygen atom. Examples of “alkynyloxy” include HCoCCH 2 0 and CH 3 CoCCH 2 0.
- alkylthio includes straight-chain and branched alkylthio moieties such as methylthio, ethylthio, and the different propylthio and butylthio isomers.
- Alkenylsulfinyl includes both enantiomers of an alkenylsulfinyl group.
- Alkynylthio includes straight-chain and branched alkynyl attached to and linked through a sulfur atom. Examples of “alkynylthio” include HCoCCH 2 S and CH 3 CoCCH 2 S.
- Alkynylsulfinyl includes both enantiomers of an alkynylsulfinyl group.
- Alkylthioalkyl denotes alkylthio substitution on alkyl.
- alkylthioalkyl include CH 3 SCH 2 , CH 3 SCH 2 CH 2 , CH 3 CH 2 SCH 2 , CH 3 CH 2 CH 2 SCH 2 and CH 3 CH 2 SCH 2 CH 2 ;
- alkylsulfinylalkyl and alkylsulfonylalkyl include the corresponding sulfoxides and sulfones, respectively.
- the terms “(alkenylthio)carbonyl” and “(alkynylthio)carbonyl” are likewise defined.
- alkenyl(thiocarbonyl) and alkynyl(thiocarbonyl) are likewise defined.
- alkenylamino(thiocarbonyl) and alkynylamino(thiocarbonyl) are likewise defined.
- alkenylthio)carbonylamino and “(alkynylthio)carbonylamino” are likewise defined. Examples of
- Alkylamino includes an NH radical substituted with a straight-chain or branched alkyl group.
- alkylamino include CH 3 CH 2 NH, CH 3 CH 2 CH 2 NH, and
- alky laminoalky G examples include CH 3 NHCH 2 , CH 3 NHCH 2 CH 2 , CH 3 CH 2 NHCH 2 ,
- alkynyloxycarbonyl are likewise defined.
- alkenylaminocarbonyl and “alkynylaminocarbonyl” are likewise defined.
- alkenylcarbonylamino and alkynylcarbonylamino are likewise defined.
- alkynylcarbonylamino include
- alkenylaminocarbonylamino and “alkynylaminocarbonylamino” are likewise defined.
- alkynylaminocarbonylamino examples include
- Alkylsulfonylamino denotes an NH radical substituted with alkylsulfonyl.
- alkenylsulfonylamino and “alkynylsulfonylamino” are likewise defined.
- alkylsulfonyloxy denotes an alkylsulfonyl group bonded to an oxygen atom.
- alkenylaminosulfonyl and “alkynylaminosulfonyl” are likewise defined.
- alkynylaminosulfonyl include
- alkenylaminosulfonylamino and
- alky ny lamino sulfony lamino are likewise defined.
- Alkoxyalkyl denotes alkoxy substitution on alkyl.
- alkoxyalkyl examples include CH 3 0CH 2 , CH 3 OCH 2 CH 2 , CH 3 CH 2 OCH 2 , CH 3 CH 2 CH 2 OCH 2 and CH 3 CH 2 OCH 2 CH 2 .
- Alkoxyalkoxy denotes alkoxy substitution on another alkoxy moiety.
- Alkoxyalkoxyalkyl denotes alkoxyalkoxy substitution on alkyl.
- alkoxyalkoxyalkyl include CH 3 OCH 2 OCH 2 , CH 3 OCH 2 OCH 2 CH 2 and CH 3 CH 2 OCH 2 OCH 2 .
- alkenylcarbonyloxy and “alkynylcarbonyloxy” are likewise defined.
- alkynylcarbonyloxy include
- alkenylaminocarbonyloxy and “alkynylaminocarbonyloxy” are likewise defined.
- Cycloalkyl includes, for example, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
- the term “cycloalkylalkyl” denotes cycloalkyl substitution on an alkyl moiety. Examples of “cycloalkylalkyl” include cyclopropylmethyl, cyclopentylethyl, and other cycloalkyl moieties bonded to a straight-chain or branched alkyl group.
- alkylcycloalkyl denotes alkyl substitution on a cycloalkyl moiety and includes, for example, ethylcyclopropyl, z-propylcyclobutyl, methylcyclopentyl and methylcyclohexyl.
- Alkylcycloalkylalkyl denotes alkylcycloalkyl substitution on alkyl. Examples of “alkylcycloalkylalkyl” include methylcyclohexylmethyl and ethylcycloproylmethyl.
- Cycloalkenyl includes groups such as cyclopentenyl and cyclohexenyl as well as groups with more than one double bond such as 1,3- or 1,4-cyclohexadienyl.
- cycloalky lcycloalkyl denotes cycloalkyl substitution on another cycloalkyl ring, wherein each cycloalkyl ring independently has from 3 to 7 carbon atom ring members.
- cycloalky lcycloalkyl examples include cyclopropylcyclopropyl (such as 1,1'- bicyclopropyl-l-yl, l,l'-bicyclopropyl-2-yl), cyclohexylcyclopentyl (such as 4- cyclopentylcyclohexyl) and cyclohexylcyclohexyl (such as I,G-bicyclohexyl-l-yl), and the different cis- and / ra nv - c y c 1 o a 1 k y 1 c y c 1 o a 1 k y 1 isomers, (such as ( 1 R.2S)- 1 , 1 '-bicyclopropyl-2-yl and ( IR,2R)- 1 , 1 '-bicyclopropyl-2-yl) .
- cyclopropylcyclopropyl such as 1,1
- cycloalkoxy denotes cycloalkyl attached to and linked through an oxygen atom including, for example, cyclopentyloxy and cyclohexyloxy.
- cycloalkoxyalkyl denotes cycloalkoxy substitution on an alkyl moiety. Examples of “cycloalkoxyalkyl” include cyclopropyloxymethyl, cyclopentyloxyethyl, and other cycloalkoxy groups bonded to a straight-chain or branched alkyl moiety.
- cycloalkylaminoalkyl denotes cycloalkylamino substitution on an alkyl group.
- examples of “cycloalkylaminoalkyl” include cyclopropylaminomethyl, cyclopentylaminoethyl, and other cycloalkylamino moieties bonded to a straight-chain or branched alkyl group.
- Cycloalkylcarbonyloxy denotes cycloalkylcarbonyl attached to and linked through an oxygen atom. Examples of “cycloalkylcarbonyloxy” include cyclohexylcarbonyloxy and cyclopentylcarbonyloxy.
- halogen either alone or in compound words such as “haloalkyl”, or when used in descriptions such as “alkyl substituted with halogen” includes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as “haloalkyl”, or when used in descriptions such as “alkyl substituted with halogen” said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of “haloalkyl” or “alkyl substituted with halogen” include CF3, CICH2, CF3CH2 and CF3CCI2.
- haloalkynyl examples include HOCCHC1, CF 3 CoC, CC1 3 CoC and FCH 2 CoCCH 2 .
- haloalkoxy examples include CF 3 0, CC1 3 CH 2 0, F 2 CHCH2CH 2 0 and CF3CH2O.
- halocycloalkyl examples include 2-chlorocyclopropyl, 2-fluorocyclobutyl, 3-bromocyclopentyl and 4-chorocyclohexyl.
- Cyanoalkyl denotes an alkyl group substituted with one cyano group. Examples of “cyanoalkyl” include NCCH 2 , NCCH 2 CH 2 and CH 3 CH(CN)CH 2 .
- “Hydroxyalkyl” denotes an alkyl group substituted with one hydroxy group. Examples of “hydroxyalkyl” include HOCH 2 CH 2 , CH 3 CH 2 (OH)CH and HOCH 2 CH 2 CH 2 CH 2 .
- Trialkylsilyl includes 3 branched and/or straight-chain alkyl radicals attached to and linked through a silicon atom, such as trimethylsilyl, triethylsilyl and / ⁇ ?/ 7-butyldi methyl si lyl.
- the term “halotrialkylsilyl” is likewise defined. Examples of “halotrialkylsilyl” include trifluormethylsilyl and trichloromethylsilyl.
- C1-C4 alkylsulfonyl designates methylsulfonyl through butylsulfonyl
- C 2 alkoxyalkyl designates CH 3 OCH 2
- C 3 alkoxyalkyl designates, for example, CH 3 CH(OCH 3 ), CH 3 OCH 2 CH 2 or CH 3 CH 2 OCH 2
- C4 alkoxyalkyl designates the various isomers of an alkyl group substituted with an alkoxy group containing a total of four carbon atoms, examples including CH 3 CH 2 CH 2 OCH 2 and CH 3 CH 2 OCH 2 CH 2 .
- a molecular fragment i.e. radical
- a series of atom symbols e.g., C, H, N, O and S
- the point or points of attachment may be explicitly indicated by a hyphen
- unsubstituted in connection with a group such as a ring or ring system means the group does not have any substituents other than its one or more attachments to the remainder of Formula 1.
- optionally substituted means that the number of substituents can be zero. Unless otherwise indicated, optionally substituted groups may be substituted with as many optional substituents as can be accommodated by replacing a hydrogen atom with a non-hydrogen substituent on any available carbon or nitrogen atom. Commonly, the number of optional substituents (when present) ranges from 1 to 3.
- the term “optionally substituted” is used interchangeably with the phrase “substituted or unsubstituted” or with the term “(un)substituted.”
- the number of optional substituents may be restricted by an expressed limitation.
- the phrase “optionally substituted with up to 3 substituents independently selected from R 13 ” means that 0, 1, 2 or 3 substituents can be present (if the number of potential connection points allows).
- a range specified for the number of substituents e.g., x being an integer from 0 to 3 in Exhibit A
- the number of positions available for substituents on a ring e.g., 1 position available for (R 13 ) x on G-7 in Exhibit A
- the actual higher end of the range is recognized to be the number of available positions.
- the dotted line in rings depicted in the present description (e.g., the rings G-44, G-45, G-48 and G-49 shown in Exhibit A) represents that the bond indicated can be a single bond or double bond.
- a “ring” or “ring system” as a component of Formula 1 is carbocyclic or heterocyclic.
- the term “ring system” denotes two or more connected rings.
- the term “spirocyclic ring system” denotes a ring system consisting of two rings connected at a single atom (so the rings have a single atom in common).
- the term “bicyclic ring system” denotes a ring system consisting of two rings sharing two or more common atoms. In a “fused bicyclic ring system” the common atoms are adjacent, and therefore the rings share two adjacent atoms and a bond connecting them.
- aromatic indicates that each of the ring atoms is essentially in the same plane and has a p-orbital perpendicular to the ring plane, and that (4n + 2) p electrons, where n is a positive integer, are associated with the ring to comply with HiickeTs rule
- carbocyclic ring denotes a ring wherein the atoms forming the ring backbone are selected only from carbon. Unless otherwise indicated, a carbocyclic ring can be a saturated, partially unsaturated, or fully unsaturated ring. When a fully unsaturated carbocyclic ring satisfies HiickeTs rule, then said ring is also called an “aromatic ring”. “Saturated carbocyclic” refers to a ring having a backbone consisting of carbon atoms linked to one another by single bonds; unless otherwise specified, the remaining carbon valences are occupied by hydrogen atoms.
- the term “partially unsaturated ring” or “partially unsaturated heterocycle” refers to a ring which contains unsaturated ring atoms and one or more double bonds but is not aromatic.
- the terms “heterocyclic ring” or “heterocycle” denotes a ring wherein at least one of the atoms forming the ring backbone is other than carbon.
- a heterocyclic ring can be a saturated, partially unsaturated, or fully unsaturated ring. When a fully unsaturated heterocyclic ring satisfies HiickeTs rule, then said ring is also called a “heteroaromatic ring” or aromatic heterocyclic ring.
- “Saturated heterocyclic ring” refers to a heterocyclic ring containing only single bonds between ring members.
- heterocyclic rings and ring systems are attached to the remainder of Formula 1 through any available carbon or nitrogen atom by replacement of a hydrogen on said carbon or nitrogen atom.
- Stereoisomers are isomers of identical constitution but differing in the arrangement of their atoms in space and include enantiomers, diastereomers, cis- and /ran.s-isomcrs (also known as geometric isomers) and atropisomers. Atropisomers result from restricted rotation about single bonds where the rotational barrier is high enough to permit isolation of the isomeric species.
- one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s).
- Compounds of this invention may be present as a mixture of stereoisomers, individual stereoisomers, or as an optically active form.
- T is T-3
- Formula 1 compounds contain at least one double bond and the configuration of substituents about that double bond can be (Z) or (E) ( cis or trans), or a mixture thereof.
- a wavy bond indicates a single bond which is linked to an adjacent double bond wherein the geometry about the adjacent double bond is either (Z)-configuration (svn-isomcr or cA-isomer) or (C)-con figuration (anti- isomer or trans- isomer), or a mixture thereof. That is, a wavy bond represents an unspecified (Z)- or ( E )- (cis- or trans-) isomer, or mixture thereof.
- the compounds of the present invention can contain one or more chiral centers and therefore exist in enantiomeric and diastereomeric forms.
- This invention also includes compounds of Formula 1 wherein one stereoisomer is enriched relative to the other stereoisomer(s).
- compounds of Formula 1 wherein T is T-3 and the substituents attached to the double bond in the T-3 moiety are in a predominately (Z)- configuration, or predominately an (Tj-configuration.
- the ratio of the (Z)- to ( ⁇ -isomers in any compounds of Formula 1, whether produced stereoselectivity or non-stereoselectivity, may take on a broad range of values.
- compounds of Formula 1 may comprise from about 10 to 90 percent by weight of the (Z)- isomer to about 90 to 10 percent by weight of the (C)-isomcr.
- Formula 1 compounds may contain from about 15 to 85 percent by weight of the (Z)- isomer and about 85 to 15 percent by weight of the ( ⁇ -isomer; in another embodiment, the mixture contains about 25 to 75 percent by weight of the (Z)- isomer and about 75 to 25 percent by weight of the (C)-isomcr; in another embodiment, the mixture contains about 35 to 65 percent by weight of the (Z)- isomer and about 65 to 35 percent by weight of the (C)-isomcr; in another embodiment, the mixture contains about 45 to 55 percent by weight of the (Z)- isomer and about 55 to 45 percent by weight of the (C)-isomcr.
- this invention includes compounds that are enriched compared to the racemic mixture in an enantiomer of Formula 1. Also included are the essentially pure enantiomers of compounds of Formula 1. When enantiomerically enriched, one enantiomer is present in greater amounts than the other, and the extent of enrichment can be defined by an expression of enantiomeric excess (“ee”), which is defined as (2x-l) ⁇ 100%, where x is the mole fraction of the dominant enantiomer in the mixture (e.g., an ee of 20% corresponds to a 60:40 ratio of enantiomers).
- ee enantiomeric excess
- compositions of this invention have at least a 50% enantiomeric excess; more preferably at least a 75% enantiomeric excess; still more preferably at least a 90% enantiomeric excess; and the most preferably at least a 94% enantiomeric excess of the more active isomer.
- enantiomerically pure embodiments of the more active isomer are enantiomerically pure embodiments of the more active isomer.
- This invention comprises mixtures of conformational isomers.
- this invention includes compounds that are enriched in one conformer relative to others.
- This invention comprises all stereoisomers, conformational isomers and mixtures thereof in all proportions as well as isotopic forms such as deuterated compounds.
- nitrogen containing heterocycles can form A-oxidcs since the nitrogen requires an available lone pair for oxidation to the oxide; one skilled in the art will recognize those nitrogen-containing heterocycles which can form /V-oxides.
- nitrogen-containing heterocycles which can form /V-oxides.
- tertiary amines can form /V-oxides.
- salts of chemical compounds are in equilibrium with their corresponding nonsalt forms, salts share the biological utility of the nonsalt forms.
- the salts of the compounds of Formula 1 include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids.
- salts also include those formed with organic or inorganic bases such as pyridine, triethylamine or ammonia, or amides, hydrides, hydroxides or carbonates of sodium, potassium, lithium, calcium, magnesium or barium. Accordingly, the present invention comprises compounds selected from Formula 1, V-oxides, and agriculturally suitable salts, and solvates thereof.
- Non-crystalline forms include embodiments which are solids such as waxes and gums as well as embodiments which are liquids such as solutions and melts.
- Crystalline forms include embodiments which represent essentially a single crystal type and embodiments which represent a mixture of polymorphs (i.e. different crystalline types).
- polymorph refers to a particular crystalline form of a chemical compound that can crystallize in different crystalline forms, these forms having different arrangements and/or conformations of the molecules in the crystal lattice.
- polymorphs can have the same chemical composition, they can also differ in composition due to the presence or absence of co-crystallized water or other molecules, which can be weakly or strongly bound in the lattice. Polymorphs can differ in such chemical, physical and biological properties as crystal shape, density, hardness, color, chemical stability, melting point, hygroscopicity, suspensibility, dissolution rate and biological availability.
- beneficial effects e.g., suitability for preparation of useful formulations, improved biological performance
- ketones of Formula l 1 i.e. compounds of Formula 1 wherein T is T-l
- ketones of Formula l 2 may exist in equilibrium with their corresponding hydrates of Formula l 2 (i.e. compounds of Formula 1 wherein T is T-2, and R 2a X and R 2b Y are both OH).
- the equilibrium typically favors the hydrate form.
- This invention comprises all ketonic and solvated forms of Formula 1 compounds, and mixtures thereof in all proportions. Unless otherwise indicated, reference to a compound by one tautomer description is to be considered to include all tautomers.
- some of the unsaturated rings and ring systems depicted in Exhibit A can have an arrangement of single and double bonds between ring members different from that depicted. Such differing arrangements of bonds for a particular arrangement of ring atoms correspond to different tautomers.
- the particular tautomer depicted is to be considered representative of all the tautomers possible for the arrangement of ring atoms shown.
- an aspect of the present invention is directed at a composition
- a composition comprising (a) at least one compound selected from Formula 1, /V-oxides, and salts thereof, with (b) at least one additional fungicidal compound. More particularly, Component (b) is selected from the group consisting of
- keto reductase inhibitor (bl7) keto reductase inhibitor (KRI) fungicides
- OSBPI oxy sterol binding protein inhibitor
- component (b54) fungicides other than fungicides of component (a) and components (bl) through (b53); and salts of compounds of (bl) through (b54).
- component (b) comprises at least one fungicidal compound from each of two different groups selected from (bl) through (b54).
- Methyl benzimidazole carbamate (MBC) fungicides (bl) (FRAC code 1) inhibit mitosis by binding to b-tubulin during microtubule assembly. Inhibition of microtubule assembly can disrupt cell division, transport within the cell and cell structure.
- Methyl benzimidazole carbamate fungicides include benzimidazole and thiophanate fungicides.
- the benzimidazoles include benomyl, carbendazim, fuberidazole and thiabendazole.
- the thiophanates include thiophanate and thiophanate-methyl.
- “Dicarboximide fungicides (b2)” (FRAC code 2) inhibit a mitogen-activated protein (MAP)/histidine kinase in osmotic signal transduction.
- MAP mitogen-activated protein
- Examples include chlozolinate, dimethachlone, iprodione, procymidone and vinclozolin.
- DMI Demethylation inhibitor
- fungicides (b3) FRAC code 3
- SBI Sterol Biosynthesis Inhibitors (SBI): Class I) inhibit C14-demethylase, which plays a role in sterol production.
- Sterols such as ergosterol, are needed for membrane structure and function, making them essential for the development of functional cell walls. Therefore, exposure to these fungicides results in abnormal growth and eventually death of sensitive fungi.
- DMI fungicides are divided between several chemical classes: piperazines, pyridines, pyrimidines, imidazoles, triazoles and triazolinthiones.
- the piperazines include triforine.
- the pyridines include buthiobate, pyrifenox, pyrisoxazole and (aS)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-4-isoxazolyl]-3- pyridinemethanol.
- the pyrimidines include fenarimol, nuarimol and triarimol.
- the imidazoles include econazole, imazalil, oxpoconazole, pefurazoate, prochloraz and triflumizole.
- the triazoles include azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole (including diniconazole-M), epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, ipfentrifluconazole, mefentrifluconazole, metconazole, myclobutanil, penconazole, propiconazole, quinconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, uniconazole-P, a-(l-chlorocyclopropyl)-a-[2-(2,2- dichlorocyclopropy
- the triazolinthiones include prothioconazole.
- Biochemical investigations have shown that all of the above mentioned fungicides are DMI fungicides as described by K. H. Kuck et al. in Modern Selective Fungicides - Properties, Applications and Mechanisms of Action, H. Lyr (Ed.), Gustav Fischer Verlag: New York, 1995, 205-258.
- Phenylamide (PA) fungicides (b4) are specific inhibitors of RNA polymerase in Oomycete fungi. Sensitive fungi exposed to these fungicides show a reduced capacity to incorporate uridine into rRNA. Growth and development in sensitive fungi is prevented by exposure to this class of fungicide.
- Phenylamide fungicides include acylalanine, oxazolidinone and butyrolactone fungicides.
- the acylalanines include benalaxyl, benalaxyl-M (also known as kiralaxyl), furalaxyl, metalaxyl and metalaxyl-M (also known as mefenoxam).
- the oxazolidinones include oxadixyl.
- the butyrolactones include ofurace.
- Amine/morpholine fungicides (also known as non-DMI sterol biosynthesis inhibitors) include morpholine, piperidine and spiroketal-amine fungicides.
- the morpholines include aldimorph, dodemorph, fenpropimorph, tridemorph and trimorphamide.
- the piperidines include fenpropidin and piperalin.
- the spiroketal-amines include spiroxamine.
- Phospholipid biosynthesis inhibitor fungicides (b6) (FRAC code 6) inhibit growth of fungi by affecting phospholipid biosynthesis.
- Phospholipid biosynthesis fungicides include phophorothiolate and dithiolane fungicides.
- the phosphorothiolates include edifenphos, iprobenfos and pyrazophos.
- the dithiolanes include isoprothiolane.
- “Succinate dehydrogenase inhibitor (SDHI) fungicides (b7)” (FRAC code 7) inhibit complex II fungal respiration by disrupting a key enzyme in the Krebs Cycle (TCA cycle) named succinate dehydrogenase. Inhibiting respiration prevents the fungus from making ATP, and thus inhibits growth and reproduction.
- SDHI fungicides include phenylbenzamide, phenyloxoethylthiophene amide, pyridinylethylbenzamide, furan carboxamide, oxathiin carboxamide, thiazole carboxamide, pyrazole-4-carboxamide, /V-cyclopropyl-ZV-benzyl-pyrazole carboxamide, /V-methoxy-(phenyl-ethyl)-pyrazole carboxamide, pyridine carboxamide and pyrazine carboxamide fungicides.
- the phenylbenzamides include benodanil, flutolanil and mepronil.
- the phenyloxoethylthiophene amides include isofetamid.
- the pyridinylethylbenzamide s include fluopyram.
- the furan carboxamides include fenfuram.
- the oxathiin carboxamides include carboxin and oxycarboxin.
- the thiazole carboxamides include thifluzamide.
- the pyrazole-4-carboxamides include benzovindiflupyr, bixafen, flubeneteram (provisional common name, Registry Number 1676101-39-5), fluindapyr, fluxapyroxad, furametpyr, inpyrfluxam, isopyrazam, penflufen, penthiopyrad, pyrapropoyne (provisional common name, Registry Number 1803108-03-3), sedaxane and /V-[2-(2,4-dichlorophenyl)-2- mcthoxy- 1 -mcthylcthylJ-3-(difluoiOmcthyl)- 1 -methyl- 1 //-pyrazolc-4-carboxamidc.
- the N- cyc lopropy 1 - A- benzy 1 -py azo lc carboxamides include isoflucypram.
- the A- mcthoxy-iphcnyl- ethyl)-pyrazole carboxamides include pydiflumetofen.
- the pyridine carboxamides include boscalid.
- the pyrazine carboxamides include pyraziflumid.
- Haldroxy-(2-amino-)pyrimidine fungicides (b8) (FRAC code 8) inhibit nucleic acid synthesis by interfering with adenosine deaminase. Examples include bupirimate, dimethirimol and ethirimol.
- AP fungicides
- FRAC code 9 a nucleophilicity factor 9 fungicides
- AP fungicides
- Examples include cyprodinil, mepanipyrim and pyrimethanil.
- A- Phenyl carbamate fungicides (blO)” (FRAC code 10) inhibit mitosis by binding to b- tubulin and disrupting microtubule assembly. Inhibition of microtubule assembly can disrupt cell division, transport within the cell and cell structure. Examples include diethofencarb.
- Quadrature outside inhibitor (Qol) fungicides (b 11 )” (FRAC code 11) inhibit complex III mitochondrial respiration in fungi by affecting ubiquinol oxidase. Oxidation of ubiquinol is blocked at the “quinone outside” (Qo) site of the cytochrome be ⁇ complex, which is located in the inner mitochondrial membrane of fungi. Inhibiting mitochondrial respiration prevents normal fungal growth and development.
- Quinone outside inhibitor fungicides include methoxyacrylate, methoxyacetamide, methoxycarbamate, oximinoacetate, oximinoacetamide and dihydrodioxazine fungicides (collectively also known as strobilurin fungicides), and oxazolidinedione, imidazolinone and benzy lcarbamate fungicides.
- the methoxy acrylates include azoxystrobin, coumoxystrobin, enoxastrobin (also known as enestroburin), flufenoxystrobin, picoxystrobin and pyraoxystrobin.
- the methoxyacetamides include mandestrobin.
- the methoxy- carbamates include pyraclostrobin, pyrametostrobin and triclopyricarb.
- the oximinoacetates include kresoxim-methyl and trifloxystrobin.
- the oximinoacetamides include dimoxystrobin, fenaminstrobin, metominostrobin and orysastrobin.
- the dihydrodioxazines include fluoxastrobin.
- the oxazolidinediones include famoxadone.
- the imidazolinones include fenamidone.
- the benzylcarbamates include pyribencarb.
- Phenylpyrrole (PP) fungicides (bl2) (FRAC code 12) inhibit a MAP/histidine kinase associated with osmotic signal transduction in fungi.
- Fenpiclonil and fludioxonil are examples of this fungicide class.
- Azanaphthalene fungicides (bl3) (FRAC code 13) are proposed to inhibit signal transduction by a mechanism which is as yet unknown. They have been shown to interfere with germination and/or appressorium formation in fungi that cause powdery mildew diseases.
- Azanaphthalene fungicides include ary loxy quinolines and quinazolinones.
- the aryloxyquinolines include quinoxyfen.
- the quinazolinones include proquinazid.
- Cell peroxidation inhibitor fungicides (bl4) are proposed to inhibit lipid peroxidation which affects membrane synthesis in fungi. Members of this class, such as etridiazole, may also affect other biological processes such as respiration and melanin biosynthesis.
- Cell peroxidation fungicides include aromatic hydrocarbon and 1,2,4-thiadiazole fungicides.
- the aromatic hydrocarboncarbon fungicides include biphenyl, chloroneb, dicloran, quintozene, tecnazene and tolclofos-methyl.
- the 1,2,4-thiadiazoles include etridiazole.
- Melanin biosynthesis inhibitor-reductase (MBI-R) fungicides (bl5)” (FRAC code 16.1) inhibit the naphthal reduction step in melanin biosynthesis.
- Melanin is required for host plant infection by some fungi.
- Melanin biosynthesis inhibitor-reductase fungicides include isobenzofuranone, pyrroloquinolinone and triazolobenzothiazole fungicides.
- the isobenzofuranones include fthalide.
- the pyrroloquinolinones include pyroquilon.
- the triazolobenzothiazoles include tricyclazole.
- Melanin biosynthesis inhibitor-dehydratase (MBI-D) fungicides (bl6a)” (FRAC code 16.2) inhibit scytalone dehydratase in melanin biosynthesis.
- Melanin is required for host plant infection by some fungi.
- Melanin biosynthesis inhibitor-dehydratase fungicides include cyclopropanecarboxamide, carboxamide and propionamide fungicides.
- the cyclopropanecarboxamides include carpropamid.
- the carboxamides include diclocymet.
- the propionamides include fenoxanil.
- MBI-P Melanin biosynthesis inhibitor-polyketide synthase
- bl6b fungicides
- FRAC code 16.3 inhibit polyketide synthase in melanin biosynthesis.
- Melanin is required for host plant infection by some fungi.
- Melanin biosynthesis inhibitor-polyketide synthase fungicides include trifluoroethylcarbamate fungicides. The trifluoroethylcarbamates include tolprocarb.
- Keto reductase inhibitor (KRI) fungicides (bl7) inhibit 3-keto reductase during C4-demethylation in sterol production.
- Keto reductase inhibitor fungicides also known as Sterol Biosynthesis Inhibitors (SBI): Class III
- SBI Sterol Biosynthesis Inhibitors
- Hydroxyanilides include fenhexamid.
- Amino-pyrazolinones include fenpyrazamine.
- Quinofumelin provisional common name, Registry Number 861647-84-9
- ipflufenoquin provisional common name, Registry Number 1314008-27-9
- Squalene-epoxidase inhibitor fungicides (bl8)” (FRAC code 18) (SBI: Class IV) inhibit squalene-epoxidase in the sterol biosynthesis pathway.
- Sterols such as ergosterol are needed for membrane structure and function, making them essential for the development of functional cell walls. Therefore exposure to these fungicides results in abnormal growth and eventually death of sensitive fungi.
- Squalene-epoxidase inhibitor fungicides include thiocarbamate and allylamine fungicides.
- the thiocarbamates include pyributicarb.
- the allylamines include naftifine and terbinafine.
- Polyoxin fungicides (bl9) (FRAC code 19) inhibit chitin synthase. Examples include polyoxin.
- Phenylurea fungicides (b20) are proposed to affect cell division. Examples include pencycuron.
- Quinone inside inhibitor (Qil) fungicides (b21) inhibit complex III mitochondrial respiration in fungi by affecting ubiquinone reductase. Reduction of ubiquinone is blocked at the “quinone inside” (Qi) site of the cytochrome be ⁇ complex, which is located in the inner mitochondrial membrane of fungi. Inhibiting mitochondrial respiration prevents normal fungal growth and development.
- Quinone inside inhibitor fungicides include cyanoimidazole, sulfamoyltriazole and picolinamide fungicides.
- the cyanoimidazoles include cyazofamid.
- the sulfamoyltriazoles include amisulbrom.
- the picolinamides include fenpicoxamid (Registry Number 517875-34-2).
- Benzamide and thiazole carboxamide fungicides inhibit mitosis by binding to b-tubulin and disrupting microtubule assembly. Inhibition of microtubule assembly can disrupt cell division, transport within the cell and cell structure.
- the benzamides include toluamides such as zoxamide.
- the thiazole carboxamides include ethylaminothiazole carboxamides such as ethaboxam.
- Enopyranuronic acid antibiotic fungicides (b23)
- FRAC code 23 inhibit growth of fungi by affecting protein biosynthesis. Examples include blasticidin-S.
- Halopyranosyl antibiotic fungicides (b24)
- FRAC code 24 inhibit growth of fungi by affecting protein biosynthesis. Examples include kasugamycin.
- Glucopyranosyl antibiotic protein synthesis fungicides (b25)” (FRAC code 25) inhibit growth of fungi by affecting protein biosynthesis. Examples include streptomycin.
- Glucopyranosyl antibiotic fungicides (b26) (FRAC code U18, previously FRAC code 26 reclassified to U18) are proposed to inhibit trehalase and inositol biosynthesis. Examples include validamycin.
- “Cyanoacetamideoxime fungicides (b27)” include cymoxanil.
- “Carbamate fungicides (b28)” (FRAC code 28) are considered multi-site inhibitors of fungal growth. They are proposed to interfere with the synthesis of fatty acids in cell membranes, which then disrupts cell membrane permeability. Iodocarb, propamacarb and prothiocarb are examples of this fungicide class.
- Oxidative phosphorylation uncoupling fungicides (b29) (FRAC code 29) inhibit fungal respiration by uncoupling oxidative phosphorylation. Inhibiting respiration prevents normal fungal growth and development.
- This class includes dinitrophenyl crotonates such as binapacryl, meptyldinocap and dinocap, and 2,6-dinitroanilines such as fluazinam.
- Organic tin fungicides (b30) (FRAC code 30) inhibit adenosine triphosphate (ATP) synthase in oxidative phosphorylation pathway.
- examples include fentin acetate, fentin chloride and fentin hydroxide.
- Carboxylic acid fungicides (b31) inhibit growth of fungi by affecting deoxyribonucleic acid (DNA) topoisomerase type II (gyrase). Examples include oxolinic acid.
- Hetero aromatic fungicides (b32) are proposed to affect DNA/ribonucleic acid (RNA) synthesis.
- Heteroaromatic fungicides include isoxazoles and isothiazolones.
- the isoxazoles include hymexazole and the isothiazolones include octhilinone.
- Phosphonate fungicides (b33) include phosphorous acid and its various salts, including fosetyl-aluminum.
- Phthalamic acid fungicides (b34) include teclofthalam.
- Benzotriazine fungicides (b35) include triazoxide.
- Benzene-sulfonamide fungicides (b36) include flusulfamide.
- “Pyridazinone fungicides (b37)” include diclomezine.
- Thiophene-carboxamide fungicides (b38) are proposed to affect ATP production. Examples include silthiofam.
- “Complex I NADH oxidoreductase inhibitor fungicides (b39)” inhibit electron transport in mitochondria and include pyrimidinamines such as diflumetorim, pyrazole- 5-carboxamides such as tolfenpyrad, and quinazoline such as fenazaquin.
- Carboxylic acid amide (CAA) fungicides (b40) inhibit cellulose synthase which prevents growth and leads to death of the target fungus.
- Carboxylic acid amide fungicides include cinnamic acid amide, valinamide carbamate and mandelic acid amide fungicides.
- the cinnamic acid amides include dimethomorph, flumorph and pyrimorph.
- the valinamide carbamates include benthiavalicarb, benthiavalicarb-isopropyl, iprovalicarb, tolprocarb and valifenalate (also known as valiphenal).
- the mandelic acid amides include mandipropamid, N- [2- [4- [ [3 -(4-chloropheny l)-2-propyn- 1 -yl] oxy ] -3 -methoxyphenyl] ethyl] -3 -methyl-2- [(methylsulfonyl)amino]butanamide and A-[2-[4-[[3-(4-chlorophenyl)-2-propyn-l-yl]oxy]-3- methoxyphenyl]ethyl]-3-methyl-2-[(ethylsulfonyl)amino]butanamide.
- Tetracycline antibiotic fungicides (b41) (FRAC code 41) inhibit growth of fungi by affecting protein synthesis. Examples include oxy tetracycline.
- Thiocarbamate fungicides (b42) include methasulfocarb.
- Benzamide fungicides (b43) inhibit growth of fungi by delocalization of spectrin-like proteins.
- examples include pyridinylmethyl benzamides such as fluopicolide and fluopimomide.
- Microbial fungicides (b44) disrupt fungal pathogen cell membranes.
- Microbial fungicides include Bacillus species such as Bacillus amyloliquefaciens strains AP-136, AP-188, AP-218, AP-219, AP-295, QST713, FZB24, F727, MB 1600, D747, TJ100 (also called strain 1 BE; known from EP2962568), and the fungicidal lipopeptides which they produce.
- QoSI fungicides include triazolopyrimidylamines such as ametoctradin.
- Plant extract fungicides (b46) (FRAC code 46) cause cell membrane disruption.
- Plant extract fungicides include terpene hydrocarbons, terpene alcohols and terpen phenols such as the extract from Melaleuca alternifolia (tea tree) and plant oils (mixtures) such as eugenol, geraniol and thymol.
- Cyanoacrylate fungicides (b47) (FRAC code 47) bind to the myosin motor domain and effect motor activity and actin assembly. Cyanoacrylates include fungicides such as phenamacril.
- Polyene fungicides (b48) cause disruption of the fungal cell membrane by binding to ergosterol, the main sterol in the membrane. Examples include natamycin (pimaricin).
- Oxysterol binding protein inhibitor (OSBPI) Fungicides (b49) (FRAC code 49) bind to the oxysterol-binding protein in oomycetes causing inhibition of zoospore release, zoospore motility and sporangia germination.
- Oxysterol binding fungicides include piperdinylthiazoleisoxazolines such as oxathiapiprolin and fluoxapiprolin.
- Aryl-phenyl-ketone fungicides (b50) (FRAC code 50, previously FRAC code U8 reclassified to 50) inhibit the growth of mycelium in fungi.
- Aryl-phenyl ketone fungicides include benzophenones such as metrafenone, and benzoylpyridines such as pyriofenone.
- “Host plant defense induction fungicides (b51)” induce host plant defense mechanisms.
- Host plant defense induction fungicides include benzothiadiazole (FRAC code P01), benzisothiazole (FRAC code P02), thiadiazole carboxamide (FRAC code P03), polysaccharide (FRAC code P04), plant extract (FRAC code P05), microbial (FRAC code P06) and phosphonate fungicides (FRAC code P07, see (b33) above).
- the benzothiadiazoles include acibenzolar-S- methyl.
- the benzisothiazoles include probenazole.
- the thiadiazole carboxamides include tiadinil and isotianil.
- the polysaccharides include laminarin.
- the plant extracts include extract from Reynoutria sachalinensis (giant knotweed).
- the microbials include Bacillus mycoides isolate J and cell walls of Saccharomyces cerevisiae strain LAS 117.
- Multi-site activity fungicides inhibit fungal growth through multiple sites of action and have contact/preventive activity.
- Multi- site activity fungicides include copper fungicides (FRAC code M01), sulfur fungicides (FRAC code M02), dithiocarbamate fungicides (FRAC code M03), phthalimide fungicides (FRAC code M04), chloronitrile fungicides (FRAC code M05), sulfamide fungicides (FRAC code M06), multi-site contact guanidine fungicides (FRAC code M07), triazine fungicides (FRAC code M08), quinone fungicides (FRAC code M09), quinoxaline fungicides (FRAC code M10), maleimide fungicides (FRAC code Mil) and thiocarbamate (FRAC code M12, see (b42) above) fungicides.
- Copper fungicides are inorganic compounds containing copper, typically in the copper(II) oxidation state; examples include copper oxychloride, copper sulfate and copper hydroxide (e.g., including compositions such as Bordeaux mixture (tribasic copper sulfate).
- Sulfur fungicides are inorganic chemicals containing rings or chains of sulfur atoms; examples include elemental sulfur.
- Dithiocarbamate fungicides contain a dithiocarbamate molecular moiety; examples include ferbam, mancozeb, maneb, metiram, propineb, thiram, zinc thiazole, zineb and ziram.
- Phthalimide fungicides contain a phthalimide molecular moiety; examples include folpet, captan and captafol. Chloronitrile fungicides contain an aromatic ring substituted with chloro and cyano; examples include chlorothalonil. Sulfamide fungicides include dichlofluanid and tolyfluanid. Multi-site contact guanidine fungicides include, guazatine, iminoctadine albesilate and iminoctadine triacetate. Triazine fungicides include anilazine. Quinone fungicides include dithianon. Quinoxaline fungicides include quinomethionate (also known as chinomethionate). Maleimide fungicides include fluoroimide.
- Biologicals with multiple modes of action include agents from biological origins showing multiple mechanisms of action without evidence of a dominating mode of action.
- This class of fungicides includes polypeptide (lectin), phenol, sesquiterpene, tritepenoid and coumarin fungicides (FRAC code BM01) such as extract from the cotyledons of lupine plantlets.
- This class also includes momicrobial fungicides (FRAC code BM02, see (b44) above).
- the phenyl-acetamides include cyflufenamid.
- the guanidines include dodine.
- the thiazolidines include flutianil.
- the pyrimidinonehydrazones include ferimzone.
- the 4-quinolylacetates include tebufloquin.
- the tetrazolyloximes include picarbutrazox.
- the (b54) class also includes bethoxazin, dichlobentiazox (provisional common name, Registry Number 957144-77-3), dipymetitrone (provisional common name, Registry Number 16114-35-5), flometoquin, neo-asozin (ferric methanearsonate), pyrrolnitrin, tolnifanide (Registry Number 304911-98-6), A-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]- V- ct h y 1 - A- met h y 1 met h an i m i da m i dc, 5-fluoro-2-[(4-fluorophenyl)methoxy]-4-pyrimidinamine and 4-fluorophenyl A-[l-[[[[l-(4-cyanophenyl)ethyl]sulfonyl]methyl]propyl]
- Additional “Fungicides other than fungicides of classes (1) through (54)” whose mode of action may be unknown, or may not yet be classified include a fungicidal compound selected from components (b54.7) through (b54.13), as described below.
- Component (54.7) relates to (lS)-2,2-bis(4-fluorophenyl)-l-methylethyl A-[[3-(acetyloxy)- 4-methoxy-2-pyridinyl]carbonyl]-L-alaninate (provisional common name florylpicoxamid, Registry Number 1961312-55-9) which is believed to be a Quinone inside inhibitor (Qil) fungicide (FRAC code 21) inhibiting the Complex III mitochondrial respiration in fungi.
- Component (54.8) relates to 1 -[ 2-[ [ [ 1 -(4-chlorophcnyl)-l /7-pyrazol-3-yl]oxy]mcthyl]-3- mcthylphcnylj- 1 ,4-di hydro-4- mcthyl-5/7-tctrazol-5-onc (provisional common name metyltetraprole, Registry Number 1472649-01-6), which is believed to be a quinone outside inhibitor (Qol) fungicide (FRAC code 45) inhibiting the Complex III mitochondrial respiration in fungi, and is effective against Qol resistant strains.
- Qol quinone outside inhibitor
- Component (54.9) relates to 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine (provisional common name pyridachlometyl, Registry Number 1358061-55-8), which is believed to be promoter tubulin polymerization, resulting antifungal activity against fungal species belonging to the phyla Ascomycota and Basidiomycota.
- Component (54.10) relates to (4-phenoxyphenyl)methyl 2-amino-6-methyl-pyridine-3- carboxylate (provisional common name aminopyrifen, Registry Number 1531626-08-0) which is believed to inhibit GWT-1 protein in glycosylphosphatidylinositol-anchor biosynthesis in Neurospora crassa.
- Component (b54.11) relates a compound of Formula b54.11 wherein
- R bl and R b3 are each independently halogen
- R b2 is H, halogen, C ⁇ -Cg alkyl, C ⁇ -Cg haloalkyl or Cg-Cg cycloalkyl.
- Examples of compounds of Formula b54.11 include (b54.11a) methyl /V-[[5-[l-(2,6-difluoro-4- formylphcnylj- 1 //-pyrazol-3-yl]-2-mcthy lphcnyl] methyl] carbamate, (b54.11b) methyl /V-[[5-[l- (4-cyclopiOpyl-2,6-dichloiOphcnyl)-l //-pyrazol-3-y lJ-2-mcthy lphcnyl J methyl Jcarbamatc,
- Component (b54.12) relates a compound of Formula b54.12 b54.12 wherein R b4 is R b6 is C2-C4 alkoxycarbonyl or C2-C4 haloalkylaminocarbonyl;
- L is CH2 or CH2O, wherein the atom to the right is connected to the phenyl ring in Formula b54.12;
- R b5 is Examples of compounds of Formula b54.12 include (b54.12a) /V-(2,2,2-trifluoroethyl)-2-[[4-[5- (trifluoromethyl)-l,2,4-oxadiazol-3-yl]phenyl]methyl]-4-oxazolecarboxamide and (b54.12b) ethyl l-[[4-[5-(trifluoromethyl)-l,2,4-oxadiazol-3-yl]phenoxy]methyl]-l -pyrazole-4- carboxylate.
- Component (b54.13) relates a compound of Formula b54.13 wherein
- R b7 , R b8 and R b9 are each independently H, halogen or cyano
- R bl ° and R bl 1 are each independently H, halogen, C [ -C3 alkyl or C [ -C3 methoxy.
- Examples of compounds of Formula b54.13 include (b54.13a) 4-( 2-ch loro-4- fluorophenyl )-/V-( 2- fluoro-4-methyl-6-nitrophenyl)-l, 3-dimethyl- l /-pyrazol-5-amine, (b54.13b) 4-(2-chloro-4- fluorophenyl)- V-(2-fluoro-6-nitrophenyl)-l, 3-dimethyl- l /-pyrazol-5-amine, (b54.13c) 3,5- difluoro-4-[5-[(4-methoxy-2-nitrophenyl)amino]- 1,3-dimethyl- l /-pyrazol-4-yl]-benzonitrile and (b54.13d) /V-(2-chloro-4
- Embodiments of the present invention as described in the Summary of the Invention include those described below.
- Formula 1 includes stereoisomers, /V-oxides, and salts thereof, and reference to “a compound of Formula 1” includes the definitions of substituents specified in the Summary of the Invention unless further defined in the Embodiments.
- Embodiment 1 The composition comprising components (a) and (b) described in the Summary of the Invention wherein in Formula 1, T is T-l.
- Embodiment 2 The composition comprising components (a) and (b) described in the Summary of the Invention wherein in Formula 1, T is T-2.
- Embodiment 3 The composition comprising components (a) and (b) described in the Summary of the Invention wherein in Formula 1, T is T-3.
- Embodiment 3a The composition comprising components (a) and (b) described in the Summary of the Invention wherein in Formula 1, T is T-2 or T-3.
- Embodiment 4 The composition comprising components (a) and (b) described in the Summary of the Invention wherein in Formula 1, R 1 is CF3.
- Embodiment 5 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 4 wherein in Formula 1, W is O or S.
- Embodiment 6 The composition of Embodiment 5 wherein W is O.
- Embodiment 7 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 4 wherein in Formula 1, W is NR 3 .
- Embodiment 9 The composition of Embodiment 8 wherein R 3 is H, cyano, C1-C2 alkyl or OR 3a .
- Embodiment 10 The composition of Embodiment 9 wherein R 3 is H, cyano or OR 3a .
- Embodiment 11 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 10 wherein in Formula 1, R 3a is H, C1-C2 alkyl, C2-C3 alkylcarbonyl or C2-C3 haloalkylcarbonyl.
- Embodiment 12 The composition of Embodiment 11 wherein R 3a is H.
- Embodiment 13 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 12 wherein in Formula 1, when R 3b is separate (i.e. not taken together with R 3c to form a ring), then R 3b is H, C1-C3 alkyl, C2-C3 alkylcarbonyl or C2-C3 haloalkylcarbonyl.
- Embodiment 14 The composition of Embodiment 13 wherein R 3b is H or methyl.
- Embodiment 15 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 14 wherein in Formula 1, when R 3c is separate (i.e. not taken together with R 3b to form a ring), then R 3C is H or C1-C2 alkyl.
- Embodiment 16 The composition of Embodiment 15 wherein R 3c is H or methyl.
- Embodiment 17 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 16 wherein in Formula 1, X is O or NR 5a .
- Embodiment 18 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 16 wherein in Formula 1, X is O, S, NH or NOH.
- Embodiment 19 The composition of Embodiment 18 wherein X is O or NOH.
- Embodiment 20 The composition of Embodiment 20 wherein X is O.
- Embodiment 21 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 20 wherein in Formula 1, Y is O or NR 5b .
- Embodiment 22 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 20 wherein in Formula 1, Y is O, S, NH or NOH.
- Embodiment 23 The composition of Embodiment 22 wherein Y is O or NOH.
- Embodiment 24 The composition of Embodiment 23 wherein Y is O.
- Embodiment 25 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 24 wherein in Formula 1, R 5a and R 5b are each independently H, hydroxy or C1-C2 alkyl.
- Embodiment 26 The composition of Embodiment 25 wherein R 5a and R 5b are each independently H, hydroxy or methyl.
- Embodiment 27 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 26 wherein in Formula 1, when R 2a and R 2b are separate (i.e. not taken together to form a ring), then R 2a and R 2b are each independently H, C1-C3 alkyl, C2-C3 alkenyl, (CR 4a R 4b ) p -OH, (CR 4a R 4b ) p -Cl or (CR 4a R 4b ) p -Br.
- Embodiment 27a Embodiment 27a.
- composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 26 wherein in Formula 1, when R 2a and R 2b are separate (i.e. not taken together to form a ring), then R 2a and R 2b are each independently H, C1-C3 alkyl, C3-C35 trialkylsilyl or C3-C35 halotrialkylsilyl.
- Embodiment 27b The composition of Embodiment 27a wherein R 2a and R 2b are each independently H, methyl, trimethylsilyl or halotrimethylsilyl.
- Embodiment 27c The composition of Embodiment 27b wherein R 2a and R 2b are each independently H, methyl, trimethylsilyl or trifluoromethylsilyl
- Embodiment 27d The composition of Embodiment 27c wherein R 2a and R 2b are each independently H, methy or trimethylsilyl.
- Embodiment 27e The composition of Embodiment 27d wherein R 2a is H and R 2b is trimethylsilyl.
- Embodiment 27f The composition of Embodiment 27d wherein R 2a is methyl and R 2b is trimethylsilyl.
- Embodiment 28 The composition of Embodiment 27 wherein R 2a and R 2b are each independently H, C r C 3 alkyl, (CR 4a R 4b ) p -Cl or (CR 4a R 4b ) p -Br.
- Embodiment 29 The composition of Embodiment 28 wherein R 2a and R 2b are each independently H, methyl, (CR 4a R 4b ) p -Cl or (CR 4a R 4b ) p -Br.
- Embodiment 30 The composition of Embodiment 28 wherein R 2a and R 2b are each independently H or C3-C3 alkyl.
- Embodiment 31 The composition of Embodiment 30 wherein R 2a and R 2b are each independently H or C3-C2 alkyl.
- Embodiment 32 The composition of Embodiment 31 wherein R 2a and R 2b are each independently H or methyl.
- Embodiment 33 The composition of Embodiment 32 wherein R 2a and R 2b are each H.
- Embodiment 34 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 33 wherein in Formula 1, when R 2a and R 2b are separate (i.e. not taken together to form a ring), then one of R 2a and R 2b is (CR 4a R 4b ) p -OH, (CR 4a R 4b ) p -SH, (CR 4a R 4b ) p -Cl or (CR 4a R 4b ) p -Br, and the other is H.
- Embodiment 35 The composition of Embodiment 34 wherein one of R 2a and R 2b is (CR 4a R 4b ) p -Cl or (CR 4a R 4b ) p -Br, and the other is H.
- Embodiment 37 The composition of Embodiment 36 wherein R 2a and R 2b are each independently H or methyl; or R 2a and R 2b are taken together with the atoms X and
- Embodiment 38 The composition of Embodiment 37 wherein R 2a and R 2b are each independently H or methyl; or R 2a and R 2b are taken together with the atoms X and
- Y to which they are attached to form a 5-membered saturated ring containing ring members, in addition to the atoms X and Y, selected from carbon atoms, the ring optionally substituted with up to 1 substituent selected from halogen, cyano and methyl on carbon atom ring members.
- Embodiment 39 The composition of Embodiment 38 wherein R 2a and R 2b are each H; or R 2a and R 2b are taken together with the atoms X and Y to which they are attached to form a 5-membered saturated ring containing ring members, in addition to the atoms X and Y, selected from carbon atoms, the ring optionally substituted with up to 1 substituent selected methyl on a carbon atom ring member.
- Embodiment 40 The composition of Embodiment 39 wherein R 2a and R 2b are each H; or R 2a and R 2b are taken together with the atoms X and Y to which they are attached to form a 5-membered saturated ring containing ring members, in addition to the atoms X and Y, selected from carbon atoms.
- Embodiment 41 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 40 wherein in Formula 1, when R 2a and R 2b are taken together to form a ring (i.e.
- Embodiment 42 The composition of Embodiment 41 wherein R 2a and R 2b are taken together with the atoms X and Y to which they are attached to form a 5-membered saturated ring containing ring members, in addition to the atoms X and Y, selected from carbon atoms, the ring optionally substituted with up to 2 substituents independently selected from halogen, cyano, methyl, halomethyl and methoxy on carbon atom ring members.
- Embodiment 43 The composition of Embodiment 42 wherein R 2a and R 2b are taken together with the atoms X and Y to which they are attached to form a 5-membered saturated ring containing ring members, in addition to the atoms X and Y, selected from carbon atoms, the ring optionally substituted with up to 1 substituent selected from halogen, methyl and halomethyl on a carbon atom ring member.
- Embodiment 44 The composition of Embodiment 43 wherein R 2a and R 2b are taken together with the atoms X and Y to which they are attached to form a 5-membered saturated ring containing ring members, in addition to the atoms X and Y, selected from carbon atoms.
- Embodiment 45 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 44 wherein in Formula 1, R 2c is C 1 -C3 alkyl, C 3 -C3 haloalkyl, C 2 -C3 alkenyl, C 2 -C3 haloalkenyl, C 2 -C3 alkynyl or C 2 -C3 haloalkynyl, each optionally substituted with up 1 substituent selected from cyano, hydroxy, SCoN and C 3 -C 2 alkoxy.
- R 2c is C 1 -C3 alkyl, C 3 -C3 haloalkyl, C 2 -C3 alkenyl, C 2 -C3 haloalkenyl, C 2 -C3 alkynyl or C 2 -C3 haloalkynyl, each optionally substituted with up 1 substituent selected from cyano, hydroxy, SC
- Embodiment 46 The composition of Embodiment 45 wherein R 2c is C 3 -C 2 alkyl, C 3 -C 2 haloalkyl, C 2 -C3 alkenyl, C 2 -C3 haloalkenyl, C 2 -C3 alkynyl or C 2 -C3 haloalkynyl, each optionally substituted with up 1 substituent selected from cyano and methoxy.
- Embodiment 46a The composition of Embodiment 46 wherein R 2c is C 3 -C 2 alkyl, C 3 -C 2 haloalkyl, C 2 -C3 alkenyl, C 2 -C3 haloalkenyl or C 2 -C3 alkynyl.
- Embodiment 47 The composition of Embodiment 46a wherein R 2c is C 3 -C 2 alkyl, C 2 -C3 alkenyl or C 2 -C3 alkynyl.
- Embodiment 48 The composition of Embodiment 47 wherein R 2c is methyl or ethyl.
- Embodiment 48a The composition of Embodiment 48 wherein R 2c is ethyl.
- Embodiment 49 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 48a wherein in Formula 1, R 2d is H, cyano, halogen or C1-C2 alkyl.
- Embodiment 49a The composition of Embodiment 49 wherein R 2d is H, cyano, Cl, F or methyl.
- Embodiment 50 The composition of Embodiment 49a wherein R 2d is H or methyl.
- Embodiment 51 The composition of Embodiment 50 wherein R 2d is H.
- Embodiment 52 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 51 wherein in Formula 1, each R 4a and R 4b is independently H or C1-C2 alkyl.
- Embodiment 53 The composition of Embodiment 52 wherein each R 4a and R 4b is independently H or methyl.
- Embodiment 54 The composition of Embodiment 53 wherein each R 4a and R 4b is H.
- Embodiment 55 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 54 wherein in Formula 1, p is 2.
- Embodiment 56 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 54 wherein in Formula 1, p is 3.
- Embodiment 57 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 56 wherein in Formula 1, wherein A 1 is CR 6c R 6d , O or S.
- Embodiment 58 The composition of Embodiment 57 wherein A 1 is CR 6c R 6d or O.
- Embodiment 59 The composition of Embodiment 58 wherein A 1 is CR 6c R 6d .
- Embodiment 60 The composition of Embodiment 58 wherein A 1 is O.
- Embodiment 61 The composition comprising components (a) and (b) described in the
- a 1 is CH2, NH, O or S.
- Embodiment 62 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 61 wherein in Formula 1, A 1 is N(R 7a ).
- Embodiment 63 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 63 wherein in Formula 1, A 2 is a direct bond, CR 6e R 6f , O or S.
- Embodiment 64 The composition of Embodiment 63 wherein A 2 is a direct bond, CR 6e R 6f or O.
- Embodiment 65 The composition of Embodiment 64 wherein A 2 is a direct bond or O.
- Embodiment 66 The composition of Embodiment 65 wherein A 2 is a direct bond.
- Embodiment 67 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 62 wherein in Formula 1, A 2 is a direct bond, CH2, NH, O or S.
- Embodiment 67a The composition of Embodiment 67 wherein A 2 is a direct bond, CH2 or
- Embodiment 68 The composition of Embodiment 67a wherein A 2 is a direct bond or O.
- Embodiment 69 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 62 wherein in Formula 1, A 2 is N(R 7b ).
- Embodiment 70 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 69 wherein in Formula 1, when A is A 1 -A 2 -CR 6a R 6b , then A 1 -A 2 -CR 6a R 6b is selected from OCH 2 , OCH(Me), CH(OH)CH 2 , CH 2 CH 2 , SCH 2 , OCF 2 and CH 2 OCH 2 .
- Embodiment 71 The composition of Embodiment 70 wherein A 1 -A 2 -CR 6a R 6b is selected from OCH 2 , OCH(Me) and CH 2 CH 2 .
- Embodiment 72 The composition of Embodiment 71 wherein A 1 -A 2 -CR 6a R 6b is selected from OCH 2 and CH 2 CH 2 .
- Embodiment 73 The composition of Embodiment 72 wherein A 1 -A 2 -CR 6a R 6b is OCtl ⁇ .
- Embodiment 74 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 74 wherein in Formula 1, when A is A ⁇ A 2 , then A'-A 2 is selected from O, CH2, OCtl ⁇ and
- Embodiment 75 The composition of Embodiment 74 wherein A'-A 2 is selected from O, CH 2 and CH 2 0.
- Embodiment 76 The composition of Embodiment 75 wherein A'-A 2 is selected from O and Ctl ⁇ .
- Embodiment 77 The composition of Embodiment 76 wherein A'-A 2 is O.
- Embodiment 78 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 77 wherein in Formula 1, R 6a , R 6b , R 6c , R 6d , R 6e and R 6f are each independently H, cyano, hydroxy, Br, Cl, F or methyl.
- Embodiment 79 The composition of Embodiment 78 wherein R 6a , R 6b , R 6c , R 6d , R 6e and R 6f are each independently H, cyano hydroxy or methyl.
- Embodiment 80 The composition of Embodiment 79 wherein R 6a , R 6b , R 6c , R 6d , R 6e and R 6f are each independently H or methyl.
- Embodiment 8E The composition of Embodiment 80 wherein R 6a , R 6b , R 6c , R 6d , R 6e and R 6f are each H.
- Embodiment 82 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 81 wherein in Formula 1, R 7a and R 7b are each independently H, C1-C2 alkyl or C2-C3 alkylcarbonyl.
- Embodiment 83 The composition of Embodiment 82 wherein R 7a and R 7b are each independently H or C1-C2 alkyl.
- Embodiment 84 The composition of Embodiment 83 wherein R 7a and R 7b are each H.
- Embodiment 85 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 84 wherein in Formula 1, when T is T-l or T-2, then A is A 1 -A 2 -CH2-
- Embodiment 86 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 85 wherein in Formula 1, when T is T-l or T-2, then A is OCH 2 , SCH 2 , NHCH 2 , CH 2 CH 2 , OCH 2 CH 2 , SCH 2 CH 2 , NHCH 2 CH 2 , CH 2 OCH 2 , CH 2 SCH 2 or CH 2 NHCH 2 .
- Embodiment 87 The composition of Embodiment 86 wherein when T is T-l or T-2, then A is OCH 2 , SCH 2 , CH 2 CH 2 , OCH 2 CH 2 , SCH 2 CH 2 , CH 2 OCH 2 or CH 2 SCH 2 .
- Embodiment 88 The composition of Embodiment 87 wherein when T is T-l or T-2, then A is OCH 2 or CH 2 CH 2 .
- Embodiment 89 The composition of Embodiment 88 wherein when T is T-l or T-2, then A is OCH 2 .
- Embodiment 90 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 89 wherein in Formula 1, when T is T-3, then A is O, OCH 2 , SCH 2 , NHCH 2 , CH 2 , CH 2 CH 2 , CH 2 0, CH 2 S or CH 2 NH.
- Embodiment 91 The composition of Embodiment 82 wherein when T is T-3, then A is O, CH 2 or OCH 2 .
- Embodiment 92 The composition of Embodiment 91 wherein when T is T-3, then A is O or CH 2 .
- Embodiment 93 The composition of Embodiment 92 wherein when T is T-3, then A is O.
- Embodiment 94 The composition comprising components (a) and (b) described in the
- J is J-l through J-3, J-6 through J- 10 or J- 14.
- Embodiment 95 The composition of Embodiment 94 wherein J is J-l, J-2, J-3, J-6 or J- 14.
- Embodiment 96 The composition of Embodiment 95 wherein J is J-l, J-6 or J- 14.
- Embodiment 97 The composition of Embodiment 96 wherein J is J-l or J-6.
- Embodiment 97a The composition of Embodiment 96 wherein J is J- 14.
- Embodiment 98 The composition of Embodiment 97 wherein J is J-l.
- Embodiment 99 The composition of Embodiment 97 wherein J is J-6.
- Embodiment 100 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 99 wherein in Formula 1, each R 8 is independently F, Cl or methyl.
- Embodiment 100a The composition of Embodiment 100 wherein each R 8 is independently F or Cl.
- Embodiment 101 The composition of Embodiment 100 wherein each R 8 is independently F or methyl.
- Embodiment 101a The composition of Embodiment 101 wherein each R 8 is F.
- Embodiment 102 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 101a wherein in Formula 1, q is 0 or 1.
- Embodiment 102a The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 101a wherein in Formula 1, q is 3 or 4.
- Embodiment 102b The composition of Embodiment 102a wherein in Formula 1, q is 4.
- Embodiment 103 The composition of Embodiment 102 wherein q is 0.
- Embodiment 103a The composition of Embodiment 102 wherein q is 1.
- Embodiment 104 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 103a wherein in Formula 1, each R 9a and R 9b is independently H, halogen, C
- Embodiment 105 The composition of Embodiment 104 wherein each R 9a and R 9b is independently H, halogen, Ci-C 2 alkyl or Ci-C 2 haloalkyl.
- Embodiment 106 The composition of Embodiment 105 wherein each R 9a and R 9b is independently H, halogen or methyl.
- Embodiment 107 The composition of Embodiment 106 wherein each R 9a and R 9b is independently H or methyl.
- Embodiment 108 The composition of Embodiment 107 wherein each R 9a and R 9b is H.
- Embodiment 109 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 108 wherein in Formula 1, n is 0, 1 or 2.
- Embodiment 109a The composition of Embodiment 109 wherein n is 1 or 2.
- Embodiment 110 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 109a wherein in Formula 1, n is 0 or 1.
- Embodiment 111 The composition of Embodiments 109, 109a or 110 wherein n is 1.
- Embodiment 112. The composition of Embodiments 109 or 110 wherein n is 0.
- Embodiment 113 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 112 wherein in Formula 1, L is a direct bond, CH2, CH(Me) or CH2CH2.
- Embodiment 113a The composition of Embodiment 113 wherein L is a direct bond, CH2 or CH 2 CH 2 .
- Embodiment 114 The composition of Embodiment 113a wherein L is a direct bond or
- Embodiment 115 The composition of Embodiment 114 wherein L is CH 2 .
- Embodiment 115a The composition of Embodiment 114 wherein L is a direct bond.
- Embodiment 116 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 115a wherein in Formula 1, E is E 1 .
- Embodiment 116a The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 116 wherein in Formula 1, when L is a direct bond, then E is E 1 .
- Embodiment 119 The composition of Embodiment 118 wherein E 1 is C ⁇ -C ⁇ alkoxy, C
- Embodiment 120 The composition of Embodiment 119 wherein E 1 is C1-C3 alkoxy,
- each carbon atom is optionally substituted with up to 1 substituent selected from R 10a and up to 3 substituents independently selected from R 10b .
- Embodiment 120a The composition of Embodiment 120 wherein E 1 is C1-C3 alkoxy or C2-C3 alkoxycarbonyl, wherein each carbon atom is optionally substituted with up to 1 substituent selected from R 10a .
- Embodiment 121 The composition of Embodiment 120 wherein E 1 is C1-C2 alkoxy, wherein each carbon atom is optionally substituted with up to 1 substituent selected from R 10a and up to 3 substituents independently selected from R 10b .
- Embodiment 121a The composition of Embodiment 120 wherein E 1 is C1-C2 alkoxy, wherein each carbon atom is optionally substituted with up to 1 substituent selected from R 10a .
- Embodiment 121b The composition of Embodiment 121a wherein E 1 is methoxy optionally substituted with up to 1 substituent selected from R 10a .
- Embodiment 121c The composition of Embodiment 121a wherein E 1 is methoxy substituted with 1 substituent selected from R 10a .
- Embodiment 122 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 121c wherein in Formula 1, R 10a is phenyl optionally substituted with up to 3 substituents independently selected from R lla ; or a 5- to 6-membered heterocyclic ring containing ring members selected from carbon atoms and 1 to 4 heteroatoms independently selected from up to 2 O, up to 2 S and up to 4 N atoms, each ring optionally substituted with up to 3 substituents independently selected from R lla on carbon atom ring members and R l lb on nitrogen atom ring members.
- Embodiment 123 The composition of Embodiment 122 wherein R 10a is phenyl optionally substituted with up to 2 substituents independently selected from R l la ; or a 5- to 6- membered heterocyclic ring containing ring members selected from carbon atoms and 1 to 4 heteroatoms independently selected from up to 2 O, up to 2 S and up to 4 N atoms, each ring optionally substituted with up to 2 substituents independently selected from R lla on carbon atom ring members and R llb on nitrogen atom ring members.
- Embodiment 123a The composition of Embodiment 123 wherein R 10a is a 5-membered heterocyclic ring containing ring members selected from carbon atoms and 1 to 4 heteroatoms independently selected from up to 2 O and up to 3 N atoms, each ring optionally substituted with up to 2 substituents independently selected from R lla on carbon atom ring members.
- Embodiment 123b The composition of Embodiment 123a wherein R 10a is pyrazolyl, imidazolyl or triazolyl, each optionally substituted with up to 2 substituents independently selected from R lla on carbon atom ring members.
- Embodiment 123c The composition of Embodiment 123b wherein R 10a is pyrazolyl or imidazolyl, each optionally substituted with up to 2 substituents independently selected from R lla on carbon atom ring members.
- Embodiment 123d The composition of Embodiment 123c wherein R 10a is pyrazolyl optionally substituted with up to 1 substituent selected from R l la on a carbon atom ring member.
- Embodiment 124 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 123c wherein in Formula 1, each R 10b is independently cyano, halogen, hydroxy, C 4 -C 4 alkyl, C 4 -C 4 haloalkyl, CyC ⁇ cycloalkyl, C 1 -C 4 alkoxy, C 4 -C 4 haloalkoxy, C 1 -C 4 alkylsulfonyl, C 4 -C 4 haloalkylsulfonyl, C 1 -C 4 alkylamino, C 2 -C 4 dialkylamino, C 2 -C 4 alkylcarbonyl or C 2 -C5 alkoxycarbonyl.
- Embodiment 125 The composition of Embodiment 124 wherein each R 10b is independently halogen, hydroxy, C 4 -C 4 alkyl, C 4 -C 4 haloalkyl, C 1 -C 4 alkoxy,
- Embodiment 125a The composition of Embodiment 125 wherein each R 10b is independently halogen, C 4 -C 2 alkyl, C 4 -C 2 haloalkyl, C 4 -C 2 alkoxy or C 2 -C 4 alkoxycarbonyl.
- Embodiment 126 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 125a wherein in Formula 1, each R l la is independently halogen, C 4 -C 4 alkyl, C 4 -C 4 haloalkyl, C % - C 4 alkenyl, C 2 -C 4 alkynyl, C 4 -C 4 alkoxy, C 4 -C 4 haloalkoxy, C 2 -C 4 alkenyloxy, C % - C 4 alkynyloxy, C 2 -C 4 alkoxyalkyl, alkylcarbonyloxy, C 1 -C 4 alkylsulfonyl,
- Embodiment 127 The composition of Embodiment 126 wherein each R lla is independently halogen, C 4 -C 4 alkyl, C 4 -C 4 haloalkyl, C 2 -C 4 alkenyl, C 1 -C 4 alkoxy, C 4 -C 4 haloalkoxy, C 2 -C 4 alkenyloxy, C 2 -C 4 alkoxyalkyl, C 2 -C 4 alkylcarbonyl, C 2 - C, alkoxycarbonyl, C3-C 7 alkenyloxycarbonyl or C 2 -C6 alkylaminocarbonyl.
- Embodiment 128 The composition of Embodiment 127 wherein each R lla is independently halogen, C 4 -C 4 alkyl, C 4 -C 4 haloalkyl, C 1 -C 4 alkoxy, C 4 -C 4 haloalkoxy, C 2 -C 4 alkenyloxy, C 2 -C 4 alkylcarbonyl, C 2 -C 4 alkoxycarbonyl or C3- C5 alkenyloxycarbonyl.
- Embodiment 128a The composition of Embodiment 128 wherein each R l la is independently halogen, C 4 -C 2 alkyl, C 4 -C 2 haloalkyl, C 1 -C 2 alkoxy or C 2 -C3 alkoxycarbonyl.
- Embodiment 128b The composition of Embodiment 128a wherein each R 1 la is independently methoxy carbonyl or ethoxycarbonyl.
- Embodiment 128c The composition of Embodiment 128b wherein each R l la is ethoxycarbonyl.
- Embodiment 129 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 128c wherein in Formula 1, each R l lb is independently C 1 -C 2 alkyl, C 1 -C 2 alkoxy, C 2 -C3 alkylcarbonyl or C 2 -C3 alkoxycarbonyl.
- Embodiment 130 The composition of Embodiment 129 wherein each R llb is independently methyl, methoxy, methylcarbonyl or methoxycarbonyl.
- Embodiment 13 E The composition of Embodiment 130 wherein each R llb is independently methyl or methoxy.
- Embodiment 132 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 131 wherein in Formula 1, E is E 2 .
- Embodiment 134 The composition of Embodiment 133 wherein G is selected from G-l through G-l 18 as shown in Exhibit A.
- G-117 G-118 wherein the floating bond is connected to Z in Formula 1 through any available carbon or nitrogen atom of the depicted ring or ring system; and x is 0, 1, 2 or 3.
- Embodiment 135. The composition of Embodiment 134 wherein G is G-l through G-16, G-20, G-22 through G-30, G-36 through G-42, G-54 through G-60, G-85, G-86, G- 108, G-110 or G-lll.
- Embodiment 136 The composition of Embodiment 135 wherein G is G-l through G-16, G-22, G-24, G-25, G-26, G-28, G-29, G-30, G-36, G-37, G-38, G-41, G-42, G-54, G-57, G-58, G-59, G-60, G-85, G-86, G-108, G-110 or G-lll.
- Embodiment 137 The composition of Embodiment 136 wherein G is G-l through G-13, G-22, G-24, G-25, G-26, G-28, G-29, G-41, G-42, G-54, G-57, G-58, G-59 or G-60.
- Embodiment 138 The composition of Embodiment 137 wherein G is G-l, G-2, G-3, G-7, G-8, G-9, G-10, G-12, G-13, G-22, G-29, G-42, G-54 or G-58.
- Embodiment 139 The composition of Embodiment 138 wherein G is G-l, G-3, G-12, G- 13, G-22 or G-42.
- Embodiment 140 The composition of Embodiment 139 wherein G is G-l, G-3, G-12, G- 13 or G-22.
- Embodiment 141 The composition of Embodiment 140 wherein G is G-l, G-3, G-12 or G-
- Embodiment 142 The composition of Embodiment 141 wherein G is G-l or G-12.
- Embodiment 143 The composition of Embodiment 142 wherein G is G-l.
- Embodiment 144 The composition of Embodiment 142 wherein G is G-12.
- Embodiment 145 The composition of Embodiment 140 wherein G is G-3.
- Embodiment 146 The composition of Embodiment 140 wherein G is G-22.
- Embodiment 147 The composition of Embodiment 143 wherein the 2-position of G-l is connected to Z and the 4-position is connected to R 13 .
- Embodiment 148 The composition of Embodiment 143 wherein the 2-position of G-l is connected to Z and the 5-position is connected to R 13 .
- Embodiment 149 The composition of Embodiment 144 wherein the 1-position of G-12 is connected to Z and the 4-position is connected to R 13 .
- Embodiment 150 The composition of Embodiment 144 wherein the 1-position of G-12 is connected to Z and the 3-position is connected to R 13 .
- Embodiment 151 The composition of Embodiment 144 wherein the 1-position of G-12 is connected to Z and the 3- and 5-positions are connected to R 13 .
- Embodiment 152 The composition of Embodiment 144 wherein the 1-position of G-12 is connected to Z and the 5-position is connected to R 13 .
- Embodiment 153 The composition of Embodiment 145 wherein the 1-position of G-3 is connected to Z and the 4-position is connected to R 13 .
- Embodiment 154 The composition of Embodiment 146 wherein the 4-position of G-22 is connected to Z and the 2-position is connected to R 13 .
- Embodiment 155 The composition of any one of Embodiments 147 through 154 wherein Z is a direct bond.
- Embodiment 156 The composition of any one of Embodiments 147 through 155 wherein x is 1 and R 13 is methoxycarbonyl or ethoxycarbonyl.
- Embodiment 157 The composition of any one of Embodiments 134 through 155 wherein x is 1 or 2.
- Embodiment 158 The composition of Embodiment 157 wherein x is 1.
- Embodiment 159 The composition of Embodiment 157 wherein x is 2.
- Embodiment 160 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 134 through 155 wherein in Formula 1, x is 0.
- Embodiment 166 The composition of Embodiment 165 wherein each R 13 is independently C2-C5 alkoxycarbonyl or C3-C5 alkenyloxycarbonyl, each optionally substituted with up to 3 substituents independently selected from R 19 .
- Embodiment 167 The composition of Embodiment 166 wherein each R 13 is independently C2-C5 alkoxycarbonyl, each optionally substituted with up to 3 substituents independently selected from R 19 .
- Embodiment 168 The composition of Embodiment 167 wherein each R 13 is independently methoxycarbonyl or ethoxycarbonyl, each optionally substituted with up to 3 substituents independently selected from R 19 .
- Embodiment 169 The composition of Embodiment 168 wherein each R 13 is independently methoxycarbonyl or ethoxycarbonyl, each optionally substituted with up to 1 substituent selected from R 19 .
- Embodiment 170 The composition of Embodiment 169 wherein each R 13 is independently ethoxycarbonyl optionally substituted with up to 1 substituent selected from R 19 .
- Embodiment 171 The composition of Embodiment 169 wherein each R 13 is independently methoxycarbonyl or ethoxycarbonyl.
- Embodiment 172 The composition of Embodiment 171 wherein each R 13 is ethoxycarbonyl.
- Embodiment 173 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 172 wherein in Formula 1, when each R 14a is separate (i.e. not taken together with R 14b to form a ring), then each R 14a is independently H, cyano, hydroxy, C 4 -C 4 alkyl, C 4 -C 4 haloalkyl, C 2 -C 4 alkenyl, C 2 -C 4 haloalkenyl, C 2 -C 4 alkynyl, C 2 -C 4 haloalkynyl, C 2 -C 4 alkylcarbonyl, C 2 -C5 alkoxycarbonyl or C3-C5 dialkylaminocarbonyl.
- Embodiment 174 The composition of Embodiment 173 wherein each R 14a is independently H, cyano, C 4 -C 4 alkyl, C 4 -C 4 haloalkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 2 -C 4 alkylcarbonyl, C 2 -C5 alkoxycarbonyl or C3-C5 dialkylaminocarbonyl.
- Embodiment 175. The composition of Embodiment 174 wherein each R 14a is independently H, C 4 -C 2 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 2 -C 4 alkylcarbonyl or C 2 -C 4 alkoxycarbonyl.
- Embodiment 176 The composition of Embodiment 175 wherein each R 14a is independently H or C 4 -C 2 alkyl.
- Embodiment 177 The composition of Embodiment 176 wherein each R 14a is independently H or methyl.
- Embodiment 177a The composition of Embodiment 177 wherein each R 14a is H.
- Embodiment 178 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 177a wherein in Formula 1, when each R 14b is separate (i.e. not taken together with R 14a to form a ring), then each R 14b is independently H, C
- Embodiment 179 The composition of Embodiment 178 wherein each R 14b is independently H, C4-C4 alkyl, C4-C4 haloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C3-C5 cycloalkyl, C4-C6 cycloalkylalkyl, C2-C4 alkoxyalkyl, C2-C4 haloalkoxyalkyl, C2-C4 alkylaminoalkyl or C3-C5 dialkylaminoalkyl.
- Embodiment 180 The composition of Embodiment 179 wherein each R 14b is independently H, C4-C3 alkyl, C4-C3 haloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C3-C5 cycloalkyl, C4-C6 cycloalkylalkyl or C2-C4 alkoxyalkyl.
- Embodiment 181 The composition of Embodiment 180 wherein each R 14b is independently H, C4-C3 alkyl, C4-C3 haloalkyl, cyclopropylmethyl or C2-C4 alkoxyalkyl.
- Embodiment 181a The composition of Embodiment 181 wherein each R 14b is independently H, C4-C2 alkyl, C4-C2 haloalkyl or cyclopropylmethyl.
- Embodiment 181b The composition of Embodiment 181a wherein each R 14b is independently H, methyl or cyclopropylmethyl.
- Embodiment 182 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 181b wherein in Formula 1, when R 14a and R 14b are taken together to form a 4- to 6-membered fully saturated heterocyclic ring, then said ring contains ring members, in addition to the connecting nitrogen atom, selected from carbon atoms and up to 1 heteroatom selected from up to 1 O, up to 1 S and up to 1 N atom, each ring optionally substituted with up to 2 substituents independently selected from halogen or methyl.
- Embodiment 183 The composition of Embodiment 182 wherein R 14a and R 14b are taken together to form an azetidinyl, morpholinyl, pyrrolidinyl, piperidinyl, piperazinyl or thiomorpholinyl ring, each ring optionally substituted with up to 2 substituents independently selected from halogen or methyl.
- Embodiment 184 The composition of Embodiment 183 wherein R 14a and R 14b are taken together to form an azetidinyl or pyrrolidinyl ring, each ring optionally substituted with up to 2 substituents independently selected from halogen or methyl.
- Embodiment 185 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 184 wherein in Formula 1, each R 15 is independently H, cyano, halogen, methyl or methoxy.
- Embodiment 186 The composition of Embodiment 185 wherein each R 15 is independently H or methyl.
- Embodiment 187 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 186 wherein in Formula 1, each R 16 is independently hydroxy, NR 20a R 20b , C4-C2 alkoxy, C2-C4 alkenyloxy, C2-C4 alkylcarbonyloxy or C2-C4 alkoxycarbonyloxy.
- Embodiment 188 The composition of Embodiment 187 wherein each R 16 is independently hydroxy, NR 20a R 20b or C4-C4 alkoxy.
- Embodiment 189 The composition of Embodiment 188 wherein each R 16 is independently hydroxy, NR 20a R 20b or methoxy.
- Embodiment 190 The composition of Embodiment 189 wherein each R 16 is hydroxy.
- Embodiment 19 E The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 190 wherein in Formula 1, each R 17 is independently H or methyl.
- Embodiment 192 The composition of Embodiment 191 wherein each R 17 is H.
- Embodiment 193 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 192 wherein in Formula 1, when each R 18a and R 18b is separate (i.e. not taken together to form a ring), then each R 18a and R 18b is independently H, methyl or ethyl.
- Embodiment 194 The composition of Embodiment 193 wherein each R 18a and R 18b is independently H or methyl.
- Embodiment 195 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 194 wherein in Formula 1, when R 18a and R 18b are taken together to form a 5- to 6-membered fully saturated heterocyclic ring, then said ring contains ring members, in addition to the connecting nitrogen atom, selected from carbon atoms and up to 1 heteroatom selected from up to 1 O, up to 1 S and up to 1 N atom, each ring optionally substituted with up to 2 methyl groups.
- Embodiment 196 The composition of Embodiment 195 wherein R 18a and R 18b are taken together to form an azetidinyl, morpholinyl, pyrrolidinyl, piperidinyl, piperazinyl, or thiomorpholinyl ring, each ring optionally substituted with up to 2 methyl groups.
- Embodiment 197 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 196 wherein in Formula 1, each R 19 is independently cyano, halogen, hydroxy, C4-C3 alkyl, C
- Embodiment 198 The composition of Embodiment 197 wherein each R 19 is independently cyano, halogen, hydroxy, C3-C2 alkyl, C3-C2 haloalkyl, C3-C6 cycloalkyl, C3-C2 alkoxy, C3-C2 haloalkoxy, C3-C2 alkylthio, C3-C2 alkylsulfonyl, C3-C2 haloalkylsulfonyl, C2-C3 alkylcarbonyl, C2-C3 haloalkylcarbonyl, C2-C3 alkoxycarbonyl or C2-C3 alkylaminocarbonyl.
- Embodiment 199 The composition of Embodiment 197 wherein each R 19 is independently cyano, halogen, C3-C2 alkyl, C3-C2 haloalkyl, C3-C6 cycloalkyl, C3-C2 alkoxy, C3-C2 haloalkoxy, C2-C3 alkylcarbonyl, C2-C3 haloalkylcarbonyl or C2-C3 alkoxycarbonyl.
- Embodiment 200 The composition of Embodiment 199 wherein each R 19 is independently cyano, halogen, cyclopropyl, cyclobutyl, methoxy, halomethoxy or methoxycarbonyl.
- Embodiment 200a The composition of Embodiment 200 wherein each R 19 is independently cyano, halogen, cyclopropyl or methoxy.
- Embodiment 200b The composition of Embodiment 200a wherein each R 19 is independently cyano, Cl, F, cyclopropyl or methoxy.
- Embodiment 204 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 203 wherein in Formula 1, each V is independently a direct bond; or C ⁇ -C ⁇ alkylene, C2-C6 alkenylene or CyC ⁇ alkynylene, each optionally substituted with up to 2 substituents independently selected from halogen, cyano, nitro, hydroxy, C3-C2 alkyl, C3-C2 haloalkyl, C3-C2 alkoxy and C3-C2 haloalkoxy.
- Embodiment 205 The composition of Embodiment 204 wherein each V is independently a direct bond; or C3-C3 alkylene, each optionally substituted with up to 2 substituents independently selected from halogen, hydroxy, C3-C2 alkyl, C3-C2 alkoxy and C 1 -C 2 haloalkoxy.
- Embodiment 206 The composition of Embodiment 205 wherein each V is independently a direct bond or C 1 -C3 alkylene.
- Embodiment 207 The composition of Embodiment 206 wherein each V is independently a direct bond or CH 2 .
- Embodiment 208 The composition of Embodiment 207 wherein each V is a direct bond.
- Embodiment 209 The composition of Embodiment 207 wherein each V is independently C 1 -C 2 alkylene.
- Embodiment 210 The composition of Embodiment 209 wherein each V is CH 2 .
- Embodiment 212 The composition of Embodiment 210 wherein each Q is independently phenyl optionally substituted with up to 2 substituents independently selected from R 27 ; or pyridinyl, pyrazolyl, imidazolyl, triazolyl, thiazolyl, oxazolyl, isoxazolyl, thienyl, isoxazolinyl, piperidinyl, morpholinyl or piperazinyl, each optionally substituted with up to 2 substituents independently selected from R 27 .
- Embodiment 213 The composition of Embodiment 212 wherein each Q is independently phenyl optionally substituted with up to 2 substituents independently selected from R 27 ; or pyridinyl, pyrazolyl, imidazolyl, triazolyl, thiazolyl or oxazolyl, each optionally substituted with up to 2 substituents independently selected from R 27 .
- Embodiment 214 The composition of Embodiment 213 wherein each Q is independently phenyl optionally substituted with up to 2 substituents independently selected from R 27 ; or pyridinyl or pyrazolyl, each optionally substituted with up to 2 substituents independently selected from R 27 .
- Embodiment 214a The composition of Embodiment 214 wherein each Q is independently phenyl or pyridinyl, each optionally substituted with up to 2 substituents independently selected from R 27 .
- Embodiment 214b The composition of Embodiment 214a wherein each Q is independently phenyl optionally substituted with up to 2 substituents independently selected from R 27 .
- Embodiment 215. The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 214b wherein in Formula 1, when each R 20a j s separate (i.e. not taken together with R 20b to form a ring), then each R 20a j s independently H, methyl or methylcarbonyl.
- Embodiment 216 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 215 wherein in Formula 1, when each R 20b j s separate (i.e. not taken together with R 20a to form a ring), then each R 20b j s independently H, cyano, methyl, methylcarbonyl, methoxycarbonyl, methoxycarbonylmethyl, methylaminocarbonyl or dimethylaminocarbonyl.
- Embodiment 217 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 216 wherein in Formula 1, when R 20a an d R 2 0 b arc taken together to form a 5- to 6-membered fully saturated heterocyclic ring, then said ring contains ring members, in addition to the connecting nitrogen atom, selected from carbon atoms and up to 1 heteroatom selected from up to 1 O, up to 1 S and up to 1 N atom, each ring optionally substituted with up to 2 methyl groups.
- Embodiment 218 The composition of Embodiment 217 wherein R 20a an d R 2 0 b arc taken together to form an azetidinyl, morpholinyl, pyrrolidinyl, piperidinyl, piperazinyl or thiomorpholinyl ring, each ring optionally substituted with up to 2 methyl groups.
- Embodiment 219. The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 218 wherein in Formula 1, each R 21 and R 23 is independently H, cyano, halogen, methyl or methoxy.
- Embodiment 220 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 219 wherein in Formula 1, each R 22 is independently H, C 1 -C3 alkyl, C 1 -C3 haloalkyl, C 2 -C3 alkylcarbonyl or C2-C3 alkoxycarbonyl; or phenyl optionally substituted with up to 2 substituents independently selected halogen and methyl; or a 5- to 6-membered fully saturated heterocyclic ring, each ring containing ring members selected from carbon atoms and up to 2 heteroatoms independently selected from up to 2 O, up to 2 S and up to 2 N atoms, each ring optionally substituted with up to 2 substituents independently selected from halogen and methyl.
- Embodiment 22 The composition of Embodiment 220 wherein each R 22 is independently H or C1-C2 alkyl.
- Embodiment 222 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 221 wherein in Formula 1, each R 24 is independently H, cyano or Ci-C 2 alkyl.
- Embodiment 223 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 222 wherein in Formula 1, each R 25 and R 26 is independently H, cyano, hydroxy, C4-C4 alkyl or C r C 4 haloalkyl.
- Embodiment 224 The composition of Embodiment 223 wherein each R 25 and R 26 is independently H, cyano, hydroxy or C4-C2 alkyl.
- Embodiment 225 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 224 wherein in Formula 1, each R 27 is independently halogen, cyano, C4-C4 alkyl, C4-C4 haloalkyl or C4-C4 alkoxy.
- Embodiment 226 The composition of Embodiment 225 wherein each R 27 is independently halogen, cyano, C4-C2 alkyl, C4-C2 haloalkyl or C4-C2 alkoxy.
- Embodiment 227 The composition of Embodiment 226 wherein each R 27 is independently halogen, methyl or methoxy.
- Embodiment 228 The composition of Embodiment 227 wherein each R 27 is independently halogen.
- Embodiment 232 The composition of Embodiment 231 wherein Z is a direct bond.
- Embodiment 233 The composition of Formula 1 or any one of Embodiments 1 through 232 wherein each R 28 is independently H or C
- Embodiment 234. The composition of Embodiment 233 wherein each R 28 is independently
- Embodiment 235 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 234 wherein in Formula 1, m is 0 or 2.
- Embodiment 236 The composition of Embodiment 235 wherein m is 2.
- Embodiment 237 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 236 wherein component (a) does not comprise an /V-oxide of a compound of Formula 1.
- component (a) comprises a compound selected from the group consisting of ethyl l-[[4-(3,3,3-trifluoro-2,2-dihydroxypropoxy)phenyl]methyl]-l//-pyrazole-4-carboxylate (Compound 1); ethyl 1 - [ [4- [ [2-(trifluoro methyl)- 1 ,3 -dioxolan-2-yl] methoxy ]phenyl] methyl] - 1 /7-pyrazolc-4- carboxylate (Compound 32); ethyl l-[[4-[[( lZ)-2-ethoxy-3, 3, 3-trifluoro-l -propen- l-yl]oxy]phenyl]methyl]- l//-pyrazole-4- carboxylate (Compound 64); ethyl l-[[4-[[( lZ)-2-ethoxy-3, 3, 3-trifluoro-l -propen-
- Embodiment 239. The composition of Embodiment 238 wherein component (a) comprises a compound selected from the group consisting of Compounds 32, 64, 71, 126, 127, 132, 162, 163, 171, 186, 218, 229, 263, 297, 330 and 331.
- Embodiment 240 The composition of Embodiment 239 wherein component (a) comprises a compound selected from the group consisting of Compounds 32, 64, 71, 126, 127,
- Embodiment 241 The composition of Embodiment 240 wherein component (a) comprises a compound selected from the group consisting of Compounds 32, 64, 126, 127, 132, 162, 163, 171 and 263.
- Embodiment 242. The composition of Embodiment 241 wherein component (a) comprises a compound selected from the group consisting of Compounds 32, 64, 126, 132, 163 and 263.
- Embodiment 243 The composition of Embodiment 242 wherein component (a) comprises a compound selected from the group consisting of Compounds 32 and 64.
- Embodiment 243a The composition of Embodiment 243 wherein component (a) is Compound 32.
- Embodiment 243b The composition of Embodiment 243 wherein component (a) is Compound 64.
- Embodiment 244 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 243 wherein component (a) is ethyl l-[[4-[[2-(trifluoromethyl)-l,3-dioxolan-2- yljmcthoxy] phenyl] methyl]- 1 //-pyrazolc-4-carboxylatc, its (£)-isomer or a mixture thereof.
- Embodiment 245. The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 243 wherein component (a) is ethyl l-[[4-[[(lZ)-2-ethoxy-3,3,3-trifluoro-l-propen-l- yl]oxy]phcnyl]mcthyl]-l /7-pyrazolc-4-carboxylatc, its ( ⁇ -isomer or a mixture thereof.
- Embodiment 246 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 243 wherein component (a) is ethyl l-[[4-[[(lZ)-2-ethoxy-3,3,3-trifluoro-l-propen-l-yl]oxy]-3- fluorophcnyljmcthylj-l /7-pyrazolc-4-carboxylatc, its (£)-isomer or a mixture thereof.
- Embodiment 247 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 243 wherein component (a) is ethyl l-[[3-[[(lZ)-2-ethoxy-3,3,3-trifluoro-l-propen-l- yl]oxy]phcnyl]mcthyl]-l /7-pyrazolc-4-carboxylatc, its ( ⁇ -isomer or a mixture thereof.
- Embodiment 248 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 243 wherein component (a) is ethyl l-[[4-[[(lZ)-2-ethoxy-3,3,3-trifluoro-l-propen-l- yljoxyjphcnoxy] methyl]- 1 /7-pyrazolc-4-carboxylatc, its (£)-isomer or a mixture thereof.
- composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 243 wherein component (a) is ethyl l-[2-[4-[[(lZ)-2-ethoxy-3,3,3-trifluoro-l-propen-l- yljoxyjphcnyljcthylj-l /7-pyrazolc-4-carboxylatc, its (£)-isomer or a mixture thereof.
- Embodiment 250 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 243 wherein component (a) is phenylmethyl l-[[4-[[(lZ)-2-ethoxy-3,3,3-trifluoro-l-propen-l- yljoxyjphcnyljmcthylj-l /7-pyrazolc-4-carboxylatc, its ( ⁇ -isomer or a mixture thereof.
- Embodiment 251 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 243 wherein component (a) is butyl l-[[4-[[(lZ)-2-ethoxy-3,3,3-trifluoro-l-propen-l- yljoxyjphcnyljmcthylj-l /7-pyrazolc-4-carboxylatc, its ( ⁇ -isomer or a mixture thereof.
- Embodiment 252 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 243 wherein component (a) is 3-chloropropyl l-[[4-[[(lZ)-2-ethoxy-3,3,3-trifluoro-l-propen-l- yljoxyjphcnyljmcthylj-l /7-pyrazolc-4-carboxylatc, its ( ⁇ -isomer or a mixture thereof.
- Embodiment 253 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 243 wherein component (a) is ethyl l-[[4-[[(lZ)-2-ethoxy-3,3,3-trifluoro-l-propen-l- yljoxyjphcnylmcthoxy] methyl]- 1 /7-pyrazolc-4-carboxylatc, its ( ⁇ -isomer or a mixture thereof.
- Embodiment 254 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 243 wherein component (a) is methyl l-[[3-[[(lZ)-2-ethoxy-3,3,3-trifluoro-l-propen-l- yl]oxy]phcnyl]mcthyl]-l /7-pyrazolc-4-carboxylatc, its ( ⁇ -isomer or a mixture thereof.
- Embodiment 255 The composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 243 wherein component (a) is propyl l-[[3-[[(lZ)-2 -ethoxy-3, 3, 3-trifluoro-l-propen-l- yl]oxy]phcnyl]mcthyl]-l /7-pyrazolc-4-carboxylatc, its ( ⁇ -isomer or a mixture thereof.
- Embodiment 256 is propyl l-[[3-[[(lZ)-2 -ethoxy-3, 3, 3-trifluoro-l-propen-l- yl]oxy]phcnyl]mcthyl]-l /7-pyrazolc-4-carboxylatc, its ( ⁇ -isomer or a mixture thereof.
- Embodiment 256 Embodiment 256.
- Embodiment 257 The composition of Embodiments 238 through 256 wherein wherin component (b) comprises at least two fungicidal compounds, and when component (b) consists of a binary combination of two fungicidal compounds, wherein one of the fungicidal compounds is cyproconazole, difenconazole, epoxiconazole, flutriafol, prothioconazole or tebuconazole then the other fungicidal compound is other than azoxystrobin, benzovindiflupyr, bixafen, fluindapyr, fluxapyroxad, isopyrazam, picoxystrobin, pyraclostrobin, or trifloxystrobin.
- Embodiment 258 The composition of Embodiment 257 wherein (b) comprises at least two fungicidal compounds, and when component (b) consists of a binary combination of two fungicidal compounds, wherein one of the fungicidal compounds is cyproconazole, difenconazole, epoxiconazole, flutriafol, prothioconazole or tebuconazole then the other fungicidal compound is other than azoxystrobin, benzovindiflupyr, bixafen, fluindapyr, fluxapyroxad, isopyrazam, picoxystrobin, pyraclostrobin or trifloxystrobin.
- Embodiments of this invention can be combined in any manner, and the descriptions of variables in the embodiments not only to the compositions comprising compounds of Formula 1 with at least one other fungicidal compound but also to compositions comprising compounds of Formula 1 with at least one invertebrate pest control compound or agent, and also to the compounds of Formula 1 and their compositions, and also to the starting compounds and intermediate compounds useful for preparing the compounds of Formula 1.
- embodiments of this invention including Embodiments 1-258 above as well as any other embodiments described herein, and any combination thereof, pertain to the methods of the present invention.
- composition disclosed above comprising (a) at least one compound selected from the compounds of Formula 1 described above, /V-oxides, and salts thereof; and at least one invertebrate pest control compound or agent.
- Combinations of Embodiments 1-258 are illustrated by:
- Embodiment A The composition comprising components (a) and (b) described Summary of the
- component (a) comprises a compound of Formula 1 or salt thereof, wherein in Formula 1,
- R 1 is CF 3 , CC1 3 or CF 2 C1;
- W is O
- R 5a and R 5b are each independently H, hydroxy or methyl
- R 2a and R 2b are each independently H or methyl
- R 2C is C
- R 2d is H or methyl
- a 1 is CR 6c R 6d or O;
- a 2 is a direct bond, CR 6e R 6f or O;
- R 6a , R 6b , R 6c , R 6d , R 6e and R 6f are each independently H, cyano, hydroxy, Br, Cl, F or methyl;
- J is J-l, J-6 or J- 14; each R 8 is independently F, Cl or methyl; each R 9a and R 9b is independently H, halogen or methyl; n is 0, 1 or 2;
- E 1 is C ⁇ -C ⁇ alkoxy, C ⁇ -C ⁇ alkylsulfonyl, C 2 -C6 alkylcarbonyl or C 2 -C6 alkoxycarbonyl, wherein each carbon atom is optionally substituted with up to 1 substituent selected from R 10a and up to 3 substituents independently selected from R 10b ;
- G is selected from the group consisting of:
- each R 14a is independently H, C [ -C 2 alkyl, C 2 -C4 alkenyl, C 2 -C4 alkynyl, C 2 -C4 alkylcarbonyl or C 2 -
- R 14a and R 14b are taken together to form an azetidinyl, morpholinyl, pyrrolidinyl, piperidinyl, piperazinyl or thiomorpholinyl ring, each ring optionally substituted with up to 2 substituents independently selected from halogen or methyl; each R 19 is independently cyano, halogen, C [ -C 2 alkyl, C [ -C 2 haloalkyl, C3-C6 cycloalkyl, C [ -C 2 alkoxy, C
- Embodiment AA The composition of Embodiment A wherein in Formula 1,
- R 1 is CF 3 ;
- X is O
- Y is O
- L is a direct bond or CH 2 ; and Z is a direct bond.
- Embodiment AAA The composition of Embodiment A wherein in Formula 1,
- R 1 is CF 3 ;
- Z is a direct bond
- Embodiment B The composition of Embodiment A wherein in Formula 1,
- T is T-2 or T-3;
- R 1 is CF 3 ;
- X is O
- Y is O
- R 2a and R 2b are each independently H or methyl
- R 2a and R 2b are taken together with the atoms X and Y to which they are attached to form a 5-membered saturated ring containing ring members, in addition to the atoms X and Y, selected from carbon atoms, the ring optionally substituted with up to 1 substituent selected from halogen, methyl and halomethyl on a carbon atom ring member;
- R 2C is methyl or ethyl
- R 2d is H
- a 1 is O
- a 2 is a direct bond or CH 2 ;
- R 6a and R 6b are each independently H, cyano hydroxy or methyl
- J is J-l or J-6; q is 0 or 1 ; each R 9a and R 9b is independently H or methyl;
- E 1 is C
- RlOa j s pyrazolyl, imidazolyl or triazolyl, each optionally substituted with up to 2 substituents independently selected from R l la on carbon atom ring members; each R 10b is independently halogen, C1-C2 alkyl, C1-C2 haloalkyl, C1-C2 alkoxy or C2-C4 alkoxycarbonyl;
- Embodiment BB The composition of Embodiment B wherein in Formula 1,
- L is a direct bond or CH2
- G is G-l or G-12; and Z is a direct bond.
- Embodiment BBB The composition of Embodiment B wherein in Formula 1,
- Z is a direct bond
- Embodiment C The composition of Embodiment B wherein in Formula 1,
- R 2a and R 2b are each H; or
- R 2a and R 2b are taken together with the atoms X and Y to which they are attached to form a 5-membered saturated ring containing ring members, in addition to the atoms X and Y, selected from carbon atoms;
- a 2 is a direct bond;
- R 6a and R 6b are each H;
- R 8 is F or Cl
- L is a direct bond, ⁇ 3 ⁇ 4 or CEECEE ;
- E 1 is C r C 2 alkoxy or C2-C3 alkoxycarbonyl, wherein each carbon atom is optionally substituted with up to 1 substituent selected from R 10a ;
- R l ° a is pyrazolyl or imidazolyl, each optionally substituted with up to 2 substituents independently selected from R lla on carbon atom ring members; each R l la is independently methoxycarbonyl or ethoxycarbonyl;
- G is G-l and the 2-position of G-l is connected to Z and the 4-position is connected to R 13 ; or G is G-12 and the 1 -position of G-12 is connected to Z and the 4-position is connected to R 13 ; or G is G-12 and the 1-position of G-12 is connected to Z and the 3-position is connected to R 13 ; x is 1;
- R 14a is H
- R 14b is H, methyl or cyclopropylmethyl
- R 19 is cyano, halogen, cyclopropyl or methoxy
- V is CH 2 ;
- Q is phenyl optionally substituted with up to 2 substituents independently selected from R 27 ;
- Embodiment CC The composition of Embodiment C wherein in Formula 1,
- L is a direct bond or CH2
- Z is a direct bond
- Embodiment D The composition of Embodiment C wherein in Formula 1,
- R 8 is F
- L is a direct bond or CH2
- E 1 is methoxy substituted with 1 substituent selected from R 10a ;
- R l ° a is pyrazolyl optionally substituted with up to 1 substituent selected from R lla on a carbon atom ring member;
- G is G-12 and the 1-position of G-12 is connected to Z and the 4-position is connected to R 13 ; or G is G-12 and the 1-position of G-12 is connected to Z and the 3-position is connected to R 13 ; and
- R 13 is C2-C5 alkoxycarbonyl optionally substituted with up to 1 substituent selected from Rl9;
- R 19 is cyano, Cl, F, cyclopropyl or methoxy; and Z is a direct bond.
- Embodiment DD The composition of Embodiment D wherein in Formula 1,
- L is a direct bond or CH2, provided that when L is a direct bond, then E is E 1 , and when L is CH2, then E is E 2 .
- Embodiment E The composition of Embodiment D wherein in Formula 1,
- L is CH 2 ;
- E is E 2 ;
- G is G-12 and the 1-position of G-12 is connected to Z and the 4-position is connected to R 13 ;
- R 13 is methoxycarbonyl or ethoxycarbonyl.
- Embodiment EE The composition of Embodiment E wherein in Formula 1,
- R 2a and R 2b are taken together with the atoms X and Y to which they are attached to form a 5-membered saturated ring containing ring members, in addition to the atoms X and Y, selected from carbon atoms.
- Embodiment F The composition of any one of Embodiments A through EE wherein in Formula 1,
- T T-2;
- R 13 is ethoxycarbonyl
- Embodiment G The composition of any one of Embodiments A through E wherein in Formula
- T T-3;
- R 13 is ethoxycarbonyl
- Embodiment H The composition any one of Embodiments A through G wherein component (a) comprises a compound selected from the group consisting of: Compound 1, Compound 32, Compound 64, Compound 71, Compound 126, Compound 127, Compound 132, Compound 162, Compound 163, Compound 171, Compound 186, Compound 218, Compound 221, Compound 229, Compound 231, Compound 262, Compound 263, Compound 265, Compound 297, Compound 330, Compound 331 and Compound 364.
- component (a) comprises a compound selected from the group consisting of: Compound 1, Compound 32, Compound 64, Compound 71, Compound 126, Compound 127, Compound 132, Compound 162, Compound 163, Compound 171, Compound 186, Compound 218, Compound 221, Compound 229, Compound 231, Compound 262, Compound 263, Compound 265, Compound 297, Compound 330, Compound 331 and Compound 364.
- Embodiment I The composition of Embodiment H wherein component (a) comprises a compound selected from the group consisting of: Compound 32, Compound 64, Compound 71, Compound 126, Compound 127, Compound 132, Compound 162, Compound 163, Compound 171, Compound 186, Compound 218, Compound 229, Compound 263, Compound 297, Compound 330 and Compound 331.
- component (a) comprises a compound selected from the group consisting of: Compound 32, Compound 64, Compound 71, Compound 126, Compound 127, Compound 132, Compound 162, Compound 163, Compound 171, Compound 186, Compound 218, Compound 229, Compound 263, Compound 297, Compound 330 and Compound 331.
- Embodiment J The composition of Embodiment I wherein component (a) comprises a Compound 32.
- Embodiment K The composition of Embodiment I wherein component (a) comprises Compound 64.
- Embodiment Bl The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (bl) methyl benzimidazole carbamate fungicides such as benomyl, carbendazim, fuberidazole thiabendazole, thiophanate and thiophanate-methyl.
- component (b) includes at least one compound selected from (bl) methyl benzimidazole carbamate fungicides such as benomyl, carbendazim, fuberidazole thiabendazole, thiophanate and thiophanate-methyl.
- Embodiment B2 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b2) dicarboximide fungicides such as chlozolinate, dimethachlone, iprodione, procymidone and vinclozolin.
- component (b) includes at least one compound selected from (b2) dicarboximide fungicides such as chlozolinate, dimethachlone, iprodione, procymidone and vinclozolin.
- Embodiment B3 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b3) demethylation inhibitor fungicides such as triforine, buthiobate, pyrifenox, pyrisoxazole fenarimol, nuarimol, triarimol econazole, imazalil, oxpoconazole, pefurazoate, prochloraz, triflumizoleazaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole (including diniconazole-M), epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazo
- Embodiment B4 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b4) phenylamide fungicides such as metalaxyl, metalaxyl-M, benalaxyl, benalaxyl-M, furalaxyl, ofurace and oxadixyl.
- phenylamide fungicides such as metalaxyl, metalaxyl-M, benalaxyl, benalaxyl-M, furalaxyl, ofurace and oxadixyl.
- Embodiment B5. The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b5) amine/morpholine fungicides such as aldimorph, dodemorph, fenpropimorph, tridemorph, trimorphamide, fenpropidin, piperalin and spiroxamine.
- component (b) includes at least one compound selected from (b5) amine/morpholine fungicides such as aldimorph, dodemorph, fenpropimorph, tridemorph, trimorphamide, fenpropidin, piperalin and spiroxamine.
- Embodiment B6 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b6) phospholipid biosynthesis inhibitor fungicides such as edifenphos, iprobenfos, pyrazophos and isoprothiolane.
- component (b) includes at least one compound selected from (b6) phospholipid biosynthesis inhibitor fungicides such as edifenphos, iprobenfos, pyrazophos and isoprothiolane.
- Embodiment B7 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b7) succinate dehydrogenase inhibitor fungicides such as benodanil, flutolanil, mepronil, isofetamid, fluopyram, fenfuram, carboxin, oxycarboxin thifluzamide, benzovindiflupyr, bixafen, fluindapyr, fluxapyroxad, furametpyr, inpyrfluxam, isopyrazam, penflufen, penthiopyrad, pyrapropoyne, sedaxane, flubeneteram, isoflucypram, pydiflumetofen, boscalid and pyraziflumid.
- succinate dehydrogenase inhibitor fungicides such as benodanil, flutolanil, me
- Embodiment B8 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b8) hydroxy(2- amino-)pyrimidine fungicides such as bupirimate, dimethirimol and ethirimol.
- Embodiment B9 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b9) anilinopyrimidine fungicides such as cyprodinil, mepanipyrim and pyrimethanil.
- component (b) includes at least one compound selected from (b9) anilinopyrimidine fungicides such as cyprodinil, mepanipyrim and pyrimethanil.
- Embodiment B10 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (blO) /V-phenyl carbamate fungicides such as diethofencarb.
- Embodiment B 11 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (bl 1) fungicides quinone outside inhibitor fungicides such as azoxystrobin, coumoxystrobin, enoxastrobin, flufenoxystrobin, picoxystrobin, pyraoxystrobin, mandestrobin, pyraclostrobin, pyrametostrobin, triclopyricarb, kresoxim-methyl, trifloxystrobin, dimoxystrobin, fenaminstrobin, metominostrobin, orysastrobin, fluoxastrobin, famoxadone, fenamidone and pyribencarb.
- fungicides quinone outside inhibitor fungicides such as azoxystrobin, coumoxystrobin, enoxastrobin, flufen
- Embodiment B12 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (bl2) phenylpyrrole fungicides compound such as fenpiclonil and fludioxonil.
- Embodiment B13 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (bl3) azanaphthalene fungicides such as quinoxyfen and proquinazid.
- component (b) includes at least one compound selected from (bl3) azanaphthalene fungicides such as quinoxyfen and proquinazid.
- Embodiment B14 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (bl4) cell peroxidation inhibitor fungicides such as biphenyl, chloroneb, dicloran, quintozene, tecnazene, tolclofos-methyl and etridiazole.
- cell peroxidation inhibitor fungicides such as biphenyl, chloroneb, dicloran, quintozene, tecnazene, tolclofos-methyl and etridiazole.
- Embodiment B15 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (bl5) melanin biosynthesis inhibitors -reductase fungicides such as fthalide, pyroquilon and tricyclazole.
- component (b) includes at least one compound selected from (bl5) melanin biosynthesis inhibitors -reductase fungicides such as fthalide, pyroquilon and tricyclazole.
- Embodiment B16a The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (bl6a) melanin biosynthesis inhibitors-dehydratase fungicides such as carpropamid, diclocymet, and fenoxanil.
- component (b) includes at least one compound selected from (bl6a) melanin biosynthesis inhibitors-dehydratase fungicides such as carpropamid, diclocymet, and fenoxanil.
- Embodiment B16b The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (bl6b) melanin biosynthesis inhibitor-polyketide synthase fungicides such as tolprocarb.
- Embodiment B17 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (bl7) keto reductase inhibitor fungicides such as fenhexamid, fenpyrazamine, quinofumelin and ipflufenoquin.
- component (b) includes at least one compound selected from (bl7) keto reductase inhibitor fungicides such as fenhexamid, fenpyrazamine, quinofumelin and ipflufenoquin.
- Embodiment B18 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (bl8) squalene- epoxidase inhibitor fungicides such as pyributicarb, naftifine and terbinafine.
- component (b) includes at least one compound selected from (bl8) squalene- epoxidase inhibitor fungicides such as pyributicarb, naftifine and terbinafine.
- Embodiment B19 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (bl9) polyoxin fungicides such as polyoxin.
- Embodiment B20 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 243 and A through K) wherein component (b) includes at least one compound selected from (b20) phenylurea fungicides such as pencycuron.
- Embodiment B21 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b21) quinone inside inhibitor fungicides such as cyazofamid, amisulbrom and fenpicoxamid (Registry Number 517875-34-2).
- component (b) includes at least one compound selected from (b21) quinone inside inhibitor fungicides such as cyazofamid, amisulbrom and fenpicoxamid (Registry Number 517875-34-2).
- Embodiment B22 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b22) benzamide and thiazole carboxamide fungicides such as zoxamide and ethaboxam.
- Embodiment B23 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b23) enopyranuronic acid antibiotic fungicides such as blasticidin-S.
- Embodiment B24 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b24) hexopyranosyl antibiotic fungicides such as kasugamycin.
- Embodiment B25 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b25) glucopyranosyl antibiotic: protein synthesis fungicides such as streptomycin.
- Embodiment B26 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b26) glucopyranosyl antibiotic: trehalase and inositol biosynthesis fungicides such as validamycin.
- Embodiment B27 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b27) cyanoacetylamideoxime fungicides such as cymoxanil.
- Embodiment B28 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b28) carbamate fungicides such as propamacarb, prothiocarb and iodocarb.
- component (b) includes at least one compound selected from (b28) carbamate fungicides such as propamacarb, prothiocarb and iodocarb.
- Embodiment B29 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b29) oxidative phosphorylation uncoupling fungicides such as fluazinam, binapacryl, meptyldinocap and dinocap.
- component (b) includes at least one compound selected from (b29) oxidative phosphorylation uncoupling fungicides such as fluazinam, binapacryl, meptyldinocap and dinocap.
- Embodiment B30 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b30) organo tin fungicides such as fentin acetate, fentin chloride and fentin hydroxide.
- organo tin fungicides such as fentin acetate, fentin chloride and fentin hydroxide.
- Embodiment B31 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b31) carboxylic acid fungicides such as oxolinic acid.
- Embodiment B32 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b32) heteroaromatic fungicides such as hymexazole and octhilinone.
- component (b) includes at least one compound selected from (b32) heteroaromatic fungicides such as hymexazole and octhilinone.
- Embodiment B33 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b33) phosphonate fungicides such as phosphorous acid and its various salts, including fosetyl-aluminum.
- Embodiment B34 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b34) phthalamic acid fungicides such as teclofthalam.
- Embodiment B35 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b35) benzotriazine fungicides such as triazoxide.
- Embodiment B36 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b36) benzene- sulfonamide fungicides such as flusulfamide.
- Embodiment B37 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b37) pyridazinone fungicides such as diclomezine.
- Embodiment B38 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b38) thiophene- carboxamide fungicides such as silthiofam.
- Embodiment B39 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b39) complex I NADH oxidoreductase inhibitor fungicides such as diflumetorim, tolfenpyrad and fenazaquin.
- component (b) includes at least one compound selected from (b39) complex I NADH oxidoreductase inhibitor fungicides such as diflumetorim, tolfenpyrad and fenazaquin.
- Embodiment B40 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b40) carboxylic acid amide fungicides such as dimethomorph, benthiavalicarb, benthiavalicarb-isopropyl, iprovalicarb, valifenalate, mandipropamid, flumorph, dimethomorph, flumorph, pyrimorph, benthiavalicarb, benthiavalicarb-isopropyl, iprovalicarb, tolprocarb, valifenalate and mandipropamid.
- carboxylic acid amide fungicides such as dimethomorph, benthiavalicarb, benthiavalicarb-isopropyl, iprovalicarb, valifenalate, mandipropamid.
- Embodiment B41 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b41) tetracycline antibiotic fungicides such as oxy tetracycline.
- Embodiment B42 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b42) thiocarbamate fungicides such as methasulfocarb.
- Embodiment B43 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b43) benzamide fungicides such as fluopicolide and fluopimomide.
- component (b) includes at least one compound selected from (b43) benzamide fungicides such as fluopicolide and fluopimomide.
- Embodiment B44 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b44) microbial fungicides such as Bacillus amyloliquefaciens strains QST713, FZB24, MB 1600, D747, F727, TJ100 (also called strain 1 BE; known from EP2962568) and the fungicidal lipopeptides which they produce.
- microbial fungicides such as Bacillus amyloliquefaciens strains QST713, FZB24, MB 1600, D747, F727, TJ100 (also called strain 1 BE; known from EP2962568) and the fungicidal lipopeptides which they produce.
- Embodiment B45 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b45) quinone outside inhibitor, stigmatellin binding fungicides such as ametoctradin.
- Embodiment B46 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b46) plant extract fungicides such as Melaleuca alternifolia, eugenol, geraniol and thymol.
- component (b) includes at least one compound selected from (b46) plant extract fungicides such as Melaleuca alternifolia, eugenol, geraniol and thymol.
- Embodiment B47 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b47) cyanoacrylate fungicides such as phenamacril.
- Embodiment B48 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b48) polyene fungicides such as natamycin.
- Embodiment B49 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b49) oxysterol binding protein inhibitor fungicides such as oxathiapiprolin and fluoxapiprolin.
- component (b) includes at least one compound selected from (b49) oxysterol binding protein inhibitor fungicides such as oxathiapiprolin and fluoxapiprolin.
- Embodiment B50 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b50) aryl-phenyl- ketone fungicides such as metrafenone and pyriofenone.
- Embodiment B5E The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b51) host plant defense induction fungicides such as acibenzolar-S-methyl, probenazole, tiadinil, isotianil, laminarin, extract from Reynoutria sachalinensis and Bacillus mycoides isolate J and cell walls of Saccharomyces cerevisiae strain LAS 117.
- host plant defense induction fungicides such as acibenzolar-S-methyl, probenazole, tiadinil, isotianil, laminarin, extract from Reynoutria sachalinensis and Bacillus mycoides isolate J and cell walls of Saccharomyces cerevisiae strain LAS 117.
- Embodiment B52 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b52) multi-site activity fungicides such as copper oxychloride, copper sulfate, copper hydroxide, Bordeaux composition (tribasic copper sulfide), elemental sulfur, ferbam, mancozeb, maneb, metiram, propineb, thiram, zinc thiazole, zineb, ziram, folpet, captan, captafol, chlorothalonil, dichlofluanid, tolyfluanid, guazatine, iminoctadine albesilate, iminoctadine triacetate, anilazine, dithianon, quinomethionate and fluoroimide.
- multi-site activity fungicides such as copper oxychloride, copper sulfate
- Embodiment B53 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b53) biological fungicides with multiple modes of action such as extract from the cotyledons of lupine plantlets.
- Embodiment B54 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b54) fungicides other than fungicides of component (a) and components (bl) through (b53), such as cyflufenamid, bethoxazin, neo-asozin, pyrrolnitrin, tebufloquin, dodine, flutianil, ferimzone, picarbutrazox, dichlobentiazox (Registry Number 957144-77-3), dipymetitrone (Registry Number 16114-35-5), flometoquin, tolnifanide (Registry Number 304911-98-6), /V-[4-[4- chloiO-3-(trinuoromcthyl)phcnoxyJ-2,5-dimcthylphc
- Embodiment B55 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes (lS)-2,2-bis(4-fluorophenyl)-l-methylethyl /V-[[3- (acetyloxy)-4-methoxy-2-pyridinyl]carbonyl]-L-alaninate (provisional common name flory lpicoxamid) .
- Embodiment B56 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes l-[2-[[[l-(4-chlorophenyl)-l -pyrazol-3-yl]oxy]methyl]- 3-mcthylphcnyl]-l ,4-dihydro-4-mcthyl-5/7-tctra/ol-5-onc (provisional common name mety ltetraprole) .
- Embodiment B57 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5- phenylpyridazine (provisional common name pyridachlometyl).
- Embodiment B58 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes (4-phenoxyphenyl)methyl 2-amino-6-methyl-pyridine-3- carboxylate (provisional common name aminopyrifen).
- Embodiment B59 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b54.11) (i.e Formula b54.11) wherein
- R bl ° and R bl 1 are each independently halogen
- R 6 is H, halogen, C ⁇ -Cg alkyl, C ⁇ -Cg haloalkyl or Cg-Cg cycloalkyl.
- Embodiment B60 The composition of Embodiment B59 wherein component (b) includes at least one fungicidal compound selected from the group consisting of methyl A- [[5- [1 -(2,6- difluoro-4-formylphenyl)-l//-pyrazol-3-yl]-2-methylphenyl] methyl]carbamate, methyl N- [[5-[l-(4-cyclopropyl-2,6-dichlorophenyl)-l -pyrazol-3-yl]-2-methylphenyl]methyl]- carbamate, methyl A/-[[5-[l-(4-chloro-2,6-difluorophenyl)-l -pyrazol-3-yl]-2-methyl- phenyl]methyl]carbamate, methyl A/-[[5-[l-(4-cyclopropyl-2,6-difluorophenyl)-l -pyrazol- 3-yl]
- Embodiment B61 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b54.12) (i.e Formula b54.12) b54.12 wherein R b4 is R b6 is C2-C4 alkoxycarbonyl or C2-C4 haloalkylaminocarbonyl;
- L is CH2 or CH2O, wherein the atom to the right is connected to the phenyl ring in Formula b54.12;
- R b5 is
- Embodiment B62 The composition of Embodiment B61 wherein component (b) includes at least one fungicidal compound selected from the group consisting of N-( 2,2,2- trifluoroethyl)-2-[[4-[5-(trifluoromethyl)-l,2,4-oxadiazol-3-yl]phenyl]methyl]-4- oxazolecarboxamide and ethyl l-[[4-[5-(trifluoromethyl)-l,2,4-oxadiazol-3-yl]phenoxy] methyl]- l /-pyrazole-4-carboxylate.
- component (b) includes at least one fungicidal compound selected from the group consisting of N-( 2,2,2- trifluoroethyl)-2-[[4-[5-(trifluoromethyl)-l,2,4-oxadiazol-3-yl]phenyl]methyl]-4- oxazolecarboxamide and ethyl l-
- Embodiment B63 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one compound selected from (b54.13) (i.e Formula b54.13) wherein
- R b7 , R b8 and R b9 are each independently H, halogen or cyano; and R bl ° and R bl 1 are each independently H, halogen, C [ -C3 alkyl or C [ -C3 methoxy Embodiment B64.
- component (b) includes at least one fungicidal compound selected from the group consisting of 4-(2-chloro-4- fl uo ro p h c n y 1 ) - A- (2 - fl u o ro - 4 - in c t h y 1 - 6 - n i t ro p h c n y 1 ) - 1 ,3-dimethyl- l /-pyrazol-5-amine, 4-(2- chloro-4-fluorophenyl)- V-(2-fluoro-6-nitrophenyl)-l, 3-dimethyl- l /-pyrazol-5-amine, 3,5- difluoro-4-[5-[(4-methoxy-2-nitrophenyl)amino]- 1,3-dimethyl- l -pyrazol-4-yl]- benzonitrile and A-(2-chloro-4- fl uo
- Embodiment B65 The composition described in the Summary of the Invention (including but not limited to the composition of any one of Embodiments 1 through 258 and A through K) wherein component (b) includes at least one fungicidal compound (fungicide) selected from the group consisting of azoxystrobin, benzovindiflupyr, boscalid (nicobifen), bixafen, bromuconazole, carbendazim, chlorothalonil, copper hydroxide, cyflufenamid, cyproconazole, difenoconazole, dimoxystrobin, epoxiconazole, famoxadone, fenbuconazole, fenpropidin, fenpropimorph, fluindapyr, flusilazole, flutriafol, fluxapyroxad, hexaconazole, ipconazole kresoxim-methyl, manzate, metconazole, metomin
- Embodiment B66 The composition of Embodiment B65 wherein component (b) includes at least one compound selected from the group consisting of azoxystrobin, benzovindiflupyr, bixafen, chlorothalonil, copper hydroxide, cyflufenamid, cyproconazole, difenoconazole, dimoxystrobin, epoxiconazole, famoxadone, fenpropidin, fenpropimorph, fluindapyr, flusilazole, flutriafol, fluxapyroxad, kresoxim-methyl, manzate, metconazole, metominostrobin, metrafenone, myclobutanil, penthiopyrad, picoxystrobin, propiconazole, proquinazid, prothioconazole, pydiflumetofen, pyraclostrobin, pyrametostrobin, pyraoxystrobin,
- Embodiment B67 The composition of Embodiment B66 wherein component (b) includes at least one compound selected from the group consisting of azoxystrobin, benzovindiflupyr, bixafen, chlorothalonil, copper hydroxide, cyproconazole, difenoconazole, epoxiconazole, fenpropidin, fenpropimorph, fluindapyr, flutriafol, fluxapyroxad, manzate, metominostrobin, picoxystrobin, prothioconazole, pydiflumetofen, pyraclostrobin, tebuconazole, trifloxystrobin, methyl /V-[[5-[l-[2,6-difluoro-4-(l-methylethyl)phenyl]-l//- pyrazol-3 -yl] -2-methylphenyl]methyl] carbamate, methyl N- [ [5- [
- Embodiment B68 The composition of Embodiment B67 wherein component (b) includes at least one compound selected from the group consisting of azoxystrobin, benzovindiflupyr, bixafen, chlorothalonil, copper hydroxide, cyproconazole, epoxiconazole, fenpropidin, fenpropimorph, fluindapyr, flutriafol, fluxapyroxad, manzate, metominostrobin, picoxystrobin, prothioconazole, pydiflumetofen, pyraclostrobin, tebuconazole, trifloxystrobin.
- azoxystrobin benzovindiflupyr, bixafen, chlorothalonil, copper hydroxide
- cyproconazole epoxiconazole
- fenpropidin fenpropimorph
- fluindapyr flutriafol
- fluxapyroxad man
- component (a) comprises a compound of Formula 1 or a salt thereof.
- compositions of the present invention comprising a fungicidally effective amount of a composition of Embodiments 1 through 258, A through K, and B1 through B68, and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.
- Embodiments of the invention further include methods for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof, or to the plant seed or seedling, a fungicidally effective amount of a composition any one of Embodiments 1 through 258, A through K, and B1 through B68 (e.g., as a composition including formulation ingredients as described herein).
- Embodiments of the invention also include methods for protecting a plant or plant seed from diseases caused by fungal pathogens comprising applying a fungicidally effective amount of a composition of any one of Embodiments 1 through 258, A through K, and B 1 through B68 to the plant or plant seed.
- Some embodiments of the invention involve control of a plant disease or protection from a plant disease that primarily afflicts plant foliage and/or applying the composition of the invention to plant foliage (i.e. plants instead of seeds).
- the preferred methods of use include those involving the above preferred compositions; and the diseases controlled with particular effectiveness include plant diseases caused by fungal plant pathogens.
- Combinations of fungicides used in accordance with this invention can facilitate disease control and retard resistance development.
- Embodiment Cl A method for protecting a plant from a disease selected from rust, powdery mildew and Septoria diseases comprising applying to the plant a fungicidally effective amount of the composition comprising components (a) and (b) described in the Summary of the Invention or any one of Embodiments 1 through 258.
- Embodiment C2 The method of Embodiment Cl wherein the disease is a rust disease and component (b) of the composition includes at least one fungicidal compound selected from (b3) demethylation inhibitor (DMI) fungicides, (b5) amine/morpholine fungicides, (b7) succinate dehydrogenase inhibitor fungicides, (b 11) quinone outside inhibitor (Qol) fungicides, (bl3) methyl benzimidazole carbamate fungicides and (b52) multi-site activity fungicides.
- DMI demethylation inhibitor
- b5 amine/morpholine fungicides
- succinate dehydrogenase inhibitor fungicides succinate dehydrogenase inhibitor fungicides
- Qol quinone outside inhibitor
- bl3 methyl benzimidazole carbamate fungicides
- multi-site activity fungicides multi-site activity fungicides.
- Embodiment C3 The method of Embodiment C2 wherein component (b) of the composition includes at least one fungicidal compound selected from (b3) demethylation inhibitor (DMI) fungicides, (b7) succinate dehydrogenase inhibitor fungicides and (b 11 ) quinone outside inhibitor (Qol) fungicides.
- DMI demethylation inhibitor
- Qol quinone outside inhibitor
- Embodiment C4 The method of Embodiment C3 wherein component (b) of the composition includes at least one fungicidal compound selected from the group consisting of azoxystrobin, cyproconazole, difenoconazole, epoxiconazole, fluindapyr, flutriafol, fluxapyroxad, picoxystrobin, prothioconazole, pyraclostrobin, tebuconazole and trifloxystrobin.
- Embodiment C5 The method of Embodiments C2 through C4 wherein the disease is Asian soybean rust caused by Puccinia recondite.
- Embodiment C6 The method of Embodiments C2 through C4 wherein the disease is wheat leaf rust caused by Phakopsora pachyrhizi.
- Embodiment C7 The method of Embodiment Cl wherein the disease is a powdery mildew disease and component (b) of the composition includes at least one fungicidal compound selected from (b3) demethylation inhibitor (DMI) fungicides, (bl 1) quinine outside inhibitor (Qol) fungicides and (bl3) azanaphthalene fungicides.
- DMI demethylation inhibitor
- Qol quinine outside inhibitor
- bl3 azanaphthalene fungicides.
- Embodiment C8 The method of Embodiment C7 wherein the disease is wheat powdery mildew.
- Embodiment C9 The method of Embodiment C7 wherein the disease is grape downy mildew.
- Embodiment CIO The method of Embodiments C7 through C9 wherein component (b) includes at least one fungicidal compound selected from (b3) DMI fungicides.
- Embodiment Cl 1. The method of Embodiment CIO wherein component (b) includes at least one fungicidal compound selected from the group consisting of cyproconazole, difenoconazole, epoxiconazole, prothioconazole and tebuconazole.
- Embodiment C12 The method of Embodiment C 11 wherein component (b) includes at least one fungicidal compound selected from the group consisting of cyproconazole, difenoconazole and prothioconazole.
- Embodiment C13 The method of Embodiments C8 through CIO wherein component (b) includes at least one fungicidal compound selected from (bl 1) Qol fungicides.
- Embodiment C14 The method of Embodiment C 12 wherein component (b) includes at least one fungicidal compound selected from the group consisting of azoxystrobin, picoxystrobin and pyraclostrobin.
- Embodiment C15 The method of Embodiment Cl wherein the disease is a Septoria disease and component (b) of the composition includes at least one fungicidal compound selected from the group consisting of epoxiconazole, metalaxyl (including metalaxyl-M), iprovalicarb and fenpropimorph.
- fungicidal compound selected from the group consisting of epoxiconazole, metalaxyl (including metalaxyl-M), iprovalicarb and fenpropimorph.
- Embodiment Cl 6 The method of Embodiment C 15 wherein the disease is wheat leaf blotch.
- Embodiment C17 The method of any one of Embodiments Cl through C16 wherein components (a) and (b) are applied in synergistically effective amounts (and in a synergistic ratio relative to each other).
- Embodiments Cl through C17 relating to a method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof, a fungicidally effective amount of a fungicidal composition of the invention.
- this invention also relates to a compound of Formula 1, or an A-oxidc or salt thereof. Also noted is that the embodiments of this invention, including Embodiments 1-258, relate also to compounds of Formula 1. Accordingly, combinations of Embodiments 1-258 are further illustrated by:
- Embodiment Dl A compound of Formula 1, or an A-oxidc or salt thereof, wherein
- T T-2;
- R 1 is CF 3 ;
- R 2a is H or methyl
- R 2b is C3-C15 trialkylsilyl or C3-C35 halotrialkylsilyl
- a 1 is O
- a 2 is a direct bond or CH2;
- R 6a and R 6b are each independently H, cyano hydroxy or methyl
- J is J-l or J-6; q is 0 or 1 ;
- L is a direct bond or CH2
- E is E 1 or E 2 ;
- E 1 is C3-C3 alkoxy, C2-C3 alkylcarbonyl or C2-C3 alkoxycarbonyl, wherein each carbon atom is optionally substituted with up to 1 substituent selected from R 10a and up to 3 substituents independently selected from R 10b ;
- Rl° a is pyrazolyl, imidazolyl or triazolyl, each optionally substituted with up to 2 substituents independently selected from R l la on carbon atom ring members; each R 10b is independently halogen, C3-C2 alkyl, C3-C2 haloalkyl, C3-C2 alkoxy or C2-C4 alkoxycarbonyl; each R l la is independently methoxycarbonyl or ethoxycarbonyl;
- R 2a is H or methyl
- R 2b is trimethylsilyl or halotrimethylsilyl
- a 2 is a direct bond
- R 6a and R 6b are each H;
- R 8 is F or Cl
- E 1 is C r C 2 alkoxy or C2-C3 alkoxycarbonyl, wherein each carbon atom is optionally substituted with up to 1 substituent selected from R 10a ;
- R l ° a is pyrazolyl or imidazolyl, each optionally substituted with up to 2 substituents independently selected from R lla on carbon atom ring members; each R l la is independently methoxycarbonyl or ethoxycarbonyl;
- G is G-l and the 2-position of G-l is connected to Z and the 4-position is connected to R 13 ; or G is G-12 and the 1 -position of G-12 is connected to Z and the 4-position is connected to R 13 ; or G is G-12 and the 1-position of G-12 is connected to Z and the 3-position is connected to R 13 ; x is 1;
- R 14a is H
- R 14b is H, methyl or cyclopropylmethyl
- R 19 is cyano, halogen, cyclopropyl or methoxy
- V is CH 2 ;
- Q is phenyl optionally substituted with up to 2 substituents independently selected from R 27 ;
- Embodiment D3 A compound of Embodiment D2 wherein
- R 2a is H or methyl
- R 2b is trimethylsilyl
- R 8 is F
- E 1 is methoxy substituted with 1 substituent selected from R 10a ;
- R l ° a is pyrazolyl optionally substituted with up to 1 substituent selected from R lla on a carbon atom ring member;
- G is G-12 and the 1-position of G-12 is connected to Z and the 4-position is connected to R 13 ; or
- G is G-12 and the 1-position of G-12 is connected to Z and the 3-position is connected to R 13 ;
- R 13 is C2-C5 alkoxycarbonyl optionally substituted with up to 1 substituent selected from Rl9;
- R 19 is cyano, Cl, F, cyclopropyl or methoxy
- Z is a direct bond
- Embodiment D3 A compound of Embodiment D3 wherein
- R 2a is methyl
- L is CH 2 ;
- E is E 2 ;
- G is G-12 and the 1-position of G-12 is connected to Z and the 4-position is connected to R 13 ;
- R 13 is methoxycarbonyl or ethoxycarbonyl.
- Additional embodiments include a fungicidal composition comprising: (1) a compound of any one of Embodiments D1 through D3; and (2) at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. Additional embodiments also include a method for protecting a plant or plant seed from diseases caused by fungal pathogens comprising applying a fungicidally effective amount of the compound of any one of Embodiments D1 through D3 to the plant (or portion thereof) or plant seed (directly or through the environment (e.g., growing medium) of the plant or plant seed). Of note are embodiments relating to a method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof, a fungicidally effective amount of a compound of any one of Embodiments D1 through D3.
- This invention also provides a fungicidal composition
- a fungicidal composition comprising a compound of Formula 1 (including all stereoisomers, /V-oxides, and salts thereof) (i.e. in a fungicidally effective amount), and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.
- a compound of Formula 1 including all stereoisomers, /V-oxides, and salts thereof
- additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.
- Compounds of Formula la (i.e. Formula 1 wherein T is T-l and W is O) wherein R 1 is CF3 can be prepared by trifluoroacetylation of organometallic compounds of Formula 2.
- the ethyl ester of trifluoroacetic acid i.e. ethyl trifluoroacetate
- trifluoroacetonitrile and various trifluoroacetate salts can also be used.
- double-addition on the trifluoroacetyl compound can occur.
- M is, wherein R 1 is CF 3
- Compounds of Formula la (i.e. Formula 1 wherein T is T-l and W is O) wherein R 1 is CF3 can also be prepared via alkylation of ethyl 4,4,4-trifluoroacetoacetate (ETFAA) with compounds of Formula 3 wherein L a is a leaving group such as halogen (e.g., Cl, Br) or sulfonate (e.g., mesylate).
- ETFAA is first treated with a base such as sodium hydride in a polar aprotic solvent such tetrahydrofuran (THF), THF/hexamethylphosphoramide (HMPA) or acetone.
- THF tetrahydrofuran
- HMPA hexamethylphosphoramide
- the ETFAA anion then displaces the leaving group in compounds of Formula 3 to give an intermediate ester which undergoes hydrolysis and decarboxylation in the presence of lithium chloride (LiCl) and N, /V-dimethylformamide (DMF) to give the ketone compound of Formula la.
- LiCl lithium chloride
- DMF N, /V-dimethylformamide
- L a is a leaving group such as Cl, Br or OMs
- compounds of Formula la i.e. Formula 1 wherein T is T-l and W is O
- R 1 is CF3
- TMS-CF3 trifluoromethyltrimethylsilane
- the reaction is run in the present of a fluoride initiator such as tetrabutylammonium fluoride, and in an anhydrous solvent such as toluene or dichloromethane at about -78 °C (for reaction conditions see, for example, Angew. Chem., Int. Ed. 1998, 37(6), 820-821).
- Cesium fluoride can also be used as an initiator in a solvent such as 1,2-dimethoxy ethane (glyme) at room temperature (for reaction conditions see, for example, J. Org. Chem., 1999, 64, 2873).
- a solvent such as 1,2-dimethoxy ethane (glyme) at room temperature (for reaction conditions see, for example, J. Org. Chem., 1999, 64, 2873).
- the reaction proceeds through a trimethylsilicate intermediate, which is hydrolyzed with aqueous acid to give the desired trifluoromethyl ketone compound of Formula la.
- Weinreb amides may also be used in place of the starting esters (see, for example, Chem. Commun. 2012, 48, 9610).
- compounds of Formula la 1 (i.e. Formula la wherein A is Ai-A 2 - CR 6a R 6b ) wherein R 1 is CF3 and at least one R 6a or R 6b is H can be prepared by reacting acid chlorides of Formula 6 with trifluoroacetic anhydride (TFAA) and pyridine in a solvent such as dichloromethane or toluene at a temperature between about 0 to 80 °C followed by aqueous hydrolysis (for reaction conditions see, for example, Tetrahedron 1995, 51, 2573-2584).
- TFAA trifluoroacetic anhydride
- Compounds of Formula 6 can be prepared from compounds of Formula 5 by ester hydrolysis to the corresponding carboxylic acid and treatment with oxalyl chloride, as known to one skilled in the art.
- R ba or R bb is H wherein R 1 is CF3 and at least one R ba or R 6b is H
- compounds of Formula lb (i.e. Formula 1 wherein T is T-2) wherein R 2a X and R 2b Y are OH can be prepared by oxidation of alcohols of Formula 4 to the corresponding dihydroxy.
- the oxidation reaction can be performed by a variety of means, such as by treatment of the alcohols of Formula 4 with manganese dioxide, Dess-Martin periodinane, pyridinium chlorochromate or pyridinium dichromate.
- manganese dioxide Dess-Martin periodinane
- pyridinium chlorochromate pyridinium dichromate
- Scheme 6 illustrates a specific example of the general method of Scheme 5 for the preparation of a compound of Formula lb 1 (i.e. Formula lb wherein L is CH2, J is phenyl (i.e. J-l), A is OCH2 and R 1 is CF3).
- a compound of Formula 4a i.e. Formula 4 wherein L is CH2, J is phenyl (i.e. J-l), A is OCH2 and R 1 is CF 3
- an oxidizing reagent such as Dess-Martin periodinane in a solvent such as dichloromethane at a temperature between about 0 to 80 °C.
- Step C illustrates the method of Scheme 6.
- M is, e.g., Li, Na, K, Cs or MgBr As shown in Scheme 8, compounds of Formula 4b (i.e. Formula 4 wherein A is
- OCR 6a R 6b can be prepared by reacting a compound of Formula 7 with an epoxide of Formula 8.
- the reaction is typically carried out in a solvent such as acetonitrile with a catalytic amount of a base such as cesium or potassium carbonate at a temperature between about 20 to 80 °C; or in a solvent such as dichloromethane with a catalytic amount of a Fewis acid such as boron trifluoride etherate at a temperature between about 0 to 40 °C.
- Step E illustrates the method of Scheme 8.
- One skilled in the art will recognize that the method of Scheme 8 can also be performed when A is SCR 6a R 6b or N(R ⁇ a )CR 6a R 6b , thus providing other compounds of Formula 4b.
- Scheme 9 illustrates a specific example of the general method of Scheme 8 for the preparation of a compound of Formula 4b 1 (i.e. Formula 4b wherein L is CH 2 , J is phenyl (i.e. J-l), R 6a and R 6b are H and R 1 is CF 3 )
- a compound of Formula 7a i.e. Formula 7 wherein L is CH 2 and J is phenyl (i.e. J-l)
- 2-(trifluoromethyl)oxirane i.e. Formula 8a
- Step B illustrates the method of Scheme 9.
- W is O
- Formula lb i.e. Formula 1 wherein T is T-2
- R 2a X and R 2b Y are OH.
- the predominance of Formula la or Formula lb is dependent upon several factors, such as environment and structure. For example, in an aqueous environment ketones of Formula la can react with water to give ketone hydrates (also known as 1,1-geminal diols) of Formula lb. Conversion back to the keto-form can usually be achieved by treatment with a dehydrating agent such as magnesium sulfate or molecular sieves.
- a dehydrating agent such as magnesium sulfate or molecular sieves.
- ketones of Formula la may also exist in equilibrium with their hemiketals, hemithioketals and hemiaminals of Formula lb 2 (i.e. Formula lb wherein R 2b Y is OH and R 2a is other than H) along with their ketals, thioketals aminals of Formula lb wherein R 2a and R 2b are other than H.
- Compounds of Formula lb 2 can be prepared by reacting a compound of Formula la with a compound of formula R 2a X-H (e.g., alcohols for X being O, thiols for X being S or amines for X being NR 5a ), usually in the presence of an catalysis, such as a Bronsted (i.e. protic) acid or Lewis acid (e.g. BF3), (see, for example, Master Organic Chemistry (Online), On Acetals and Hemiacetals, May 28, 2010, www.masterorganic- chemistry.com/2010/201728/on-acetals-and-hemiacetals).
- a compound of formula R 2a X-H e.g., alcohols for X being O, thiols for X being S or amines for X being NR 5a
- an catalysis such as a Bronsted (i.e. protic) acid or Lewis acid (e.g. BF3)
- compounds of Formula lb 2 can be treated with a compound of formula R 2b Y-H (e.g., alcohols for Y being O, thiols for Y being S or amines for Y being NR 5b ) under dehydrating conditions, or other means of water removal that will drive the equilibrium in the reaction to the right, to provide compounds of Formula lb wherein R 2a and R 2b are other than H.
- R 2b Y-H e.g., alcohols for Y being O, thiols for Y being S or amines for Y being NR 5b
- ketones of Formula la can initially be treated with two equivalents (or an excess amount) of an alcohol, thiol or amine typically in the presence of a catalysis together with a dehydrating agent to provide compounds of Formula lb directly (see, for example, the preparation of the dimethylketals using methanol and trimethyl orthoformate in US 6,350,892).
- cyclic ketals of Formula lb 3 (i.e. Formula lb wherein X and Y are O, and R 2a and R 2b are taken together to form a 5- to 7-membered ring) can be prepared by treating the corresponding ketones of Formula la with haloalcohols (e.g., 2-chloroethanol or 2- bromopropanol) in the presence of a base such as potassium carbonate or potassium ieri-butoxide and in as solvent such as acetonitrile or/V,/V-dimethylformamide (DMF).
- haloalcohols e.g., 2-chloroethanol or 2- bromopropanol
- a base such as potassium carbonate or potassium ieri-butoxide
- solvent such as acetonitrile or/V,/V-dimethylformamide (DMF).
- Scheme 12 illustrates a specific example where a ketone hydrate of Formula lb 4 (i.e. Formula lb wherein L is CH 2 , J is phenyl (i.e. J-l), A is OCH 2 , R 2a X and R 2b Y are OH and R 1 is CF 3 ) is reacted with 2-chloroethanol in the presence of potassium carbonate in acetonitrile at a temperature between about 25 to 70 °C to provide a compound of Formula lb 5 (i.e. Formula lb wherein L is CH 2 , J is phenyl (i.e. J-l), A is OCH 2 , X and Y are O, R 2a and R 2b are taken together to form a 5-membered ring and R 1 is CF 3 ).
- Present Example 2 illustrates the method of Scheme 13.
- Compounds of Formula 10 can be prepared using commercial precursors and known methods. For example, as shown in Scheme 15, compounds of Formula 10a (i.e. Formula 10 wherein R 6a and R 6b are H, X and Y are O and R 2a and R 2b are taken together to form a 5- membered ring) can be prepared reacting compounds of Formula 11 with haloalcohols (e.g., 2- chloroethanol or 3-bromopropanol) under basic conditions (e.g., potassium ieri-butoxide in a solvent such as A, A-di methyl formamidc or tetrahydrofuran) to provide compounds of Formula 12.
- haloalcohols e.g., 2- chloroethanol or 3-bromopropanol
- basic conditions e.g., potassium ieri-butoxide in a solvent such as A, A-di methyl formamidc or tetrahydrofuran
- a mesylate or tosylate group can be installed by treating the alcohol with methanesulfonyl chloride (mesyl chloride) or 4-toluenesulfonyl chloride (tosyl chloride) in the presence of a base such as triethylamine at a temperature between about 0 to 40 °C and in a solvent such as dichloromethane.
- a triflate group can be installed by treating the alcohol with triflic anhydride (CFgSC ⁇ O as illustrated in Example 4, Step C.
- Compounds of Formula 11 are known and can be prepared by methods known to one skilled in the art.
- Compounds of Formula lc (i.e. Formula 1 wherein T is T-3 and X is O) can be prepared by reacting a compound of Formula la (i.e. Formula 1 wherein T is T-l and W is O) wherein at least one of R 6a and R 6b is H with a compound of Formula 14 in the presence of a base, as illustrated in Scheme 16.
- Suitable bases include cesium or potassium carbonate in a solvent such as A,A-di methyl formamidc (DMF) or dimethyl sulfoxide at temperatures from about 20 to 80 °C.
- the method of Scheme 16 results in a mixture of O-alkylated product (typically as a mixture of ( E )- and (Z)-isomers), along with C-alkylated product.
- Purification can be achieved using standard techniques such as column chromatography (see Magnetic Resonance in Chemistry 1991, 29, 675-678).
- Compounds of Formula 14 are commercially available and can be easily synthesized by general methods known to one skilled in the art.
- Scheme 16 wherein at least one L& is a leaving group such as of R 6a and R 6b is H Cl, Br, I, OMs, OTs or OTf
- the method of Scheme 16 is also useful for preparing compounds of Formula lc stating from the corresponding ketone hydrate.
- Scheme 17 illustrates a specific example where a ketone hydrate of Formula lb 4 (i.e. Formula lb wherein L is CH 2 , J is phenyl (i.e.
- Compounds of Formula 1 wherein T is T-l and W is S can be prepared from the corresponding compounds wherein W is O by treatment with phosphorus pentasulfide or 2,4- bis(4-methoxyphenyl)-l,3-dithia-2,4-diphosphetane-2, 4-disulfide (Lawesson’s reagent) in solvents such as toluene, xylene or tetrahydrofuran.
- solvents such as toluene, xylene or tetrahydrofuran.
- E-L- moieties present in the compounds of Formula 1 and the intermediate compounds of Formulae 2 through 7 and 9 are common organic functional groups whose methods of preparation have been documented in the literature.
- these well-known chemistry classes esters, amides, sulfonamides, sulfones, ethers, carbamates, ureas, heterocycles
- can be readily prepared by a variety of methods see, for example, WO 2018/080859, WO 2018/118781, WO 2018/187553 and WO 2019/010192).
- Step A Preparation of ethyl l-[(4-hydroxyphenyl)methyl]-l//-pyrazole-4-carboxylate
- Step B Preparation of ethyl l-[[4-(3,3,3-trifluoro-2-hydroxypropoxy)phenyl]methyl]-177- pyrazole-4-carboxylate
- Step C Preparation of ethyl 1 - [[4-(3, 3, 3-trifluoro-2, 2-dihydiOxypropoxy)phcny 1] methyl J-
- Step A Preparation of methyl 2-(trifluoromethyl)-l,3-dioxolane-2-carboxylate
- Step B Preparation of 2-(trifluoromethyl)- 1 ,3-dioxolane-2-methanol
- Step C Preparation of [2-(trifluoromethyl)-l,3-dioxolan-2-yl]methyl 1,1,1-trifluoro- methanesulfonate
- Step D Preparation of ethyl l-[[4-[[2-(trifluoromethyl)-l,3-dioxolan-2-yl]methoxy]- phenyl] methyl] - 1 /7-pyrazolc-4-carboxylatc
- the filtrate was concentrated under reduced pressure to provide the title compound, a compound of the present invention, as a white solid (0.80 g).
- a portion of the solid was further purified by silica gel chromatography (eluting with a gradient of 0 to 50% ethyl acetate in hexanes) to provide a solid melting at 59- 60 °C.
- a nuclear Overhauser effect (NOE) was observed between the trifluoromethyl moiety and the vinyl proton indicating a c/.s-con figuration.
- Step C Preparation of ethyl 1 -[[3-(accty loxy)phcnylJ methyl J-l /7-pyrazolc-4-carboxy late
- Step D Preparation of ethyl l-[(3-hydroxyphenyl)methyl]-17/-pyrazole-4-carboxylate
- Step E Preparation of ethyl l-[[3-(3,3,3-trifluoro-2-hydroxypropoxy)phenyl]methyl]-177- pyrazole-4-carboxylate
- Step F Preparation of ethyl 1 - [[3-(3, 3, 3-trifluoiO-2,2-dihydiOxypiOpoxy)phcnyl] methyl J-
- Step A Preparation of ethyl 1 -(hydroxymethyl)- 1 //-pyrazolc-4-carboxylatc
- Step B Preparation of ethyl 1 -(chloromcthyl)- 1 //-pyrazolc-4-carboxylatc
- Step C Preparation of ethyl 1 -[(4-mcthoxyphcnoxy)mcthylJ- 1 A-pyrazolc-4-carboxylatc
- Step D Preparation of ethyl 1 -[(4-hydiOxyphenoxy)methylJ- 1 A-pyrazole-4-carboxy late
- Step E Preparation of ethyl l-[[4-(3,3,3-trifluoro-2-hydroxypropoxy)phenoxy]methyl]-
- Step L Preparation of ethyl l-[[4-(3,3,3-trifluoro-2,2-dihydroxypropoxy)phenoxy]- mcthylj- 1 //-pyrazolc-4-carboxylatc
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062988098P | 2020-03-11 | 2020-03-11 | |
US202062991306P | 2020-03-18 | 2020-03-18 | |
PCT/US2021/021806 WO2021183707A2 (en) | 2020-03-11 | 2021-03-11 | Fungicidal halomethyl ketones and hydrates and their mixtures |
Publications (2)
Publication Number | Publication Date |
---|---|
EP4117432A2 true EP4117432A2 (en) | 2023-01-18 |
EP4117432A4 EP4117432A4 (en) | 2024-03-27 |
Family
ID=78401931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21766969.6A Pending EP4117432A4 (en) | 2020-03-11 | 2021-03-11 | Fungicidal halomethyl ketones and hydrates and their mixtures |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP4117432A4 (en) |
JP (1) | JP2023518172A (en) |
CN (1) | CN115460921A (en) |
AU (1) | AU2021233845A1 (en) |
BR (1) | BR112022018107A2 (en) |
CA (1) | CA3174932A1 (en) |
CO (1) | CO2022014334A2 (en) |
TW (1) | TW202200013A (en) |
UY (1) | UY39123A (en) |
WO (1) | WO2021183707A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR127103A1 (en) | 2021-09-22 | 2023-12-20 | Syngenta Crop Protection Ag | FUNGICIDE COMPOSITIONS |
TW202342431A (en) | 2022-02-15 | 2023-11-01 | 美商富曼西公司 | Fungicidal halomethyl ketones, hydrates and enol ethers |
WO2024013106A1 (en) | 2022-07-11 | 2024-01-18 | Syngenta Crop Protection Ag | Fungicidal compositions |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6414179B1 (en) * | 2000-02-18 | 2002-07-02 | Bristol-Myers Squibb Company | Alpha-and beta-substituted trifluoromethyl ketones as phospholipase inhibitors |
TWI504350B (en) * | 2010-09-01 | 2015-10-21 | Du Pont | Fungicidal pyrazoles and their mixtures |
CN102924201B (en) * | 2012-10-24 | 2015-02-25 | 大连理工大学 | Method for preparing perfluoroalkyl alkyl ketone compound |
TW201418223A (en) * | 2012-10-25 | 2014-05-16 | Du Pont | Substituted tolyl fungicides |
WO2017085100A1 (en) * | 2015-11-19 | 2017-05-26 | Basf Se | Substituted oxadiazoles for combating phytopathogenic fungi |
JP2019516670A (en) * | 2016-04-12 | 2019-06-20 | シンジェンタ パーティシペーションズ アーゲー | Microbicidal oxadiazole derivative |
EP3529246B1 (en) * | 2016-10-24 | 2023-10-18 | FMC Corporation | Oxadiazoles having fungicidal activity |
MA53606A (en) * | 2018-09-14 | 2021-12-22 | Fmc Corp | HALOMETHYL KETONE AND HYDRATES FUNGICIDES |
-
2021
- 2021-03-03 TW TW110107422A patent/TW202200013A/en unknown
- 2021-03-10 UY UY0001039123A patent/UY39123A/en unknown
- 2021-03-11 EP EP21766969.6A patent/EP4117432A4/en active Pending
- 2021-03-11 BR BR112022018107A patent/BR112022018107A2/en unknown
- 2021-03-11 CN CN202180031728.9A patent/CN115460921A/en active Pending
- 2021-03-11 WO PCT/US2021/021806 patent/WO2021183707A2/en unknown
- 2021-03-11 AU AU2021233845A patent/AU2021233845A1/en active Pending
- 2021-03-11 JP JP2022554496A patent/JP2023518172A/en active Pending
- 2021-03-11 CA CA3174932A patent/CA3174932A1/en active Pending
-
2022
- 2022-10-07 CO CONC2022/0014334A patent/CO2022014334A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA3174932A1 (en) | 2021-09-16 |
JP2023518172A (en) | 2023-04-28 |
CO2022014334A2 (en) | 2022-10-31 |
WO2021183707A8 (en) | 2022-11-03 |
WO2021183707A2 (en) | 2021-09-16 |
TW202200013A (en) | 2022-01-01 |
BR112022018107A2 (en) | 2022-11-08 |
AU2021233845A1 (en) | 2022-10-20 |
UY39123A (en) | 2021-10-29 |
CN115460921A (en) | 2022-12-09 |
WO2021183707A3 (en) | 2021-11-11 |
EP4117432A4 (en) | 2024-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11634393B2 (en) | Substituted tolyl fungicides | |
EP3606920B1 (en) | Fungicidal oxadiazoles | |
EP3558984B1 (en) | Fungicidal oxadiazoles | |
AU2019337618A1 (en) | Fungicidal halomethyl ketones and hydrates | |
WO2021183707A2 (en) | Fungicidal halomethyl ketones and hydrates and their mixtures | |
US20230165251A1 (en) | Substituted tolyl fungicides and their mixtures | |
EP4361150A2 (en) | Fungicidal oxadiazoles and their mixtures | |
US11540518B2 (en) | Fungicidal oxadiazoles | |
WO2021146522A1 (en) | Fungicidal amides | |
TWI843750B (en) | Fungicidal halomethyl ketones and hydrates | |
US20240122180A1 (en) | Fungicidal halomethyl ketones and hydrates and their mixtures | |
WO2023158602A1 (en) | Fungicidal halomethyl ketones, hydrates and enol ethers | |
US20240166638A1 (en) | Fungicidal oxadiazoles | |
WO2017105999A1 (en) | N-[[5-[[[1-(phenyl)ethylidene]amino]oxy]phenyl]-methyl]carbamate derivatives and related compounds as fungicides for controlling plant diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20221004 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20240227 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A01N 47/14 20060101ALI20240221BHEP Ipc: A01N 47/10 20060101ALI20240221BHEP Ipc: A01N 43/90 20060101ALI20240221BHEP Ipc: A01N 43/82 20060101ALI20240221BHEP Ipc: A01N 43/80 20060101ALI20240221BHEP Ipc: A01N 43/713 20060101ALI20240221BHEP Ipc: A01N 43/653 20060101ALI20240221BHEP Ipc: A01N 43/647 20060101ALI20240221BHEP Ipc: A01N 43/54 20060101ALI20240221BHEP Ipc: A01N 43/50 20060101ALI20240221BHEP Ipc: A01N 43/44 20060101ALI20240221BHEP Ipc: A01N 37/40 20060101ALI20240221BHEP Ipc: A01N 37/34 20060101ALI20240221BHEP Ipc: A01N 37/32 20060101ALI20240221BHEP Ipc: A01N 37/06 20060101ALI20240221BHEP Ipc: A01P 3/00 20060101ALI20240221BHEP Ipc: A01N 43/78 20060101ALI20240221BHEP Ipc: A01N 43/76 20060101ALI20240221BHEP Ipc: A01N 43/56 20060101ALI20240221BHEP Ipc: A01N 43/28 20060101AFI20240221BHEP |